Here you can type a keyword, INN or CAS numbers.
You can find your search history by clicking on the button on the left side of the search bar.
You can use the Advanced search by clicking on the Advanced search button, or you can use the following shortcuts:
Notas.
1. A) Cualquier producto que responda al texto específico de una de las partidas 28.44 ó 28.45, se clasifica en dicha partida, y no en otra de la Nomenclatura, excepto los minerales de metales radiactivos.
B) Salvo lo dispuesto en el apartado A) anterior, cualquier producto que responda al texto específico de una de las partidas 28.43, 28.46 ó 28.52, se clasifica en dicha partida y no en otra de esta Sección.
2. Sin perjuicio de las disposiciones de la Nota 1 anterior, cualquier producto que, por su presentación en forma de dosis o por su acondicionamiento para la venta al por menor, pueda incluirse en una de las partidas 30.04, 30.05, 30.06, 32.12, 33.03, 33.04, 33.05, 33.06, 33.07, 35.06, 37.07 ó 38.08, se clasifica en dicha partida y no en otra de la Nomenclatura.
3. Los productos presentados en surtidos que consistan en varios componentes distintos comprendidos, en su totalidad o en parte, en esta Sección e identificables como destinados, después de mezclados, a constituir un producto de las Secciones VI o VII, se clasifican en la partida correspondiente a este último producto siempre que los componentes sean:
a) netamente identificables, por su acondicionamiento, como destinados a utilizarse juntos sin previo reacondicionamiento;
b) presentados simultáneamente;
c) identificables, por su naturaleza o por sus cantidades respectivas, como complementarios unos de otros.
Notas.
1. Salvo disposición en contrario, las partidas de este Capítulo comprenden solamente:
a) los compuestos orgánicos de constitución química definida presentados aisladamente, aunque contengan impurezas;
b) las mezclas de isómeros de un mismo compuesto orgánico (aunque contengan impurezas), excepto las mezclas de isómeros de los hidrocarburos acíclicos saturados o sin saturar (distintos de los estereoisómeros) (Capítulo 27);
c) los productos de las partidas 29.36 a 29.39, los éteres, acetales y ésteres de azúcares, y sus sales, de la partida 29.40, y los productos de la partida 29.41, aunque no sean de constitución química definida;
d) las disoluciones acuosas de los productos de los apartados a), b) o c) anteriores;
e) las demás disoluciones de los productos de los apartados a), b) o c) anteriores, siempre que constituyan un modo de acondicionamiento usual e indispensable, exclusivamente motivado por razones de seguridad o necesidades del transporte y que el disolvente no haga al producto más apto para usos determinados que para uso general;
f) los productos de los apartados a), b), c), d) o e) anteriores, con adición de un estabilizante (incluido un antiaglomerante) indispensable para su conservación o transporte;
g) los productos de los apartados a), b), c), d), e) o f) anteriores, con adición de una sustancia antipolvo, un colorante o un odorante para facilitar su identificación o por razones de seguridad, siempre que estas adiciones no hagan al producto más apto para usos determinados que para uso general;
h) los productos siguientes, normalizados, para la producción de colorantes azoicos: sales de diazonio, copulantes utilizados para estas sales y aminas diazotables y sus sales.
2. Este Capítulo no comprende:
a) los productos de la partida 15.04 y el glicerol en bruto de la partida 15.20;
b) el alcohol etílico (partidas 22.07 ó 22.08);
c) el metano y el propano (partida 27.11);
d) los compuestos de carbono mencionados en la Nota 2 del Capítulo 28;
e) Los productos inmunológicos de la partida 30.02;
f) la urea (partidas 31.02 ó 31.05);
g) las materias colorantes de origen vegetal o animal (partida 32.03), las materias colorantes orgánicas sintéticas, los productos orgánicos sintéticos de los tipos utilizados como agentes de avivado fluorescente o como luminóforos (partida 32.04), así como los tintes y demás materias colorantes presentados en formas o en envases para la venta al por menor (partida 32.12);
h) las enzimas (partida 35.07);
ij) el metaldehído, la hexametilentetramina y los productos análogos, en tabletas, barritas o formas similares que impliquen su utilización como combustibles, así como los combustibles líquidos y los gases combustibles licuados, en recipientes de los tipos utilizados para cargar o recargar encendedores o mecheros, de capacidad inferior o igual a 300 cm3 (partida 36.06);
k) los productos extintores presentados como cargas para aparatos extintores o en granadas o bombas extintoras de la partida 38.13; los productos borradores de tinta acondicionados en envases para la venta al por menor, clasificados en la partida 38.24;
l) los elementos de óptica, por ejemplo, los de tartrato de etilendiamina (partida 90.01).
3. Cualquier producto que pueda clasificarse en dos o más partidas de este Capítulo se clasificará en la última de dichas partidas por orden de numeración.
4. En las partidas 29.04 a 29.06, 29.08 a 29.11 y 29.13 a 29.20, cualquier referencia a los derivados halogenados, sulfonados, nitrados o nitrosados, se aplica también a los derivados mixtos, tales como los sulfohalogenados, nitrohalogenados, nitrosulfonados o nitrosulfohalogenados.
Para la aplicación de la partida 29.29, los grupos nitrados o nitrosados no deben considerarse funciones nitrogenadas.
En las partidas 29.11, 29.12, 29.14, 29.18 y 29.22, se entiende por funciones oxigenadas (grupos orgánicos característicos que contienen oxígeno) solamente las citadas en los textos de las partidas 29.05 a 29.20.
5. A) Los ésteres de compuestos orgánicos de función ácida de los Subcapítulos I a VII con compuestos orgánicos de los mismos Subcapítulos se clasifican con el compuesto que pertenezca a la última partida por orden de numeración de dichos Subcapítulos.
B) Los ésteres del alcohol etílico con compuestos orgánicos de función ácida de los Subcapítulos I a VII se clasifican en la partida de los compuestos de función ácida correspondientes.
C) Salvo lo dispuesto en la Nota 1 de la Sección VI y en la Nota 2 del Capítulo 28:
1°) las sales inorgánicas de compuestos orgánicos, tales como los compuestos de función ácida, función fenol o función enol o las bases orgánicas, de los Subcapítulos I a X o de la partida 29.42, se clasifican en la partida que comprenda el compuesto orgánico correspondiente;
2°) las sales formadas por reacción entre compuestos orgánicos de los Subcapítulos I a X o de la partida 29.42 se clasifican en la última partida del Capítulo por orden de numeración que comprenda la base o el ácido del que se han formado (incluidos los compuestos de función fenol o de función enol);
3°) los compuestos de coordinación, excepto los productos del Subcapítulo XI o la partida 29.41, se clasifican en la partida del Capítulo 29 situada en último lugar por orden de numeración entre las correspondientes a los fragmentos formados por escisión de todos los enlaces metálicos, excepto los enlaces metal-carbono.
D) Los alcoholatos metálicos se clasifican en la misma partida que los alcoholes correspondientes, salvo en el caso del etanol (partida 29.05).
E) Los halogenuros de los ácidos carboxílicos se clasifican en la misma partida que los ácidos correspondientes.
6. Los compuestos de las partidas 29.30 y 29.31 son compuestos orgánicos cuya molécula contiene, además de átomos de hidrógeno, oxígeno o nitrógeno, átomos de otros elementos no metálicos o de metales, tales como azufre, arsénico o plomo, directamente unidos al carbono.
Las partidas 29.30 (tiocompuestos orgánicos) y 29.31 (los demás compuestos órgano-inorgánicos) no comprenden los derivados sulfonados o halogenados ni los derivados mixtos, que solo contengan en unión directa con el carbono, los átomos de azufre o de halógeno que les confieran el carácter de tales, sin considerar el hidrógeno, oxígeno o nitrógeno que puedan contener.
7. Las partidas 29.32, 29.33 y 29.34 no comprenden los epóxidos con tres átomos en el ciclo, los peróxidos de cetonas, los polímeros cíclicos de los aldehídos o de los tioaldehídos, los anhídridos de ácidos carboxílicos polibásicos, los ésteres cíclicos de polialcoholes o de polifenoles con ácidos polibásicos ni las imidas de ácidos polibásicos.
Las disposiciones anteriores solo se aplican cuando la estructura heterocíclica proceda exclusivamente de las funciones ciclantes antes citadas.
8. En la partida 29.37:
a) el término hormonas comprende los factores liberadores o estimulantes de hormonas, los inhibidores de hormonas y los antagonistas de hormonas (antihormonas);
b) la expresión utilizados principalmente como hormonas, se aplica no solamente a los derivados de hormonas y a sus análogos estructurales utilizados principalmente por su acción hormonal, sino también a los derivados y análogos estructurales de hormonas utilizados principalmente como intermedios en la síntesis de productos de esta partida.
°
° °
Notas de subpartida.
1. Dentro de una partida de este Capítulo, los derivados de un compuesto químico (o de un grupo de compuestos químicos) se clasifican en la misma subpartida que el compuesto (o grupo de compuestos), siempre que no estén comprendidos más específicamente en otra subpartida y que no exista una subpartida residual «Los/Las demás» en la serie de subpartidas involucradas.
2. La Nota 3 del Capítulo 29 no se aplica a las subpartidas de este Capítulo.
LIST
OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ARRANGED IN ALPHABETICAL ORDER BY TYPE OF DRUG
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol
|
Name |
HS subheading |
CAS No. |
Convention Schedule No |
|
Acetorphine (INN) |
2939.19 |
25333-77-1 |
4 |
|
Acetorphine hydrochloride |
2939.19 |
25333-78-2 |
4 |
|
Acetyldihydrocodeine |
2939.19 |
3861-72-1 |
2 |
|
Acetyldihydrocodeine hydrochloride |
2939.19 |
|
2 |
|
Acetylmethadol (INN) |
2922.19 |
509-74-0 |
1 |
|
Acetyl-a-methylfentanyl |
2933.39 |
|
4 |
|
Acetylmorphine |
2939.19 |
|
1 |
|
3-Acetylmorphine |
2939.19 |
|
1 |
|
6-Acetylmorphine |
2939.19 |
2784-73-8 |
1 |
|
Alfentanil (INN) |
2933.33 |
71195-58-9 |
1 |
|
Alfentanil hydrochloride |
2933.33 |
69049-06-5 |
1 |
|
Allylprodine (INN) |
2933.39 |
25384-17-2 |
1 |
|
Allylprodine hydrochloride |
2933.39 |
|
1 |
|
Alphacetylmethadol (INN) |
2922.19 |
17199-58-5 |
1 |
|
L-Alphacetylmethadol |
2922.19 |
|
|
|
Alphacetylmethadol hydrochloride |
2922.19 |
|
1 |
|
Alphameprodine (INN) |
2933.39 |
468-51-9 |
1 |
|
Alphamethadol (INN) |
2922.19 |
17199-54-1 |
1 |
|
Alphaprodine (INN) |
2933.39 |
77-20-3 |
1 |
|
Alphaprodine hydrochloride |
2933.39 |
561-78-4 |
1 |
|
Anileridine (INN) |
2933.33 |
144-14-9 |
1 |
|
Anileridine dihydrochloride |
2933.33 |
126-12-5 |
1 |
|
Anileridine phosphate |
2933.39 |
4268-37-5 |
1 |
|
Benzethidine (INN) |
2933.39 |
3691-78-9 |
1 |
|
Benzethidine hydrobromide |
2933.39 |
|
1 |
|
Benzethidine hydrochloride |
2933.39 |
|
1 |
|
Benzoylmorphine |
2939.19 |
|
1 |
|
Benzylmorphine |
2939.19 |
14297-87-1 |
1 |
|
Benzylmorphine hydrochloride |
2939.19 |
630-86-4 |
1 |
|
Benzylmorphine mesilate |
2939.19 |
|
1 |
|
Betacetylmethadol (INN) |
2922.19 |
17199-59-6 |
1 |
|
Betameprodine (INN) |
2933.39 |
468-50-8 |
1 |
|
Betamethadol (INN) |
2922.19 |
17199-55-2 |
1 |
|
Betaprodine (INN) |
2933.39 |
468-59-7 |
1 |
|
Betaprodine hydrochloride |
2933.39 |
|
1 |
|
Bezitramide (INN) |
2933.33 |
15301-48-1 |
1 |
|
Bezitramide hydrochloride |
2933.33 |
|
1 |
|
Cannabis |
1211.90 |
|
4 |
|
Cannabis extracts and tinctures |
1302.19 |
|
|
|
Cannabis oil |
1302.19 |
|
|
|
Cannabis resin |
1301.90 |
|
|
|
Clonitazene (INN) |
2933.99 |
3861-76-5 |
1 |
|
Clonitazene hydrochloride |
2933.99 |
|
1 |
|
Clonitazene mesilate |
2933.99 |
|
1 |
|
Coca leaf |
1211.30 |
|
|
|
Cocaine |
2939.71 |
50-36-2 |
1 |
|
d-Cocaine |
2939.71 |
478-73-9 |
|
|
Cocaine benzoate |
2939.71 |
|
1 |
|
Cocaine borate |
2939.71 |
|
1 |
|
Cocaine citrate |
2939.71 |
|
1 |
|
Cocaine formate |
2939.71 |
|
1 |
|
Cocaine hydriodide |
2939.71 |
|
1 |
|
Cocaine hydrobromide |
2939.71 |
|
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Cocaine hydrochloride |
2939.71 |
53-21-4 |
1 |
|
Cocaine lactate |
2939.71 |
1 |
|
|
Cocaine nitrate |
2939.71 |
5913-62-2 |
1 |
|
Cocaine salicylate |
2939.71 |
5913-64-4 |
1 |
|
Cocaine sulfate |
2939.71 |
1 |
|
|
Cocaine tartrate |
2939.71 |
1 |
|
|
Codeine |
2939.11 |
76-57-3 |
2 |
|
Codeine acetate |
2939.11 |
2 |
|
|
Codeine allobarbiturate |
2939.11 |
2 |
|
|
Codeine barbiturate |
2939.11 |
2 |
|
|
Codeine camphosulfonate |
2939.11 |
2 |
|
|
Codeine citrate |
2939.11 |
5913-73-5 |
2 |
|
Codeine cyclobarbiturate |
2939.11 |
2 |
|
|
Codeine cyclopentobarbiturate |
2939.11 |
2 |
|
|
Codeine 6-glucuronide |
2939.19 |
2 |
|
|
Codeine hydrobromide |
2939.11 |
125-25-7 |
2 |
|
Codeine hydrochloride |
2939.11 |
1422-07-7 |
2 |
|
Codeine hydroiodide |
2939.11 |
125-26-8 |
2 |
|
Codeine methylbromide |
2939.19 |
125-27-9 |
2 |
|
Codeine phenobarbiturate |
2939.11 |
2 |
|
|
Codeine phosphate |
2939.11 |
52-28-8 |
2 |
|
Codeine resinate |
3003.49 |
2 |
|
|
Codeine salicylate |
2939.11 |
2 |
|
|
Codeine sulfate |
2939.11 |
1420-53-7 |
2 |
|
Codeine-N-oxide |
2939.19 |
3688-65-1 |
|
|
Codeine-N-oxide hydrochloride |
2939.19 |
||
|
Codoxime (INN) |
2939.19 |
7125-76-0 |
1 |
|
Concentrate of poppy straw |
1302.11 |
1 |
|
|
2939.11 |
|
||
|
Desomorphine (INN) |
2939.19 |
427-00-9 |
4 |
|
Desomorphine hydrobromide |
2939.19 |
4 |
|
|
Desomorphine hydrochloride |
2939.19 |
4 |
|
|
Desomorphine sulfate |
2939.19 |
4 |
|
|
Dextromoramide (INN) |
2934.91 |
357-56-2 |
1 |
|
Dextromoramide dihydrochloride |
2934.91 |
1 |
|
|
Dextromoramide hydrochloride |
2934.91 |
1 |
|
|
Dextromoramide hydrogen tartrate (bitartrate) |
2934.99 |
2922-44-3 |
1 |
|
Dextropropoxyphene (INN) |
2922.14 |
469-62-5 |
2 |
|
Dextropropoxyphene hydrochloride |
2922.14 |
1639-60-7 |
2 |
|
Napsilate |
2922.19 |
17140-78-2 |
2 |
|
Dextropropoxyphene resinate |
3003.90 |
2 |
|
|
Diampromide (INN) |
2924.29 |
552-25-0 |
1 |
|
Diampromide sulfate |
2924.29 |
1 |
|
|
Diethylthiambutene (INN) |
2934.99 |
86-14-6 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Diethylthiambutene hydrochloride |
2934.99 |
132-19-4 |
1 |
|
Difenoxin (INN) |
2933.33 |
28782-42-5 |
1 |
|
Difenoxin hydrochloride |
2933.33 |
35607-36-4 |
1 |
|
Dihydrocodeine (INN) |
2939.11 |
125-28-0 |
2 |
|
Dihydrocodeine hydrochloride |
2939.11 |
2 |
|
|
Dihydrocodeine hydrogen tartrate (bitartrate) |
2939.11 |
5965-13-9 |
2 |
|
Dihydrocodeine phosphate |
2939.11 |
24204-13-5 |
2 |
|
Dihydrocodeine resinate |
3003.49 |
2 |
|
|
Dihydrocodeine thiocyanate |
2939.11 |
2 |
|
|
Dihydroisomorphin |
2939.19 |
||
|
Dihydroisomorphin 6-glucuronide |
2939.19 |
||
|
Dihydromorphine |
2939.19 |
509-60-4 |
2 |
|
Dihydromorphine hydriodide |
2939.19 |
2 |
|
|
Dihydromorphine hydrochloride |
2939.19 |
1421-28-9 |
2 |
|
Dihydromorphine picrate |
2939.19 |
2 |
|
|
Dimenoxadol (INN) |
2922.19 |
509-78-4 |
1 |
|
Dimenoxadol hydrochloride |
2922.19 |
242-75-1 |
1 |
|
Dimepheptanol (INN) |
2922.19 |
545-90-4 |
1 |
|
Dimepheptanol hydrochloride |
2922.19 |
1 |
|
|
Dimethylthiambutene (INN) |
2934.99 |
524-84-5 |
1 |
|
Dimethylthiambutene hydrochloride |
2934.99 |
1 |
|
|
Dioxaphetyl butyrate (INN) |
2934.99 |
467-86-7 |
1 |
|
Dioxaphetyl butyrate hydrochloride |
2934.99 |
1 |
|
|
Diphenoxylate (INN) |
2933.33 |
915-30-0 |
1 |
|
Diphenoxylate hydrochloride |
2933.33 |
3810-80-8 |
1 |
|
Dipipanone (INN) |
2933.33 |
467-83-4 |
1 |
|
Dipipanone hydrobromide |
2933.33 |
1 |
|
|
Dipipanone hydrochloride |
2933.33 |
75783-06-1 |
1 |
|
Drotebanol (INN) |
2933.49 |
3176-03-2 |
1 |
|
Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine |
2939.71 |
481-37-8 |
1 |
|
Ecgonine benzoylethyl ester |
2939.71 |
1 |
|
|
Ecgonine benzoylpropyl ester |
2939.71 |
1 |
|
|
Ecgonine cinnamoylmethyl ester |
2939.71 |
1 |
|
|
Ecgonine 2,6-dimethyl-benzoylmethyl ester |
2939.71 |
1 |
|
|
Ecgonine hydrochloride |
2939.71 |
1 |
|
|
Ecgonine methyl ester |
2939.71 |
1 |
|
|
Ecgonine methyl ester hydrochloride |
2939.71 |
1 |
|
|
Ecgonine phenylacetyl-methyl ester |
2939.71 |
1 |
|
|
Ethylmethylthiambutene (INN) |
2934.99 |
441-61-2 |
1 |
|
Ethylmethylthiambutene hydrochloride |
2934.99 |
1 |
|
|
Ethylmorphine |
2939.11 |
76-58-4 |
2 |
|
Ethylmorphine camphosulfonate |
2939.11 |
2 |
|
|
Ethylmorphine hydrobromide |
2939.11 |
2 |
|
|
Ethylmorphine hydrochloride |
2939.11 |
125-30-4 |
2 |
|
Ethylmorphine methyliodide |
2939.19 |
2 |
|
|
Ethylmorphine phenobarbiturate |
2939.11 |
2 |
|
|
Etonitazene (INN) |
2933.99 |
911-65-9 |
1 |
|
Etonitazene hydrochloride |
2933.99 |
1 |
|
|
Etorphine (INN) |
2939.11 |
14521-96-1 |
4 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Etorphine hydrochloride |
2939.11 |
13764-49-3 |
4 |
|
Etorphine 3-methyl ether |
2939.19 |
4 |
|
|
Etoxeridine (INN) |
2933.39 |
469-82-9 |
1 |
|
Etoxeridine hydrochloride |
2933.39 |
1 |
|
|
Fentanyl (INN) |
2933.33 |
437-38-7 |
1 |
|
Fentanyl citrate |
2933.33 |
990-73-8 |
1 |
|
p-Fluorofentanyl |
2933.39 |
4 |
|
|
p-Fluorofentanyl hydrochloride |
2933.39 |
4 |
|
|
Furethidine (INN) |
2934.99 |
2385-81-1 |
1 |
|
Furethidine hydrobromide |
2934.99 |
1 |
|
|
Furethidine methyliodide |
2934.99 |
1 |
|
|
Furethidine picrate |
2934.99 |
1 |
|
|
Heroin |
2939.11 |
561-27-3 |
4 |
|
Heroin hydrochloride |
2939.11 |
1502-95-0 |
4 |
|
Heroin methyliodide |
2939.19 |
4 |
|
|
Hydrocodone (INN) |
2939.11 |
125-29-1 |
1 |
|
Hydrocodone citrate |
2939.11 |
1 |
|
|
Hydrocodone hydriodide |
2939.11 |
1 |
|
|
Hydrocodone hydrochloride |
2939.11 |
25968-91-6 |
1 |
|
Hydrocodone hydrogen tartrate (bitartrate) |
2939.11 |
143-71-5 |
1 |
|
Hydrocodone methyliodide |
2939.19 |
1 |
|
|
Hydrocodone phosphate |
2939.11 |
34366-67-1 |
1 |
|
Hydrocodone resinate |
3003.49 |
1 |
|
|
Hydrocodone terephthalate |
2939.11 |
1 |
|
|
Hydromorphinol (INN) |
2939.19 |
2183-56-4 |
1 |
|
Hydromorphinol hydrochloride |
2939.19 |
1 |
|
|
Hydromorphinol hydrogen tartrate (bitartrate) |
2939.19 |
1 |
|
|
Hydromorphone (INN) |
2939.11 |
466-99-9 |
1 |
|
Hydromorphone hydrochloride |
2939.11 |
71-68-1 |
1 |
|
Hydromorphone sulfate |
2939.11 |
1 |
|
|
Hydromorphone terephthalate |
2939.11 |
1 |
|
|
ß-Hydroxyfentanyl |
2933.39 |
4 |
|
|
ß-Hydroxyfentanyl hydrochloride |
2933.39 |
4 |
|
|
(+)-cis-ß-Hydroxy-3-m-methylfentanyl |
2933.39 |
||
|
ß-Hydroxy-3-methylfentanyl |
2933.39 |
4 |
|
|
ß-Hydroxy-3-methylfentanyl hydrochloride |
2933.39 |
4 |
|
|
Hydroxypethidine (INN) |
2933.39 |
468-56-4 |
1 |
|
Hydroxypethidine hydrochloride |
2933.39 |
1 |
|
|
Isomethadone (INN) |
2922.39 |
466-40-0 |
1 |
|
d-Isomethadone |
2922.39 |
||
|
l-Isomethadone |
2922.39 |
||
|
Isomethadone hydrobromide |
2922.39 |
1 |
|
|
Isomethadone hydrochloride |
2922.39 |
1 |
|
|
Ketobemidone (INN) |
2933.33 |
469-79-4 |
4 |
|
Ketobemidone hydrochloride |
2933.33 |
5965-49-1 |
4 |
|
Levacetylmethadol (INN) |
2922.19 |
34433-66-4 |
1 |
|
Levomethorphan (INN)(*) |
2933.49 |
125-70-2 |
1 |
|
Levomethorphan hydrobromide |
2933.49 |
1 |
|
|
Levomethorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Levomoramide (INN) |
2934.99 |
5666-11-5 |
1 |
|
Levomoramide dihydrochloride |
2934.99 |
1 |
|
|
Levophenacylmorphan (INN) |
2933.49 |
10061-32-2 |
1 |
|
Levophenacylmorphan hydrochloride |
2933.49 |
1 |
|
|
Levophenacylmorphan methylsulfonate |
2933.49 |
1 |
|
|
Levopropoxyphene (INN) |
2922.19 |
2338-37-6 |
|
|
Levorphanol (INN)(**) |
2933.41 |
77-07-6 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Levorphanol hydrogen tartrate (bitartrate) |
2933.41 |
125-72-4 |
1 |
|
Levorphanol hydrochloride |
2933.41 |
1 |
|
|
Metazocine (INN) |
2933.39 |
3734-52-9 |
1 |
|
Metazocine hydrobromide |
2933.39 |
1 |
|
|
Metazocine hydrochloride |
2933.39 |
1 |
|
|
l-Methadol |
2922.19 |
||
|
Methadone (INN) |
2922.31 |
76-99-3 |
1 |
|
d-Methadone |
2922.31 |
||
|
l-Methadone |
2922.31 |
1 |
|
|
Methadone hydrobromide |
2922.31 |
1 |
|
|
Methadone hydrochloride |
2922.31 |
1095-90-5 |
1 |
|
Methadone hydrogen tartrate (bitartrate) |
2922.31 |
1 |
|
|
d-Methadone hydrochloride |
2922.31 |
||
|
l-Methadone hydrochloride |
2922.31 |
||
|
l-Methadone hydrogen tartrate (bitartrate) |
2922.31 |
1 |
|
|
Methadone (INN) intermediate4-cyano-2-dimethylamino-4,4-diphenylbutane or 2-dimethylamino-4,4-diphenyl-4-cyanobutane |
2926.30 |
1 |
|
|
Methyldesorphine (INN) |
2939.19 |
16008-36-9 |
1 |
|
Methyldesorphine hydrochloride |
2939.19 |
1 |
|
|
Methyldihydromorphine (INN) |
2939.19 |
509-56-8 |
1 |
|
3-Methylfentanyl |
2933.39 |
4 |
|
|
3-Methylfentanyl hydrochloride |
2933.39 |
|
4 |
|
α-Methylfentanyl |
2933.39 |
4 |
|
|
α-Methylfentanyl hydrochloride |
2933.39 |
4 |
|
|
α-Methylthiofentanyl |
2934.99 |
1 |
|
|
α-Methylthiofentanyl hydrochloride |
2934.99 |
1 |
|
|
3-Methylthiofentanyl |
2934.99 |
4 |
|
|
3-Methylthiofentanyl hydrochloride |
2934.99 |
4 |
|
|
(+)-cis-3-Methylthiofentanyl |
2934.99 |
4 |
|
|
(+)-cis-3-Methylthioentanyl-hydrochloride |
2934.99 |
||
|
Metopon (INN) |
2939.19 |
143-52-2 |
1 |
|
Metopon hydrochloride |
2939.19 |
1 |
|
|
Moramide intermediate |
2934.99 |
1 |
|
|
Morpheridine (INN) |
2934.99 |
469-81-8 |
1 |
|
Morpheridine dihydrochloride |
2934.99 |
1 |
|
|
Morpheridine picrate |
2934.99 |
1 |
|
|
Morphine |
2939.11 |
57-27-2 |
1 |
|
Morphine acetate |
2939.11 |
596-15-6 |
1 |
|
Morphine citrate |
2939.11 |
1 |
|
|
Morphine 3,6-diglucuronide |
2939.19 |
1 |
|
|
Morphine dimethyl ether |
2939.19 |
||
|
Morphine gluconate |
2939.19 |
1 |
|
|
Morphine 3-glucuronide |
2939.19 |
1 |
|
|
Morphine 3-glucuronide |
2939.19 |
1 |
|
|
Morphine 6-glucuronide |
2939.19 |
1 |
|
|
Morphine 3-β-D-glucuronide |
2939.19 |
1 |
|
|
Morphine 6-β-D-glucuronide |
2939.19 |
1 |
|
|
Morphine hydriodide |
2939.11 |
1 |
|
|
Morphine hydrobromide |
2939.11 |
630-81-9 |
1 |
|
Morphine hydrochloride |
2939.11 |
52-26-6 |
1 |
|
Morphine hypophosphite |
2939.11 |
1 |
|
|
Morphine isobutyrate |
2939.11 |
1 |
|
|
Morphine lactate |
2939.11 |
1 |
|
|
Morphine meconate |
2939.11 |
1 |
|
|
Morphine methobromide |
2939.19 |
1 |
|
|
Morphine methylbromide |
2939.19 |
1 |
|
|
Morphine methylchoride |
2939.19 |
1 |
|
|
Morphine methyliodide |
2939.19 |
1 |
|
|
Morphine methylsulfonate |
2939.11 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Morphine mucate |
2939.11 |
1 |
|
|
Morphine nitrate |
2939.11 |
596-16-7 |
1 |
|
Morphine phenylpropionate |
2939.11 |
1 |
|
|
Morphine phosphate |
2939.11 |
1 |
|
|
Morphine phthalate |
2939.11 |
1 |
|
|
Morphine stearate |
2939.11 |
1 |
|
|
Morphine sulfate |
2939.11 |
64-31-3 |
1 |
|
Morphine tartrate |
2939.11 |
302-31-8 |
1 |
|
Morphine valerate |
2939.11 |
1 |
|
|
Morphine-N-oxide |
2939.19 |
639-46-3 |
1 |
|
Morphine-N-oxide quinate |
2939.19 |
1 |
|
|
MPPP |
2933.39 |
4 |
|
|
MPPP hydrochloride |
2933.39 |
4 |
|
|
MT-45 |
2933.59 |
1 |
|
|
Myrophine (INN) |
2939.19 |
467-18-5 |
1 |
|
Myrophine hydrochloride |
2939.19 |
1 |
|
|
Nicocodine (INN) |
2939.19 |
3688-66-2 |
2 |
|
Nicocodine hydrochloride |
2939.19 |
2 |
|
|
Nicodicodine (INN) |
2939.19 |
808-24-2 |
2 |
|
Nicomorphine (INN) |
2939.11 |
639-48-5 |
1 |
|
Nicomorphine hydrochloride |
2939.11 |
1 |
|
|
Noracymethadol (INN) |
2922.19 |
1477-39-0 |
1 |
|
Noracymethadol gluconate |
2922.19 |
1 |
|
|
Noracymethadol hydrochloride |
2922.19 |
1 |
|
|
Norcodeine (INN) |
2939.19 |
467-15-2 |
2 |
|
Norcodeine acetate |
2939.19 |
2 |
|
|
Norcodeine hydriodide |
2939.19 |
2 |
|
|
Norcodeine hydrochloride |
2939.19 |
14648-14-7 |
2 |
|
Norcodeine nitrate |
2939.19 |
2 |
|
|
Norcodeine platinichloride |
2843.90 |
2 |
|
|
Norcodeine sulfate |
2939.19 |
2 |
|
|
Norlevorphanol (INN) |
2933.49 |
1531-12-0 |
1 |
|
Norlevorphanol hydrobromide |
2933.49 |
1 |
|
|
Norlevorphanol hydrochloride |
2933.49 |
1 |
|
|
Normethadone (INN) |
2922.31 |
467-85-6 |
1 |
|
Normethadone 2,6-di-tert- butylnaphthalenedisulfonate |
2922.31 |
1 |
|
|
Normethadone hydrobromide |
2922.31 |
1 |
|
|
Normethadone hydrochloride |
2922.31 |
847-84-7 |
1 |
|
Normethadone methyliodide |
2922.39 |
1 |
|
|
Normethadone oxalate |
2922.31 |
1 |
|
|
Normethadone picrate |
2922.31 |
1 |
|
|
Normethadone (INN) intermediate |
2926.90 |
||
|
Normorphine (INN) |
2939.19 |
466-97-7 |
1 |
|
Normorphine hydrochloride |
2939.19 |
1 |
|
|
Norpipanone (INN) |
2933.39 |
561-48-8 |
1 |
|
Norpipanone hydrobromide |
2933.39 |
1 |
|
|
Norpipanone hydrochloride |
2933.39 |
1 |
|
|
Ocfentanil (INN) |
2933.39 |
1 |
|
|
Opium |
1302.11 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Opium, mixed alkaloids of |
1302.11(*) |
||
|
2939.11(**) |
|||
|
Opium, prepared |
1302.19 |
||
|
2939.11 |
|||
|
Oripavine |
2939.19 |
|
1 |
|
Oripavine hydrochloride |
2939.19 |
|
1 |
|
Oxycodone (INN) |
2939.11 |
76-42-6 |
1 |
|
Oxycodone camphosulfonate |
2939.11 |
1 |
|
|
Oxycodone hydrochloride |
2939.11 |
124-90-3 |
1 |
|
Oxycodone hydrogen tartrate (bitartrate) |
2939.11 |
1 |
|
|
Oxycodone pectinate |
2939.11 |
1 |
|
|
Oxycodone phenylpropionate |
2939.11 |
1 |
|
|
Oxycodone phosphate |
2939.11 |
1 |
|
|
Oxycodone terephthalate |
2939.11 |
1 |
|
|
Oxymorphone (INN) |
2939.11 |
76-41-5 |
1 |
|
Oxymorphone hydrochloride |
2939.11 |
357-07-3 |
1 |
|
Papaver bracteatum |
1211.90 |
||
|
PEPAP |
2933.39 |
4 |
|
|
PEPAP hydrochloride |
2933.39 |
4 |
|
|
Pethidine (INN) |
2933.33 |
57-42-1 |
1 |
|
Pethidine hydrochloride |
2933.33 |
50-13-5 |
1 |
|
Pethidine (INN) intermediate A |
2933.33 |
1 |
|
|
Pethidine (INN) intermediate B |
2933.39 |
1 |
|
|
Pethidine intermediate B hydrobromide |
2933.39 |
1 |
|
|
Pethidine intermediate B hydrochloride |
2933.39 |
1 |
|
|
Pethidine (INN) intermediate C |
2933.39 |
1 |
|
|
Phenadoxone (INN) |
2934.99 |
467-84-5 |
1 |
|
Phenadoxone hydrochloride |
2934.99 |
545-91-5 |
1 |
|
Phenampromide (INN) |
2933.39 |
129-83-9 |
1 |
|
Phenampromide hydrochloride |
2933.39 |
1 |
|
|
Phenazocine (INN) |
2933.39 |
127-35-5 |
1 |
|
Phenazocine hydrobromide |
2933.39 |
1 |
|
|
Phenazocine hydrochloride |
2933.39 |
7303-75-5 |
1 |
|
Phenazocine mesilate |
2933.39 |
1 |
|
|
Phenomorphan (INN) |
2933.49 |
468-07-5 |
1 |
|
Phenomorphan hydrobromide |
2933.49 |
1 |
|
|
Phenomorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Phenomorphan methylbromide |
2933.49 |
1 |
|
|
Phenoperidine (INN) |
2933.33 |
562-26-5 |
1 |
|
Phenoperidine hydrochloride |
2933.33 |
3627-49-4 |
1 |
|
Pholcodine (INN) |
2939.11 |
509-67-1 |
2 |
|
Pholcodine hydrogen tartrate (bitartrate) |
2939.11 |
2 |
|
|
Pholcodine citrate |
2939.11 |
2 |
|
|
Pholcodine guaiacolsulfonate |
2939.11 |
2 |
|
|
Pholcodine hydrochloride |
2939.11 |
2 |
|
|
Pholcodine phenylacetate |
2939.11 |
2 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Pholcodine phosphate |
2939.11 |
2 |
|
|
Pholcodine sulfonate |
2939.11 |
2 |
|
|
Pholcodine tartrate |
2939.11 |
7369-11-1 |
2 |
|
Piminodine (INN) |
2933.39 |
13495-09-5 |
1 |
|
Piminodine dihydrochloride |
2933.39 |
1 |
|
|
Piminodine esilate |
2933.39 |
7081-52-9 |
1 |
|
Piritramide (INN) |
2933.33 |
302-41-0 |
1 |
|
Poppy straw |
1211.40 |
||
|
Proheptazine (INN) |
2933.99 |
77-14-5 |
1 |
|
Proheptazine citrate |
2933.99 |
1 |
|
|
Proheptazine hydrobromide |
2933.99 |
1 |
|
|
Proheptazine hydrochloride |
2933.99 |
1 |
|
|
Properidine (INN) |
2933.39 |
561-76-2 |
1 |
|
Properidine hydrochloride |
2933.39 |
1 |
|
|
Propiram (INN) |
2933.33 |
15686-91-6 |
2 |
|
Propiram fumarate |
2933.33 |
2 |
|
|
Racemethorphan (INN) |
2933.49 |
510-53-2 |
1 |
|
Racemethorphan hydrobromide |
2933.49 |
1 |
|
|
Racemethorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Racemoramide (INN) |
2934.99 |
545-59-5 |
1 |
|
Racemoramide dihydrochloride |
2934.99 |
1 |
|
|
Racemoramide hydrogen tartrate (bitartrate) |
2934.99 |
1 |
|
|
Racemoramide tartrate |
2934.99 |
1 |
|
|
Racemorphan (INN) |
2933.49 |
297-90-5 |
1 |
|
Racemorphan hydrobromide |
2933.49 |
1 |
|
|
Racemorphan hydrochloride |
2933.49 |
1 |
|
|
Racemorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Remifentanil (INN) |
2933.39 |
1 |
|
|
Remifentanil hydrochloride |
2933.39 |
1 |
|
|
Sufentanil (INN) |
2934.91 |
56030-54-7 |
1 |
|
Sufentanil citrate |
2934.91 |
1 |
|
|
Thebacon (INN) |
2939.11 |
466-90-0 |
1 |
|
Thebacon hydrochloride |
2939.11 |
20236-82-2 |
1 |
|
Thebaine hydrochloride |
2939.11 |
1 |
|
|
Thebaine hydrogen tartrate (bitartrate) |
2939.11 |
1 |
|
|
Thebaine oxalate |
2939.11 |
1 |
|
|
Thebaine salicylate |
2939.11 |
1 |
|
|
Tetrahydrofuranylfentanyl |
2934.99 |
1 |
|
|
Thiofentanyl |
2934.99 |
4 |
|
|
Thiofentanyl acetate |
2934.99 |
1 |
|
|
Thiofentanyl hydrochloride |
2934.99 |
4 |
|
|
Tilidine (INN) |
2922.44 |
20380-58-9 |
1 |
|
Tilidine hydrochloride |
2922.44 |
27107-79-5 |
1 |
|
Trimeperidine (INN) |
2933.33 |
64-39-1 |
1 |
|
Trimeperidine hydrochloride |
2933.33 |
125-80-4 |
1 |
|
U-47700 |
2924.29 |
|
1 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
AB-CHMINACA |
2933.99 |
|
2 |
|
AB-PINACA |
2933.99 |
|
2 |
|
Allobarbital (INN) |
2933.53 |
52-43-7 |
4 |
|
Allobarbital aminophenazone |
2933.54 |
4 |
|
|
Alprazolam (INN) |
2933.91 |
28981-97-7 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
AM-2201; JWH-2201 |
2933.99 |
|
2 |
|
Amfepramone (INN) |
2922.31 |
90-84-6 |
4 |
|
Amfepramone glutamate |
2922.42 |
4 |
|
|
Amfepramone hydrochloride |
2922.31 |
134-80-5 |
4 |
|
Amfepramone resinate |
3003.90 |
4 |
|
|
Amfetamine (INN) |
2921.46 |
300-62-9 |
2 |
|
Amfetamine acetylsalicylate |
2921.46 |
2 |
|
|
Amfetamine adipate |
2921.46 |
2 |
|
|
Amfetamine p-aminophenylacetate |
2922.49 |
2 |
|
|
Amfetamine aspartate |
2922.49 |
2 |
|
|
Amfetamine p-chloro- phenoxyacetate |
2921.46 |
2 |
|
|
Amfetamine hydrochloride |
2921.46 |
2 |
|
|
Amfetamine hydrogen tartrate (bitartrate) |
2921.46 |
2 |
|
|
Amfetamine pentobarbiturate |
2933.54 |
2 |
|
|
Amfetamine phosphate |
2921.46 |
139-10-6 |
2 |
|
Amfetamine resinate |
3003.90 |
2 |
|
|
Amfetamine sulfate |
2921.46 |
60-13-9 |
2 |
|
Amfetamine tannate |
3201.90 |
2 |
|
|
Amfetamine tartrate |
2921.46 |
2 |
|
|
Amineptine (INN) |
2922.49 |
2 |
|
|
Amineptine hydrochloride |
2922.49 |
2 |
|
|
Aminorex (INN) |
2934.91 |
2207-50-3 |
4 |
|
Aminorex fumarate |
2934.91 |
|
4 |
|
Aminorex hydrochloride |
2934.91 |
|
4 |
|
Amobarbital (INN) |
2933.53 |
57-43-2 |
3 |
|
Amobarbital resinate |
3003.90 |
3 |
|
|
Amobarbital sodium |
2933.53 |
64-43-7 |
3 |
|
Barbital (INN) |
2933.53 |
57-44-3 |
4 |
|
Barbital calcium |
2933.53 |
4 |
|
|
Barbital magnesium |
2933.53 |
4 |
|
|
Barbital sodium |
2933.53 |
144-02-5 |
4 |
|
Benzfetamine (INN) |
2921.46 |
156-08-1 |
4 |
|
Benzfetamine hydrochloride |
2921.46 |
5411-22-3 |
4 |
|
N-Benzylpiperazine; Benzylpiperazine; BZP |
2933.59 |
|
2 |
|
N-Benzylpiperazine dihydrochloride |
2933.59 |
|
2 |
|
N-Benzylpiperazine hydrochloride |
2933.59 |
|
2 |
|
25B-NBOMe; 2C-B-NBOMe |
2922.29 |
|
1 |
|
25B-NBOMe hydrochloride |
2922.29 |
|
1 |
|
Brolamfetamine (INN) (DOB) |
2922.29 |
64638-07-9 |
1 |
|
Brolamfetamine (DOB) hydrochloride |
2922.29 |
1 |
|
|
Bromazepam (INN) |
2933.33 |
1812-30-2 |
4 |
|
Brotizolam (INN) |
2934.91 |
57801-81-7 |
4 |
|
Buprenorphine (INN) |
2939.11 |
52485-79-7 |
3 |
|
Buprenorphine hydrochloride |
2939.11 |
53152-21-9 |
3 |
|
Buprenorphine hydrogen tartrate (bitartrate) |
2939.11 |
3 |
|
|
Buprenorphine sulfate |
2939.11 |
3 |
|
|
Butalbital (INN) |
2933.53 |
77-26-9 |
3 |
|
Butobarbital |
2933.53 |
77-28-1 |
4 |
|
Camazepam (INN) |
2933.91 |
36104-80-0 |
4 |
|
Cathine (INN) |
2939.43 |
492-39-7 |
3 |
|
Cathine hydrochloride |
2939.43 |
2153-98-2 |
3 |
|
Cathine phenobarbiturate |
2939.43 |
3 |
|
|
Cathine resinate |
3003.49 |
3 |
|
|
Cathine sulfate |
2939.43 |
3 |
|
|
Cathinone (INN) |
2939.79 |
71031-15-7 |
1 |
|
Cathinone hydrochloride |
2939.79 |
1 |
|
|
2C-B |
2922.29 |
2 |
|
|
2C-B hydrochloride |
2922.29 |
2 |
|
|
Chlordiazepoxide (INN) |
2933.91 |
58-25-3 |
4 |
|
Chlordiazepoxide dibunate |
2933.91 |
4 |
|
|
Chlordiazepoxide hydrochloride |
2933.91 |
438-41-5 |
4 |
|
Clobazam (INN) |
2933.72 |
22316-47-8 |
4 |
|
Clonazepam (INN) |
2933.91 |
1622-61-3 |
4 |
|
Clorazepate |
2933.91 |
4 |
|
|
Clorazepate dipotassium |
2933.91 |
57109-90-7 |
4 |
|
Clorazepate monopotassium |
2933.91 |
5991-71-9 |
4 |
|
Clotiazepam (INN) |
2934.91 |
33671-46-4 |
4 |
|
Cloxazolam (INN) |
2934.91 |
24166-13-0 |
4 |
|
Cyclobarbital (INN) |
2933.53 |
52-31-3 |
3 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Cyclobarbital calcium |
2933.53 |
5897-20-1 |
3 |
|
Delorazepam (INN) |
2933.91 |
2894-67-9 |
4 |
|
DET |
2939.79 |
61-51-8 |
1 |
|
DET hydrochloride |
2939.79 |
1 |
|
|
Dexamfetamine (INN) |
2921.46 |
51-64-9 |
2 |
|
Dexamfetamine adipate |
2921.46 |
2 |
|
|
Dexamfetamine carboxy- methylcellulose |
3912.31 |
2 |
|
|
Dexamfetamine hydrochloride |
2921.46 |
405-41-4 |
2 |
|
Dexamfetamine hydrogen tartrate (bitartrate) |
2921.46 |
2 |
|
|
Dexamfetamine pento- barbiturate |
2933.54 |
2 |
|
|
Dexamfetamine phosphate |
2921.46 |
7528-00-9 |
2 |
|
Dexamfetamine resinate |
3003.90 |
2 |
|
|
Dexamfetamine saccharate |
2921.49 |
2 |
|
|
Dexamfetamine sulfate |
2921.46 |
51-63-8 |
2 |
|
Dexamfetamine tannate |
3201.90 |
2 |
|
|
Diazepam (INN) |
2933.91 |
439-14-5 |
4 |
|
DMA |
2922.29 |
1 |
|
|
DMA hydrochloride |
2922.29 |
1 |
|
|
DMHP |
2932.99 |
1 |
|
|
DMT |
2939.79 |
61-50-7 |
1 |
|
DMT hydrochloride |
2939.79 |
1 |
|
|
DMT methyliodide |
2939.79 |
1 |
|
|
DOET |
2922.29 |
1 |
|
|
DOET hydrochloride |
2922.29 |
1 |
|
|
Estazolam (INN) |
2933.91 |
29975-16-4 |
4 |
|
Ethchlorvynol (INN) |
2905.51 |
113-18-8 |
4 |
|
Ethinamate (INN) |
2924.24 |
126-52-3 |
4 |
|
Ethyl loflazepate (INN) |
2933.91 |
29177-84-2 |
4 |
|
N-Ethyl MDA |
2932.99 |
1 |
|
|
N-Ethyl MDA hydrochloride |
2932.99 |
1 |
|
|
Eticyclidine (PCE) (INN) |
2921.49 |
2201-15-2 |
1 |
|
Eticyclidine (PCE) hydrochloride |
2921.49 |
1 |
|
|
Etilamfetamine (INN) |
2921.46 |
457-87-4 |
4 |
|
Etilamfetamine hydrochloride |
2921.46 |
4 |
|
|
Etryptamine (INN) |
2939.79 |
1 |
|
|
Etryptamine acetate |
2939.79 |
1 |
|
|
Etryptamine hydrochloride |
2939.79 |
1 |
|
|
5F-ADB; 5F-MDMB-PINACA |
2933.99 |
2 |
|
|
5F-APINACA; 5F-AKB-48 |
2933.99 |
2 |
|
|
5F-PB-22 |
2933.49 |
2 |
|
|
Fencamfamin (INN) |
2921.46 |
1209-98-9 |
4 |
|
Fencamfamin hydrochloride |
2921.46 |
2240-14-4 |
4 |
|
Fenetylline (INN) |
2939.51 |
3736-08-1 |
2 |
|
Fenetylline hydrochloride |
2939.51 |
1892-80-4 |
2 |
|
Fenproporex (INN) |
2926.30 |
15686-61-0 |
4 |
|
Fenproporex diphenylacetate |
2926.30 |
4 |
|
|
Fenproporex hydrochloride |
2926.30 |
18305-29-8 |
4 |
|
Fenproporex resinate |
3003.90 |
4 |
|
|
Fludiazepam (INN) |
2933.91 |
3900-31-0 |
4 |
|
Flunitrazepam (INN) |
2933.91 |
1622-62-4 |
4 |
|
Flurazepam (INN) |
2933.91 |
17617-23-1 |
4 |
|
Flurazepam dihydrochloride |
2933.91 |
1172-18-5 |
4 |
|
Flurazepam hydrochloride |
2933.91 |
36105-20-1 |
4 |
|
Glutethimide (INN) |
2925.12 |
77-21-4 |
3 |
|
Halazepam (INN) |
2933.91 |
23092-17-3 |
4 |
|
Haloxazolam (INN) |
2934.91 |
59128-97-1 |
4 |
|
N-Hydroxy MDA |
2932.99 |
1 |
|
|
N-Hydroxy MDA hydrochloride |
2932.99 |
1 |
|
|
Ketazolam (INN) |
2934.91 |
27223-35-4 |
4 |
|
Lefetamine (INN) |
2921.46 |
7262-75-1 |
4 |
|
Lefetamine hydrochloride |
2921.46 |
14148-99-3 |
4 |
|
Levamfetamine (INN) |
2921.46 |
156-34-3 |
2 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Levamfetamine alginate |
3913.10 |
2 |
|
|
Levamfetamine succinate |
2921.49 |
5634-40-2 |
2 |
|
Levamfetamine sulfate |
2921.49 |
2 |
|
|
Levometamfetamine |
2939.71 |
2 |
|
|
Levometamfetamine hydrochloride |
2939.71 |
2 |
|
|
Loprazolam (INN) |
2933.55 |
61197-73-7 |
4 |
|
Loprazolam mesilate |
2933.55 |
4 |
|
|
Lorazepam (INN) |
2933.91 |
846-49-1 |
4 |
|
Lorazepam acetate |
2933.91 |
4 |
|
|
Lorazepam mesilate |
2933.91 |
4 |
|
|
Lorazepam pivalate |
2933.91 |
4 |
|
|
Lormetazepam (INN) |
2933.91 |
848-75-9 |
4 |
|
Lysergide (INN), LSD, LSD-25 |
2939.69 |
50-37-3 |
1 |
|
(+)-Lysergide tartrate |
2939.69 |
1 |
|
|
Mazindol (INN) |
2933.91 |
22232-71-9 |
4 |
|
MDMA |
2932.99 |
1 |
|
|
MDMA hydrochloride |
2932.99 |
1 |
|
|
Mecloqualone (INN) |
2933.55 |
340-57-8 |
2 |
|
Mecloqualone hydrochloride |
2933.55 |
2 |
|
|
Medazepam (INN) |
2933.91 |
2898-12-6 |
4 |
|
Medazepam dibunate |
2933.91 |
4 |
|
|
Medazepam hydrochloride |
2933.91 |
4 |
|
|
Mefenorex (INN) |
2921.46 |
17243-57-1 |
4 |
|
Mefenorex hydrochloride |
2921.46 |
4 |
|
|
Meprobamate (INN) |
2924.11 |
57-53-4 |
4 |
|
Mescaline |
2939.79 |
54-04-6 |
1 |
|
Mescaline aurichloride |
2843.30 |
1 |
|
|
Mescaline hydrochloride |
2939.79 |
832-92-8 |
1 |
|
Mescaline picrate |
2939.79 |
1 |
|
|
Mescaline platinichloride |
2843.90 |
1 |
|
|
Mescaline sulfate |
2939.79 |
1152-76-7 |
1 |
|
Mesocarb (INN) |
2934.71 |
34262-84-5 |
4 |
|
Metamfetamine (INN) |
2939.71 |
537-46-2 |
2 |
|
Metamfetamine hydrochloride |
2939.71 |
51-57-0 |
2 |
|
Metamfetamine hydrogen tartrate (bitartrate) |
2939.71 |
2 |
|
|
Metamfetamine racemate |
2939.71 |
4846-07-5 |
2 |
|
Metamfetamine sulfate |
2939.71 |
2 |
|
|
Methaqualone (INN) |
2933.55 |
72-44-6 |
2 |
|
Methaqualone hydrochloride |
2933.55 |
340-56-7 |
2 |
|
Methaqualone resinate |
3003.90 |
2 |
|
|
Methylaminorex |
2934.99 |
1 |
|
|
Methylaminorex hydrochloride |
2934.99 |
1 |
|
|
Methylphenidate (INN) |
2933.33 |
113-45-1 |
2 |
|
Methylphenidate hydrochloride |
2933.33 |
298-59-9 |
2 |
|
Methylphenobarbital (INN) |
2933.53 |
115-38-8 |
4 |
|
Methylphenobarbital sodium |
2933.53 |
4 |
|
|
Methyprylon (INN) |
2933.72 |
125-64-4 |
4 |
|
Midazolam (INN) |
2933.91 |
59467-70-8 |
4 |
|
Midazolam hydrochloride |
2933.91 |
4 |
|
|
Midazolam maleate |
2933.91 |
4 |
|
|
MMDA |
2932.99 |
1 |
|
|
MMDA hydrochloride |
2932.99 |
1 |
|
|
Nimetazepam (INN) |
2933.91 |
2011-67-8 |
4 |
|
Nitrazepam (INN) |
2933.91 |
146-22-5 |
4 |
|
Nordazepam (INN) |
2933.91 |
1088-11-5 |
4 |
|
Oxazepam (INN) |
2933.91 |
604-75-1 |
4 |
|
Oxazepam acetate |
2933.91 |
4 |
|
|
Oxazepam hemisuccinate |
2933.91 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Oxazepam succinate |
2933.91 |
4 |
|
|
Oxazepam valproate |
2933.91 |
4 |
|
|
Oxazolam (INN) |
2934.91 |
24143-17-7 |
4 |
|
Parahexyl |
2932.99 |
1 |
|
|
Pemoline (INN) |
2934.91 |
2152-34-3 |
4 |
|
Pemoline copper |
2934.91 |
4 |
|
|
Pemoline iron |
2934.91 |
4 |
|
|
Pemoline magnesium |
2934.91 |
4 |
|
|
Pemoline nickel |
2934.91 |
4 |
|
|
Pentazocine (INN) |
2933.33 |
359-83-1 |
3 |
|
Pentazocine hydrochloride |
2933.33 |
3 |
|
|
Pentazocine lactate |
2933.33 |
17146-95-1 |
3 |
|
Pentobarbital (INN) |
2933.53 |
76-74-4 |
3 |
|
Pentobarbital calcium |
2933.53 |
7563-42-0 |
3 |
|
Pentobarbital sodium |
2933.53 |
57-33-0 |
3 |
|
Phencyclidine (INN) (PCP) |
2933.33 |
77-10-1 |
2 |
|
Phencyclidine hydrobromide |
2933.33 |
2 |
|
|
Phencyclidine hydrochloride |
2933.33 |
956-90-1 |
2 |
|
Phendimetrazine (INN) |
2934.91 |
634-03-7 |
4 |
|
Phendimetrazine hydrochloride |
2934.91 |
4 |
|
|
Phendimetrazine hydrogen tartrate (bitartrate) |
2934.91 |
50-58-8 |
4 |
|
Phendimetrazine pamoate |
2934.91 |
4 |
|
|
Phenmetrazine (INN) |
2934.91 |
134-49-6 |
2 |
|
Phenmetrazine hydrochloride |
2934.91 |
1707-14-8 |
2 |
|
Phenmetrazine hydrogen tartrate (bitartrate) |
2934.91 |
2 |
|
|
Phenmetrazine sulfate |
2934.91 |
2 |
|
|
Phenmetrazine teoclate |
2939.59 |
13931-75-4 |
2 |
|
Phenobarbital (INN) |
2933.53 |
50-06-6 |
4 |
|
Phenobarbital ammonium |
2933.53 |
4 |
|
|
Phenobarbital calcium |
2933.53 |
58766-25-9 |
4 |
|
Phenobarbital diethylamine |
2933.53 |
4 |
|
|
Phenobarbital diethylaminoethanol |
2933.53 |
4 |
|
|
Phenobarbital lysidine |
2933.53 |
4 |
|
|
Phenobarbital magnesium |
2933.53 |
4 |
|
|
Phenobarbital propylhexedrine |
2933.53 |
4 |
|
|
Phenobarbital quinidine |
2939.20 |
4 |
|
|
Phenobarbital sodium, magnesium |
2933.53 |
4 |
|
|
Phenobarbital sodium (INN) |
2933.53 |
57-30-7 |
4 |
|
Phenobarbital sparteine |
2939.79 |
4 |
|
|
Phenobarbital tetramethyl- ammonium |
2933.53 |
4 |
|
|
Phenobarbital yohimbine |
2939.79 |
4 |
|
|
Phentermine (INN) |
2921.46 |
122-09-8 |
4 |
|
Phentermine hydrochloride |
2921.46 |
1197-21-3 |
4 |
|
Phentermine resinate |
3003.90 |
4 |
|
|
Pinazepam (INN) |
2933.91 |
52463-83-9 |
4 |
|
Pipradrol (INN) |
2933.33 |
467-60-7 |
4 |
|
Pipradrol hydrochloride |
2933.33 |
71-78-3 |
4 |
|
PMA |
2922.29 |
1 |
|
|
PMA hydrochloride |
2922.29 |
1 |
|
|
Prazepam (INN) |
2933.91 |
2955-38-6 |
4 |
|
Psilocine, psilotsin |
2939.79 |
1 |
|
|
Psilocine, psilotsin hydrochloride |
2939.79 |
1 |
|
|
Psilocybine (INN) |
2939.79 |
520-52-5 |
1 |
|
Psilocybine hydrochloride |
2939.79 |
1 |
|
|
Pyrovalerone (INN) |
2933.91 |
3563-49-3 |
4 |
|
Pyrovalerone hydrochloride |
2933.91 |
1147-62-2 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Rolicyclidine (INN) (PHP, PCPY) |
2933.99 |
2201-39-0 |
1 |
|
Secbutabarbital (INN) |
2933.53 |
125-40-6 |
4 |
|
Secbutabarbital sodium |
2933.53 |
4 |
|
|
Secobarbital (INN) |
2933.53 |
76-73-3 |
2 |
|
Secobarbital calcium |
2933.53 |
2 |
|
|
Secobarbital resinate |
3003.90 |
2 |
|
|
Secobarbital sodium |
2933.53 |
309-43-3 |
2 |
|
STP, DOM |
2922.29 |
15588-95-1 |
1 |
|
STP, DOM hydrochloride |
2922.29 |
1 |
|
|
Temazepam (INN) |
2933.91 |
846-50-4 |
4 |
|
Tenamfetamine (INN) (MDA) |
2932.99 |
51497-09-7 |
1 |
|
Tenamfetamine (MDA) hydrochloride |
2932.99 |
1 |
|
|
Tenocyclidine (INN) |
2934.99 |
21500-98-1 |
1 |
|
Tenocyclidine hydrochloride |
2934.99 |
1 |
|
|
Tetrahydrocannabinols, all isomers |
2932.95 |
various |
2 |
|
d-9-Tetrahydrocannabinol |
2932.95 |
1972-08-3 |
2 |
|
Tetrazepam (INN) |
2933.91 |
10379-14-3 |
4 |
|
TMA |
2922.29 |
1 |
|
|
TMA hydrochloride |
2922.29 |
1 |
|
|
Triazolam (INN) |
2933.91 |
28911-01-5 |
4 |
|
Vinylbital (INN) |
2933.53 |
2430-49-1 |
4 |
|
Zipeprol (INN) |
2933.55 |
34758-83-3 |
2 |
III. Precursors
|
Name |
HS subheading |
CAS No. |
|
Acetic anhydride |
2915.24 |
108-24-7 |
|
Acetone |
2914.11 |
67-64-1 |
|
N-Acetylanthranilic acid |
2924.23 |
89-52-1 |
|
alpha-Phenylacetoacetonitrile (APAAN) |
2926.40 |
4468-48-8 |
|
Anthranilic acid |
2922.43 |
118-92-3 |
|
Butanone (ethyl methyl ketone) |
2914.12 |
78-93-3 |
|
Diethyl ether |
2909.11 |
60-29-7 |
|
Ephedrine |
2939.41 |
299-42-3 |
|
Ephedrine hydrochloride |
2939.41 |
50-98-6 |
|
Ephedrine nitrate |
2939.41 |
81012-98-8 |
|
Ephedrine sulfate |
2939.41 |
134-72-5 |
|
Ergometrine (INN) |
2939.61 |
60-79-7 |
|
Ergometrine hydrochloride |
2939.61 |
74283-21-9 |
|
Ergometrine hydrogen maleate |
2939.61 |
129-51-1 |
|
Ergometrine oxalate |
2939.61 |
|
|
Ergometrine tartrate |
2939.61 |
129-50-0 |
|
Ergotamine (INN) |
2939.62 |
113-15-5 |
|
Ergotamine hydrochloride |
2939.62 |
|
|
Ergotamine succinate |
2939.62 |
|
|
Ergotamine tartrate |
2939.62 |
379-79-3 |
|
Hydrogen chloride (hydrochloric acid) |
2806.10 |
7647-01-0 |
|
Isosafrole |
2932.91 |
120-58-1 |
|
Lysergic acid |
2939.63 |
82-58-6 |
|
3,4-(Methylenedioxy)phenyl-2- propanone |
2932.92 |
4676-39-5 |
|
Norephedrine |
2939.44 |
14838-15-4 |
|
Norephedrine hydrochloride |
2939.44 |
154-41-6 |
|
Phenylacetone (benzyl methyl ketone, phenylpropan-2-one) |
2914.31 |
103-79-7 |
|
Phenylacetic acid |
2916.34 |
103-82-2 |
|
Piperidine |
2933.32 |
110-89-4 |
|
Piperidine aurichloride |
2843.30 |
|
|
Piperidine hydrochloride |
2933.32 |
6091-44-7 |
|
Piperidine hydrogen tartrate (bitartrate) |
2933.32 |
6091-46-9 |
|
Piperidine nitrate |
2933.32 |
6091-45-8 |
|
Piperidine phosphate |
2933.32 |
|
|
Piperidine picrate |
2933.32 |
6091-49-2 |
|
Piperidine platinichloride |
2843.90 |
|
|
Piperidine thiocyanate |
2933.32 |
22205-64-7 |
|
Piperonal |
2932.93 |
120-57-0 |
|
Potassium permanganate |
2841.61 |
7722-64-7 |
|
Pseudoephedrine (INN) |
2939.42 |
90-82-4 |
|
Pseudoephedrine hydrochloride |
2939.42 |
345-78-8 |
|
Pseudoephedrine sulfate |
2939.42 |
7460-12-0 |
|
Safrole |
2932.94 |
94-59-7 |
|
Sulphuric acid |
2807.00 |
7664-93-9 |
|
Toluene |
2902.30 |
108-88-3 |
______________________
LIST OF PRECURSORS AND ESSENTIAL CHEMICALS WHICH ARE MOST COMMONLY USED IN THE ILLEGAL PRODUCTION OF CERTAIN CONTROLLED SUBSTANCES
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
HEROIN or DIACETY- MORPHINE (2939.11) |
(i) Codeine (P) (2939.11) |
Codicept Coducept 7,8-Didehydro‑4,5- epoxy-3-methoxy-17-methylmorphinan-6-o1 Methylmorphine 3‑O‑Methylmorphine Morphinan‑6‑ol, 7,8‑ didehydro‑4,5‑epoxy‑ 3‑methoxy‑17‑methyl Morphine, 3-methyl ether Morphine monomethyl ether |
76‑57‑3 52‑28‑8 (S) |
|
(ii) Morphine (P) (2939.11) |
7,8‑Didehydro‑4,5‑ epoxy‑17‑methyl‑ morphinan‑3,6‑diol Morphinan‑3,6‑diol, 7,8‑didehydro‑4,5‑ epoxy‑17‑methyl |
57-27-2 (anhydrous) 6009-81-0 (monohydrate) |
|
|
(iii) Acetic anhydride (E) (2915.24) |
Acetanhydride Acetic oxide Acetyl oxide Ethanoic anhydride |
108‑24‑7 |
|
|
(iv) Acetyl chloride (E) (2915.90) |
Ethanoyl chloride |
75‑36‑5 |
|
|
(v) Ethylidene diacetate (E) (2915.39) |
Acetic acid, ethylidene ester 1,1‑Diacetoxyethane |
542‑10‑9 |
|
|
COCAINE or METHYL BENZOYL- ECGONINE (2939.71) |
(i) Acetone (E) (2914.11) |
2‑Propanone Dimethylketone β‑Ketopropane Pyroacetic ether Propane‑2‑one |
67‑64‑1 |
|
(ii) Diethyl ether (E) (2909.11) |
Ethyl ether Ether Ethoxyethane Ethyl oxide Diethyl oxide Anaesthetic ether |
60‑29‑7 |
|
|
(iii) Methyl ethyl ketone (MEK) (E) (2914.12) |
Butanone |
78‑93‑3 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
LYSERGIDE (INN) or LSD or N,N‑DIETHYL- LYSERGAMIDE (2939.69) |
(i) Ergotamine (INN) (P) (2939.62) |
5'‑Benzyl‑12'‑hydroxy‑ 2'‑ methylergotaman-3',6',18‑trione Ergotaman‑3',6',18‑ trione, 12'‑hydroxy‑2'‑ methyl‑5'‑ (phenylmethyl) 12'‑Hydroxy‑2'‑methyl-5'‑(phenylmethyl) ergotaman‑3',6', 18‑ trione Indolo[4,3‑fg]quinoline, ergotaman‑3',6',18‑ trione derivative 8H‑Oxazolo[3,2,‑a]- pyrrolo[2,1‑c]pyrazine, ergotaman‑3',6',18‑ trione derivative N‑(5‑Benzyl‑10b‑ hydroxy‑ 2‑methyl‑3,6-dioxoperhydrooxazolo- [3,2‑a]pyrrolo[2,1‑c]- pyrazin‑2‑yl)‑D‑ lysergamide Ergam Ergate Ergomar Ergostat Ergotamine bitartrate Ergotamine, tartrate (2 : 1) (S) Ergotamini tartras Ergotaman‑3',6',18‑ trione, 12'‑hydroxy‑2'-methyl‑5'‑(phenyl- methyl)‑, ‑2,3dihydroxy-butanedioate (2 : 1) (S) Ergotartrate Etin Exmigra Femergin Gotamine tartrate Gynergene Lingraine Lingran Medihaler Ergotamine Neo‑Ergotine Rigetamine Secagyne Secupan |
113‑15‑5 379‑79‑3 (S) |
|
(ii) Lysergamide (P) (2939.69) |
9,10‑Didehydro‑6‑ methylergoline‑8‑ carboxamide Ergine Ergoline‑8‑carboxamide, 9,10‑didehydro‑6‑methyl Indolo[4,3‑fg]quinoline, ergoline‑8-carboxamide derivative |
478‑94‑4 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
(iii) Lysergic acid (P) (2939.63) |
Ergoline‑8‑carboxylic acid, 9,10‑didehydro‑6‑ methyl- indolo [4,3‑fg] quinoline, ergoline‑8‑carboxylic acid derivative 4,6,6a,7,8,9‑Hexahydro‑ 7‑methylindolo‑[4,3‑fg]- quinoline‑9‑carboxylic acid 9,10‑Didehydro‑ 6‑methyl- ergoline‑8‑ carboxylic acid |
82‑58‑6 |
|
|
(iv) Methyl 6-methylnicotinate (P) (2933.39) |
Methyl 6‑methylpyridine‑3‑ carboxylate 6‑Methylnicotinic acid, methyl ester Nicotinic acid, 6‑methyl‑, methyl ester 3‑Pyridinecarboxylic acid, 6‑methyl‑, methyl ester |
5470‑70‑2 |
|
|
(v) Ergometrine (INN) (P) (2939.61) |
Ergonovine Ergobasine Ergotocine Ergostetrine Ergotrate Ergoklinine Syntometrine 9,10‑Didehydro‑N‑(2‑ hydroxy‑1‑methylethyl)‑ 6‑methylergoline‑8‑ carboxamide N‑(2‑Hydroxy‑1‑methyl‑ etethyl)lysergamide Lysergic acid, 2‑propanolamide |
60‑79‑7 60-79-7 |
|
|
Lysergic acid, 2‑hydroxy‑1‑methylethyl amide Hydroxypropyllyserg‑ amide Basergin Neofemergen Cornocentin Ermetrine |
129‑50‑0 (S) 129‑51‑1 (S) |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
AMFETAMINE (INN) (AMPHETAMINE) or α‑METHYL- PHENETHYLAMINE (2921.46) |
(i) Allylbenzene (P) (2902.90) |
3‑Phenylprop‑1‑ene |
300‑57‑2 |
|
(ii) Phenyl-acetone (P) (2914.31) |
P‑2‑P Phenylpropan‑2‑one 1‑Phenyl‑2‑oxopropane Benzyl methyl ketone BMK |
103-79-7 |
|
|
(iii) Cathine (INN) (P) (2939.43) |
Norpseudoephedrine Adiposetten N 2‑Amino‑1‑hydroxy‑1‑ phenylpropane 2‑Amino‑2‑methyl‑1‑ phenylethanol 2‑Amino‑1‑phenylpropan-1-ol Benzenemethanol, α‑(1‑aminoethyl) E 50 Exponcit Fugoa‑Depot Katine Miniscap M.D. Minusin(e) Norisoephedrine 1‑Phenyl‑2‑aminopropan-1-ol Phenylpropanolamine Pseudonorephedrin(e) Reduform |
37577-07-04 36393‑56‑3 492-39-7 |
|
|
(iv) Phenylacetic acid (P) (2916.34) |
Benzeneacetic acid α‑Toluic acid |
103‑82‑2 |
|
|
(v) Formamide (P) (2924.19) |
Methanamide Carbamaldehyde Formic acid amide |
75‑12‑7 |
|
|
(vi) Benzaldehyde (P) (2912.21) |
Benzoic aldehyde Benzenecarbonal |
100‑52‑7 |
|
|
(vii) Ammonium formate (E) (2915.12) |
― |
540‑69‑2 |
|
|
(viii) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(ix) Hydroxyl- ammonium chloride (E) (2825.10) |
Hydroxylamine hydrochloride Oxammonium hydro‑ chloride |
5470‑11‑1 |
|
|
(x) Trans-β-Methyl-styrene (P) (2902.90) |
1‑Phenylpropene Prop-1-enylbenzene |
873‑66‑5 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
METHYLENE DIOXYAMPHETA- MINE or MDA or α‑METHYL‑3,4‑ METHYLENE- DIOXYPHEN-ETHYLAMINE (2932.99) |
(i) Piperonal (P) (2932.93) |
1,3‑Benzodioxole‑5‑ carbaldehyde Protocatechualdehyde, methylene ether 1,3‑Benzodioxole‑5‑ carboxaldehyde 3,4‑(Methylenedioxy)-benzaldehyde Heliotropin Piperonylaldehyde Dioxymethyleneproto‑ catechuic aldehyde |
120‑57‑0 |
|
(ii) Safrole (P) (2932.94) |
5‑Allyl‑1,3-benzodioxole 1,2‑Methylenedioxy‑ 4‑prop‑2‑enylbenzene 5‑Prop‑2‑enyl‑1,3‑ benzodioxole |
94‑59‑7 |
|
|
(iii) Isosafrole (P) (2932.91) |
5‑Prop‑1‑enyl‑1,3-benzodioxole 1,2‑Methylenedioxy‑4-prop‑1‑enylbenzene |
120‑58‑1 |
|
|
(iv) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(v) 1-(1,3‑Benzo-dioxole‑5‑yl) propan‑2‑ one (P) (2932.92) |
3,4‑Methylenedioxy-phenylacetone 3,4‑Methylenedioxy-phenylpropane-2-one |
4676‑39‑5 |
|
|
(vi) Ammonium formate (E) (2915.12) |
― |
540‑69‑2 |
|
|
(vii) Hydroxyl-ammonium chloride (E) (2825.10) |
Hydroxylamine hydrochloride Oxammonium hydrochloride |
5470‑11‑1 |
|
|
(viii) Formamide (E) (2924.19) |
Methanamide Carbamaldehyde Formic acid amide |
75‑12‑7 |
|
|
METAMFETAMINE (INN) (METHAMPHE-TAMINE) or 2-METHYLAMINO-1- PHENYLPROPANE or DEOXYEPHEDRINE (2939.71) |
(i) Pheny-lacetone (P) (2914.31) |
P‑2‑P Phenylpropan‑2‑one 1‑Phenyl‑2‑oxopropane Benzyl methyl ketone BMK |
103‑79‑7 |
|
(ii) N‑Methyl-formamide (P) (2924.19) |
Methylformamide |
123‑39‑7 |
|
|
(iii) Benzyl chloride(P) (2903.99) |
(Chloromethyl)benzene α‑Chlorotoluene |
100‑44‑7 |
|
|
(iv) Ephedrine (P) (2939.41) |
1‑Phenyl‑1‑hydroxy‑2‑ methylaminopropane 2‑Methylamino‑1-phenyl-propan-1-ol |
299‑42‑3 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
(v) Methylamine (P) (2921.11) |
Aminomethane Monomethylamin(e) Methanamine |
74‑89‑5 |
|
|
(vi) Phenylacetic acid (P) (2916.34) (vii) Benzaldehyde (P) (2912.21) |
Benzeneacetic acid α‑Toluic acid Benzoic aldehyde Benzenecarbonal |
103‑82‑2 100‑52‑7 |
|
|
METHYLENE- DIOXYMETHAM-PHETAMINE or MDMA or α‑METHYL‑3,4-METHYLENE- DIOXYPHENETHYL- (METHYL)AMINE or XTC (Ecstasy) (2932.99) |
(i) Methylamine (E) (2921.11) |
Aminomethane Monomethylamine Methanamine |
74‑89‑5 |
|
(ii) Piperonal (P) (2932.93) |
1,3‑Benzodioxole‑5‑ carbaldehyde Protocatechualdehyde, methylene ether 1,3‑Benzodioxole‑5‑ carboxaldehyde 3,4‑(Methylenedioxy)‑ benzaldehyde Heliotropin Piperonylaldehyde Dioxymethyleneprotoca‑ technic aldehyde |
120‑57‑0 |
|
|
(iii) Safrole (P) (2932.94) |
5‑Allyl‑1,3‑ benzodioxole 1,2‑Methylenedioxy‑4-prop‑2‑enylbenzene 5‑Prop‑2‑enyl‑1,3‑ benzodioxole |
94‑59‑7 |
|
|
(iv) Isosafrole (P) (2932.91) |
5‑Prop‑1‑enyl‑1,3‑ benzodioxole 1,2‑Methylenedioxy‑4-prop‑1‑enylbenzene |
120‑58‑1 |
|
|
(v) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(vi) 1‑(1,3‑Benzo-dioxole‑5‑yl) propan- 2‑one (P) (2932.92) |
3,4‑Methylenedioxy‑ phenylacetone 3,4‑Methylenedioxyphenyl-propane-2-one |
4676‑39‑5 |
|
|
METHAQUALONE (INN) or 2‑METHYL‑3‑O-TOLYL‑4‑(3H)-QUINAZOLINONE (2933.55) |
(i) Anthranilic acid (P) (2922.43) |
o‑Aminobenzoic acid 2‑Aminobenzoic acid |
118‑92‑3 |
|
(ii) o‑Toluidine (P) (2921.43) |
o‑Aminotoluene 2‑Aminotoluene |
95‑53‑4 |
|
|
(iii) o‑Nitro- toluene (P) (2904.20) |
1-Methyl‑2-nitrobenzene 2‑Nitrotoluene |
88‑72‑2 |
|
|
(iv) Acetic anhydride (E) (2915.24) |
Acetanhydride Acetic oxide Acetyl oxide Ethanoic anhydride |
108‑24‑7 |
|
|
(v) 2‑Methyl‑ 1,3-benzoxazole (P) (2934.99) |
― |
95‑21‑6 |
|
|
(vi) 2-Acetamido- benzoic acid (P) (2924.23) |
2‑Acetylaminobenzoic acid o‑Acetylaminobenzoic acid N‑Acetylanthranilic acid |
89‑52‑1 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
MESCALINE or 3,4,5-TRIMETHOXY-PHENETHYLAMINE (2939.79) |
(i) 3,4,5-Trimethoxy-benzalde-hyde (P) (2912.49) (ii) 3,4,5‑ Trimethoxy-benzoic acid (P) (2918.99) |
3,4,5‑Trimethoxyformyl‑ benzene Gallic acid, trimethyl |
86‑81‑7 118‑41‑2 |
|
(iii) 3,4,5‑Trimeth-oxybenzoyl chloride (P) (2918.99) |
― |
4521‑61‑3 |
|
|
(iv) 3,4,5‑Trimeth-oxybenzyl alcohol (P) (2909.49) |
― |
3840‑31‑1 |
|
|
(v) Nitromethane (E) (2904.20) |
― |
75‑52‑5 |
|
|
PHENCYCLIDINE (INN) or PCP or 1‑(1‑PHENYLCYCLOHEXYL) PIPERIDINE (2933.33) |
(i) Piperidine (P) (2933.32) |
Hexahydropyridine Pentamethylenimine |
110‑89‑4 |
|
(ii) Cyclohexanone (P) (2914.22) |
Pimelic ketone Ketohexamethylene Hytrol o Anone Nadone |
108‑94‑1 |
|
|
(iii) Bromobenzene (P) (2903.99) |
Monobromobenzene Phenyl bromide |
108‑86‑1 |
______________________
CHEMICAL STRUCTURES OF CERTAIN PRODUCTS DESCRIBED IN THE EXPLANATORY NOTES TO CHAPTER 29
|
Page |
Heading |
Paragraph
|
Description in the Explanatory Notes |
Chemical Structure |
||||
|
General |
(G) |
Classification of esters, salts, co-ordination compounds and certain halides |
||||||
|
(1) |
Esters |
|||||||
|
VI-29-7 |
(a) |
|
||||||
|
(b) |
|
|||||||
|
(c) |
(Butyl hydrogenphthalate) 29.17 |
|||||||
|
(VI-29-7) |
(G) |
(1) |
(d) |
|
||||
|
(d) |
|
|||||||
|
(2) |
Salts |
|||||||
|
(a)(i) |
|
|||||||
|
(VI-29-7) |
(G) |
(2) |
(a)(i) |
|
||||
|
VI-29-8 |
(ii) |
|
||||||
|
(b)(i) |
|
|||||||
|
(ii) |
|
|||||||
|
VI-29-9 |
(G) |
(4) |
Halides of carboxylic acids (Isobutyryl chloride : 29.15) |
|
||||
|
29.02 |
Cyclic hydrocarbons |
|||||||
|
(B) |
CYCLOTERPENES |
|||||||
|
VI-2902-2 |
(3) |
Limonene |
|
|||||
|
(C) |
AROMATIC HYDROCARBONS |
|||||||
|
VI-2902-3 |
(I) |
(c) |
o-xylene |
|
||||
|
(d)(1) |
Styrene |
|
||||||
|
(VI-2902-3) |
(29.02) |
(C) |
(I) |
(d)(4) |
p-Cymene |
|
||
|
29.03 |
Halogenated derivatives of hydrocarbons |
|||||||
|
(F) |
HALOGANATED DERIVATIVES OF AROMATIC HYDROCARBONS |
|||||||
|
VI-2903-4 |
(6) |
DDT (ISO) (clofenotane (INN), 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane or dichlorodiphenyltrichloroethane) |
|
|||||
|
(11) |
2.2'.4.4'.5.5'-hexabromobiphenyl |
|
||||||
|
29.04 |
Sulphonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated |
|||||||
|
(A) |
SULPHONATED DERIVATIVES |
|||||||
|
VI-2904-1 |
(1) |
(a) |
Ethylenesulphonic acid |
|
||||
|
(B) |
NITRATED DERIVATIVES |
|||||||
|
(1) |
(d) |
Trinitromethane |
CH(NO2)3 |
|||||
|
(C) |
NITROSATED DERIVATIVES |
|||||||
|
VI-2904-2 |
(2) |
Nitrosotoluene |
|
|||||
|
(D) |
SULPHOHALOGENATED DERIVATIVES |
|||||||
|
(1) |
Chlorobenzenesulphonic acid |
|
||||||
|
(5) |
Perfluorooctane sulphonic acid (PFOS) |
|
||||||
|
3 |
29.05 |
Acyclic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives |
||||||
|
(B) |
UNSATURATED MONOHYDRIC ALCOHOLS |
|||||||
|
VI-2905-3 |
(1) |
Allyl alcohol |
|
|||||
|
(C) |
DIOLS AND OTHER POLYHYDRIC ALCOHOLS |
|||||||
|
(II) |
(4) |
Mannitol |
|
|||||
|
29.06 |
Cyclic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
CYCLANIC, CYCLENIC OR CYCLOTERPENIC ALCOHOLS AND THEIR HALOGENATED, SULPHONATED, NITRATED OR NITROSATED DERIVATIVES |
|||||||
|
VI-2906-1 |
(1) |
Menthol |
|
|||||
|
29.07 |
Phenols; phenol‑alcohols |
|||||||
|
(A) |
MONONUCLEAR MONOPHENOLS |
|||||||
|
VI-2907-2 |
(2) |
Cresol(s) |
(o-Cresol) (m-Cresol) (p-Cresol) |
|||||
|
(B) |
POLYNUCLEAR MONOPHENOLS |
|||||||
|
(1) |
Naphthol(s) |
(α-Naphthol) (β-Naphthol) |
||||||
|
(C) |
POLYPHENOLS |
|||||||
|
(1) |
Resorcinol |
|
||||||
|
VI-2907-3 |
(29.07) |
(C) |
(3) |
Bisphenol A |
|
|||
|
29.09 |
Ethers, ether‑alcohols, ether‑phenols, ether-alcohol-phenols, alcohol peroxides, ether peroxides, ketone peroxides (whether or not chemically defined), and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(C) |
ETHER-PHENOLS AND ETHER-ALCOHOL-PHENOLS |
|||||||
|
VI-2909-3 |
(1) |
Guaiacol |
|
|||||
|
(D) |
ALCOHOL PEROXIDES, ETHER PEROXIDES AND KETONE PEROXIDES |
|||||||
|
VI-2909-4 |
Ketone peroxides (Cyclohexanone peroxide) |
|
||||||
|
29.10 |
Epoxides, epoxyalcohols, epoxyphenols and epoxyethers, with a three-membered ring, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2910-1 |
(1) |
Oxirane |
|
|||||
|
29.11 |
Acetals and hemiacetals, whether or not with other oxygen function, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2911-1 |
(A) |
ACETALS AND HEMIACETALS |
|
|||||
|
Peroxyketals 1,1-di(tert-butylperoxy)cyclohexane |
|
|||||||
|
29.12 |
Aldehydes, whether or not with other oxygen function; cyclic polymers of aldehydes; paraformaldehyde |
|||||||
|
VI-2912-2 |
(A) |
ALDEHYDES |
|
|||||
|
VI-2912-3 |
(IV) |
(1) |
Benzaldehyde |
|
||||
|
(B) |
ALDEHYDE-ETHERS, ALDEHYDE-PHENOLS AND ALDEHYDES WITH OTHER OXYGEN FUNCTION |
|||||||
|
(4) |
Vanillin |
|
||||||
|
(C) |
CYCLIC POLYMERS OF ALDEHYDES |
|||||||
|
VI-2912-4 |
(1) |
Trioxan |
|
|||||
|
29.14 |
Ketones and quinones, whether or not with other oxygen function, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2914-2 |
(A) |
(I) |
KETONES |
|
||||
|
(8) |
Diacetyl |
|
||||||
|
(9) |
Acetylacetone |
|
||||||
|
(10) |
Acetonylacetone |
|
||||||
|
(II) |
(1) |
Camphor |
|
|||||
|
VI-2914-4 |
(29.14) |
(E) |
QUINONES |
|||||
|
(1) |
Anthraquinone |
|
||||||
|
|
(29.14) |
(F) |
|
|
QUINONE-ALCOHOLS, QUINONE-PHENOLS, QUINONE-ALDEHYDES AND OTHER OXYGEN FUNCTION QUINONES |
|||
|
(4) |
Coenzyme Q10 (ubidecarenone (INN)) |
|
||||||
|
29.15 |
Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2915-1 |
(C) |
ACID PEROXIDES |
|
|||||
|
VI-2915-5 |
(V) |
(a) |
n-Butyric acid |
|
||||
|
29.16 |
Unsaturated acyclic monocarboxylic acids, cyclic monocarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
UNSATURATED ACYCLIC MONOCARBOXYLIC ACIDS AND THEIR SALTS, ESTERS AND OTHER DERIVATIVES |
|||||||
|
VI-2916-1 |
(1) |
Acrylic acid |
|
|||||
|
(C) |
AROMATIC SATURATED MONOCARBOXYLIC ACIDS AND THEIR SALTS, ESTERS AND OTHER DERIVATIVES |
|||||||
|
VI-2916-2 |
(1) |
Benzoic acid |
|
|||||
|
(a) |
Benzoyl peroxide |
|
||||||
|
(VI-2916-2) |
(29.16) |
(C) |
(1) |
(b) |
Benzoyl chloride |
|
||
|
29.17 |
Polycarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
ACYCLIC POLYCARBOXYLIC ACIDS AND THEIR ESTERS, SALTS AND DERIVATIVES |
|||||||
|
VI-2917-1 |
(3) |
Azelaic acid |
|
|||||
|
VI-2917-2 |
(5) |
Maleic anhydride |
|
|||||
|
(C) |
AROMATIC POLYCARBOXYLIC ACIDS AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
(1) |
Phthalic anhydride |
|
||||||
|
(VI-2917-2) |
(29.17) |
(C) |
(2) |
Terephthalic acid |
|
|||
|
29.18 |
Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
CARBOXYLIC ACIDS WITH ALCOHOL FUNCTION AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
VI-2918-2 |
(3) |
Citric acid |
|
|||||
|
VI-2918-3 |
(29.18) |
(A) |
(6) |
Phenylglycolic acid |
|
|||
|
(8) |
2,2-Diphenyl-2-hydroxyacetic acid (benzilic acid) |
|
||||||
|
(B) |
CARBOXYLIC ACIDS WITH PHENOL FUNCTION AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
(VI-2918-3) |
(29.18) |
(B) |
(I) |
Salicylic acid |
|
|||
|
29.19 |
Phosphoric esters and their salts, including lactophosphates; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|
|||||
|
VI-2919-2 |
(3) |
Tributyl phosphate |
|
|||||
|
29.20 |
Esters of other inorganic acids of non-metals (excluding esters of hydrogen halides) and their salts; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
Thiophosphoric esters |
|||||||
|
VI-2920-1 |
Sodium O,O-dibutyldithiophosphates |
|
||||||
|
|
(B) |
|
|
PHOSPHITE ESTERS AND THEIR SALTS. |
|
|||
|
Dimethyl phosphite |
|
|||||||
|
VI-2920-2 |
(D) |
Nitrous and nitric esters |
||||||
|
Methyl nitrite |
|
|||||||
|
(VI-2920-2) |
(29.20) |
(D) |
Nitroglycerol |
|
||||
|
(E) |
Carbonic or peroxocarbonic esters and their salts |
|||||||
|
(1) |
Diguaiacyl carbonate |
|
||||||
|
(F) |
Silicic acid esters and their salts |
|||||||
|
Tetraethyl silicate |
|
|||||||
|
VI-2921-1 |
29.21 |
Amine-function compounds |
|
|||||
|
(A) |
ACYCLIC MONOAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
VI-2921-2 |
(4) |
Ethylamine |
CH3-CH2-NH2 |
|||||
|
(VI-2921-2) |
(29.21) |
(B) |
ACYCLIC POLYAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
VI-2921-3 |
(2) |
Hexamethylenediamine |
|
|||||
|
(D) |
AROMATIC MONOAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
(1) |
Aniline |
|
||||||
|
(2) |
Toluidine(s) |
|
||||||
|
(4) |
1-Naphtylamine |
|
||||||
|
(VI-2921-4) |
(29.21) |
(E) |
AROMATIC POLYAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
(1) |
Phenylenediamine(s) |
|
||||||
|
29.22 |
Oxygen-function amino-compounds |
|||||||
|
(A) |
AMINO-ALCOHOLS, THEIR ETHERS AND ESTERS; SALTS THEREOF |
|||||||
|
VI-2922-2 |
(1) |
Monoethanolamine |
|
|||||
|
(B) |
AMINO-NAPHTHOLS AND OTHER AMINO-PHENOLS, THEIR ETHERS AND ESTERS; SALTS THEREOF |
|||||||
|
(1) |
Aminohydroxynaphthalenesulphonic acids |
|
||||||
|
VI-2922-3 |
(29.22) |
(B) |
(a) |
Anisidine(s) |
|
|||
|
(b) |
Dianisidine(s) |
|
||||||
|
(D) |
AMINO-ACIDS AND THEIR ESTERS; SALTS THEREOF |
|||||||
|
(1) |
Lysine |
|
||||||
|
29.23 |
Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined |
|||||||
|
VI-2923-1 |
(1) |
Choline (Choline hydroxide) |
|
|||||
|
(VI-2923-1) |
(29.23) |
(2) |
Lecithin |
|
||||
|
29.24 |
Carboxyamide-function compounds; amide-function compounds of carbonic acid |
|||||||
|
(B) |
CYCLIC AMIDES |
|||||||
|
VI-2924-2 |
(1) |
(ii) |
Diethyldiphenylurea |
|
||||
|
29.25 |
Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds |
|||||||
|
(A) |
IMIDES |
|||||||
|
VI-2925-1 |
(1) |
Saccharin |
|
|||||
|
(VI-2925-1) |
(29.25) |
(B) |
IMINES |
|||||
|
(1) |
guanidine |
 |
||||||
|
VI-2925-2 |
(a) |
Diphenylguanidine |
|
|||||
|
(3) |
Imino ethers |
|
||||||
|
29.26 |
Nitrile-function compounds |
|||||||
|
VI-2926-1 |
(1) |
Acrylonitrile |
|
|||||
|
(2) |
1-Cyanoguanidine |
|
||||||
|
(VI-2926-1) |
(29.26) |
(19) |
alpha-Phenylacetoacetonitrile (APAAN) |
|
||||
|
29.27 |
Diazo-, azo- or azoxy-compounds |
|||||||
|
(A) |
DIAZO-COMPOUNDS |
|||||||
|
VI-2927-1 |
(1) |
(a) |
Benzenediazonium chloride |
|
||||
|
(B) |
AZO-COMPOUNDS |
R1N = NR2 |
||||||
|
VI-2927-2 |
(C) |
AZOXY-COMPOUNDS |
R1-N2O-R2 |
|||||
|
(1) |
Azoxybenzene |
|
||||||
|
29.28 |
Organic derivatives of hydrazine or of hydroxylamine |
|||||||
|
VI-2928-1 |
(1) |
Phenylhydrazine |
|
|||||
|
(11) |
Phenylglyoxime |
|
||||||
|
29.29 |
Compounds with other nitrogen function |
|||||||
|
VI-2929-1 |
(1) |
Isocyanates |
|
|||||
|
S-Ch. X General |
ORGANO-INORGANIC COMPOUNDS, HETEROCYCLIC COMPOUNDS, NUCLEIC ACIDS AND THEIR SALTS, AND SULPHONAMIDES |
|||||||
|
(A) |
FIVE-MEMBERED RINGS |
|||||||
|
VI-2930-1 |
(1) |
(a) |
Furan |
|
||||
|
(VI-2930-1) |
(General) |
(A) |
(1) |
(b) |
Thiophen |
|
||
|
(c) |
Pyrrole |
|
||||||
|
(2) |
(a) |
Oxazole |
|
|||||
|
(a) |
Isoxazole |
|
||||||
|
(b) |
Thiazole |
|
||||||
|
(VI-2930-1) |
(General) |
(A) |
(2) |
(c) |
Imidazole |
|
||
|
(c) |
Pyrazole |
|
||||||
|
(3) |
(a) |
Furazan |
|
|||||
|
(b) |
Triazole (1,2,4-Triazole) |
|
||||||
|
(c) |
Tetrazole |
|
||||||
|
VI-2930-2 |
(General) |
(B) |
SIX-MEMBERED RINGS |
|||||
|
(1) |
(a) |
Pyran (2H-Pyran) |
|
|||||
|
(b) |
Thiin |
|
||||||
|
(c) |
Pyridine |
|
||||||
|
(2) |
(a) |
Oxazine (1,4-Oxazine) |
|
|||||
|
(b) |
Thiazine (1,4-Thiazine) |
|
||||||
|
(VI-2930-2) |
(General) |
(B) |
(2) |
(c) |
Pyridazine |
|
||
|
(c) |
Pyrimidine |
|
||||||
|
(c) |
Pyrazine |
|
||||||
|
(c) |
Piperazine |
|
||||||
|
(C) |
OTHER MORE COMPLEX HETEROCYCLIC COMPOUNDS |
|||||||
|
(a) |
Coumarone |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(b) |
Benzopyran |
|
|||
|
(c) |
Xanthene |
|
||||||
|
(d) |
Indole |
|
||||||
|
(e) |
Quinoline and isoquinoline |
|
||||||
|
(f) |
Acridine |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(g) |
Benzothiophene (Thionaphthene) |
|
|||
|
(h) |
Indazole |
|
||||||
|
(ij) |
Benzimidazole |
|
||||||
|
(k) |
Phenazine |
|
||||||
|
(l) |
Phenoxazine |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(m) |
Benzoxazole |
|
|||
|
(n) |
Carbazole |
|
||||||
|
(o) |
Quinazoline |
|
||||||
|
(p) |
Benzothiazole |
|
||||||
|
29.30 |
Organo-sulphur compounds |
Compounds with C-S bond |
||||||
|
VI-2930-3 |
(A) |
DITHIOCARBONATES (XANTHATES) |
ROC(S)SR1 R1 = Metal or an organic radical |
|||||
|
(1) |
Sodium ethyldithiocarbonate |
|
||||||
|
(VI-2930-3) |
(29.30) |
(B) |
THIOCARBAMATES, DITHIOCARBAMATES AND THIURAM SULPHIDES |
|||||
|
(2) |
Dithiocarbamates |
|
||||||
|
VI-2930-4 |
(C) |
SULPHIDES (OR THIOETHERS) |
|
|||||
|
(1) |
Methionine |
|
||||||
|
(D) |
THIOAMIDES |
|
||||||
|
(2) |
Thiocarbanilide |
|
||||||
|
29.31 |
Other organo-inorganic compounds |
|||||||
|
|
(3) |
|
|
Organo-phosphorus compounds |
Compounds with C-P bond |
|||
|
Dimethyl methylphosphonate |
|
|||||||
|
(VI-2931-1) |
(29.31) |
(4) |
Organo-silicon compounds |
Compounds with C-Si bond |
||||
|
Hexamethyldisiloxane |
|
|||||||
|
29.32 |
Heterocyclic compounds with oxygen hetero-atom(s) only |
|||||||
|
VI-2932-1 |
(A) |
Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure |
(See structure of furan against page VI-2930-1 for Sub-Chapter X (A) (1) (a)) |
|||||
|
(2) |
2-Furaldehyde |
|
||||||
|
(3) |
Furfuryl alcohol |
|
||||||
|
(5) |
Sucralose |
|
||||||
|
VI-2932-2 |
(29.32) |
(B) |
Lactones |
|
||||
|
(a) |
Coumarin |
|
||||||
|
VI-2932-3 |
(p) |
Phenolphthalein |
|
|||||
|
(C) |
Other heterocyclic compounds with oxygen hetero-atom(s) only |
|||||||
|
(5) |
Safrole |
|
||||||
|
(VI-2932-3) |
(29.32) |
(C) |
(8) |
Piperonal |
|
|||
|
VI-2932-4 |
(10) |
1-(1,3-Benzodioxol-5-yl)propan-2-one |
|
|||||
|
Ketone peroxides (exclusion) – see 29.09 |
|
|||||||
|
Example for esters (lactone) forming part of two rings (Subheading Explanatory Notes) |
|
|||||||
|
Example for dilactone (Subheading Explanatory Notes) |
|
|||||||
|
(VI-2932-4) |
(29.32) |
Internal Hemiacetals |
|
|||||
|
29.33 |
Heterocyclic compounds with nitrogen hetero-atom(s) only |
|||||||
|
VI-2933-2 |
(A) |
Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure |
(See structure of pyrazole against page VI-2930-1 for Sub-Chapter X (A) (2) (c)) |
|||||
|
(1) |
Phenazone |
|
||||||
|
(VI-2933-2) |
(29.33) |
(B) |
Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure |
(See structure of imidazole against page VI-2930-1 for Sub-Chapter X (A) (2) (c)) |
||||
|
(1) |
Hydantoin |
|
||||||
|
VI-2933-3 |
(C) |
Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure |
(See structure of pyridine against page VI-2930-2 for Sub-Chapter X (B) (1) (c)) |
|||||
|
VI-2933-4 |
(D) |
Compounds containing a quinoline or isoquiniline ring-system (whether or not hydrogenated), not further fused |
(See structures of quinoline and isoquinoline against page VI-2930-2 for Sub-Chapter X (C) (e)) |
|||||
|
(4) |
Tetrahydromethylquinoline (5,6,7,8-Tetrahydromethylquinoline) |
|
||||||
|
(E) |
Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure |
(See structure of pyrimidine against page VI-2930-2 for Sub-Chapter X (B) (2) (c)) |
||||||
|
(1) |
Malonylurea (Barbituric acid) |
|
||||||
|
VI-2933-5 |
(29.33) |
(F) |
Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure |
|
||||
|
(1) |
Melamine |
|
||||||
|
(G) |
Lactams |
|
||||||
|
VI-2933-6 |
(29.33) |
(H) |
Other heterocyclic compounds with nitrogen hetero-atom(s) only |
|||||
|
(1) |
Carbazole |
|
||||||
|
(2) |
Acridine |
(See structure of acridine against page VI-2930-2 for Sub-Chapter X (C) (f)) |
||||||
|
VI-2933-7 |
Oxazepam (Subheading Explanatory Notes) |
|
||||||
|
Example for amide (lactam) forming part of two rings (Subheading Explanatory Notes) |
|
|||||||
|
29.34 |
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds |
|||||||
|
VI-2934-1 |
(A) |
Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure |
(See structure of thiazole against page VI-2930-1 for Sub-Chapter X (A) (2) (b)) |
|||||
|
(B) |
Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fused |
(See structure of benzothiazole against page VI-2930-2 for Sub-Chapter X (C) (p)) |
||||||
|
VI-2934-2 |
(C) |
Compounds containing a phenothiazine ring-system (whether or not hydrogenated), not further fused |
|
|||||
|
(D) |
Other heterocyclic compounds |
|||||||
|
(1) |
Sultones |
|
||||||
|
(a) |
Phenolsulfonephthalein |
|
||||||
|
(VI-2934-2) |
(29.34) |
(D) |
(2) |
Sultams |
|
|||
|
(4) |
Furazolidone (INN) |
|
||||||
|
VI-2935-1 |
29.35 |
Sulphonamides |
|
|||||
|
(1) |
Perfluorooctane sulphonamide |
|
||||||
|
(5) |
p-Aminobenzenesulphonamide |
|
||||||
|
29.37 |
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones |
|||||||
|
(V) |
Analogues of hormones, prostaglandins, thromboxanes and leukotrienes |
|||||||
|
VI-2937-2 |
(b) |
Gonane |
|
|||||
|
(B) |
STEROIDAL HORMONES, THEIR DERIVATIVES AND STRUCTURAL ANALOGUES |
|||||||
|
(1) |
Corticosteroid hormones |
|||||||
|
VI-2937-5 |
(a) |
Cortisone (INN) |
|
|||||
|
(VI-2937-5) |
(29.37) |
(B) |
(1) |
(b) |
Hydrocortisone (INN) |
|
||
|
VI-2937-6 |
(3) |
Oestrogens and progestogens |
||||||
|
(a) |
Progesterone (INN) |
|
||||||
|
VI-2937-8 |
List |
Androstane |
|
|||||
|
VI-2937-9 |
(29.37) |
List |
Estrone (INN) |
|
||||
|
VI-2937-12 |
Prednisolone (INN) |
|
||||||
|
Prednisone (INN) |
|
|||||||
|
VI-2937-13 |
(29.37) |
List |
Testosterone (INN) |
|
||||
|
- |
Estrane |
|
||||||
|
- |
Pregnane |
|
||||||
|
29.38 |
Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives |
|||||||
|
VI-2938-1 |
(1) |
Rutoside |
|
|||||
|
29.39 |
Vegetable alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives |
|||||||
|
(A) |
ALKALOIDS OF OPIUM AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
VI-2939-2 |
(1) |
Morphine |
|
|||||
|
(VI-2939-3) |
(29.39) |
(B) |
ALKALOIDS OF CINCHONA AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
(1) |
Quinine |
|
||||||
|
(C) |
CAFFEINE AND ITS SALTS |
|||||||
|
Caffeine |
|
|||||||
|
(VI-2939-3) |
(29.39) |
(D) |
EPHEDRINES AND THEIR SALTS |
|||||
|
(1) |
Ephedrine |
|
||||||
|
(E) |
THEOPHYLLINE AND AMINOPHYLLINE (THEOPHYLLINE-ETHYLENEDIAMINE) AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
(E) |
Theophylline |
|
||||||
|
(VI-2939-3) |
(29.39) |
(G) |
NICOTINE AND ITS SALTS |
|||||
|
Nicotine |
|
|||||||
|
VI-2939-6 |
|
|
OTHER ALKALOIDS OF NON VEGETAL ORIGIN |
|||||
|
(IJ) |
Viridicatin (fungal), histrionicotoxin (animal), coccinelline (insect), varacin (marine) and procyanine (bacterial) |
|
||||||
|
29.40 |
Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 29.37, 29.38 or 29.39 |
|||||||
|
(A) |
SUGARS, CHEMICALLY PURE |
|||||||
|
(1) |
Galactose |
|
||||||
|
(B) |
SUGAR ETHERS, SUGAR ACETALS AND SUGAR ESTERS, AND THEIR SALTS |
|||||||
|
VI-2940-2 |
(1) |
Hydroxypropyl sucrose |
|
|||||
|
29.41 |
Antibiotics |
|||||||
|
VI-2941-1 |
(1) |
Penicillins |
|
|||||
|
(VI-2941-1) |
(29.41) |
(2) |
Streptomycin |
|
||||
|
VI-2941-2 |
Streptamine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
||||||
|
(VI-2941-2) |
(29.41) |
Streptidine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||
|
Methylglucosamine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||||
|
5-deoxylyxose (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
 |
|||||||
|
VI-2941-1 |
(3) |
Tetracycline |
|
|||||
|
VI-2941-3 |
(29.41) |
(3) |
4-dimethylamino-naphthacene-2-carboxamide (fully hydrogenated) (constituent of the tetracycline skeleton) (Subheading Explanatory Notes) |
|
||||
|
(4) |
N-(2-hydroxy-1-methyl-2-phenethyl)acetamide (constituent of the chloramphenicol skeleton) (Subheading Explanatory Notes) |
|
||||||
|
VI-2941-1 |
(5) |
Erythromycin |
|
|||||
|
(VI-2941-3) |
(29.41) |
(5) |
13-ethyl-13-tridecanolide (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
|
||||
|
Desosamine (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
 |
|||||||
|
Mycarose (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
 |
|||||||
|
29.42 |
Other organic compounds |
|||||||
|
VI-2942-1 |
(1) |
Ketenes |
|
|||||
|
(2) |
Boron trifluoride complexes with diethyl ether |
|
||||||
______________________
(*) Dextromethorphan (INN) ((+)-3- methoxy-N- Methylmorphinan) is specifically excluded from thislist.
(**) Dextrophane (INN) ((+)-3-hydroxy-N-methylmorphinan) is specifically excluded from this list.
(*) Other substances not added.
(**) Natural mixtures, constituents other than alkaloids sufficiently removed, other substances not added .
Notas.
1. A) Cualquier producto que responda al texto específico de una de las partidas 28.44 ó 28.45, se clasifica en dicha partida, y no en otra de la Nomenclatura, excepto los minerales de metales radiactivos.
B) Salvo lo dispuesto en el apartado A) anterior, cualquier producto que responda al texto específico de una de las partidas 28.43, 28.46 ó 28.52, se clasifica en dicha partida y no en otra de esta Sección.
2. Sin perjuicio de las disposiciones de la Nota 1 anterior, cualquier producto que, por su presentación en forma de dosis o por su acondicionamiento para la venta al por menor, pueda incluirse en una de las partidas 30.04, 30.05, 30.06, 32.12, 33.03, 33.04, 33.05, 33.06, 33.07, 35.06, 37.07 ó 38.08, se clasifica en dicha partida y no en otra de la Nomenclatura.
3. Los productos presentados en surtidos que consistan en varios componentes distintos comprendidos, en su totalidad o en parte, en esta Sección e identificables como destinados, después de mezclados, a constituir un producto de las Secciones VI o VII, se clasifican en la partida correspondiente a este último producto siempre que los componentes sean:
a) netamente identificables, por su acondicionamiento, como destinados a utilizarse juntos sin previo reacondicionamiento;
b) presentados simultáneamente;
c) identificables, por su naturaleza o por sus cantidades respectivas, como complementarios unos de otros.
Notas.
1. Salvo disposición en contrario, las partidas de este Capítulo comprenden solamente:
a) los compuestos orgánicos de constitución química definida presentados aisladamente, aunque contengan impurezas;
b) las mezclas de isómeros de un mismo compuesto orgánico (aunque contengan impurezas), excepto las mezclas de isómeros de los hidrocarburos acíclicos saturados o sin saturar (distintos de los estereoisómeros) (Capítulo 27);
c) los productos de las partidas 29.36 a 29.39, los éteres, acetales y ésteres de azúcares, y sus sales, de la partida 29.40, y los productos de la partida 29.41, aunque no sean de constitución química definida;
d) las disoluciones acuosas de los productos de los apartados a), b) o c) anteriores;
e) las demás disoluciones de los productos de los apartados a), b) o c) anteriores, siempre que constituyan un modo de acondicionamiento usual e indispensable, exclusivamente motivado por razones de seguridad o necesidades del transporte y que el disolvente no haga al producto más apto para usos determinados que para uso general;
f) los productos de los apartados a), b), c), d) o e) anteriores, con adición de un estabilizante (incluido un antiaglomerante) indispensable para su conservación o transporte;
g) los productos de los apartados a), b), c), d), e) o f) anteriores, con adición de una sustancia antipolvo, un colorante o un odorante para facilitar su identificación o por razones de seguridad, siempre que estas adiciones no hagan al producto más apto para usos determinados que para uso general;
h) los productos siguientes, normalizados, para la producción de colorantes azoicos: sales de diazonio, copulantes utilizados para estas sales y aminas diazotables y sus sales.
2. Este Capítulo no comprende:
a) los productos de la partida 15.04 y el glicerol en bruto de la partida 15.20;
b) el alcohol etílico (partidas 22.07 ó 22.08);
c) el metano y el propano (partida 27.11);
d) los compuestos de carbono mencionados en la Nota 2 del Capítulo 28;
e) Los productos inmunológicos de la partida 30.02;
f) la urea (partidas 31.02 ó 31.05);
g) las materias colorantes de origen vegetal o animal (partida 32.03), las materias colorantes orgánicas sintéticas, los productos orgánicos sintéticos de los tipos utilizados como agentes de avivado fluorescente o como luminóforos (partida 32.04), así como los tintes y demás materias colorantes presentados en formas o en envases para la venta al por menor (partida 32.12);
h) las enzimas (partida 35.07);
ij) el metaldehído, la hexametilentetramina y los productos análogos, en tabletas, barritas o formas similares que impliquen su utilización como combustibles, así como los combustibles líquidos y los gases combustibles licuados, en recipientes de los tipos utilizados para cargar o recargar encendedores o mecheros, de capacidad inferior o igual a 300 cm3 (partida 36.06);
k) los productos extintores presentados como cargas para aparatos extintores o en granadas o bombas extintoras de la partida 38.13; los productos borradores de tinta acondicionados en envases para la venta al por menor, clasificados en la partida 38.24;
l) los elementos de óptica, por ejemplo, los de tartrato de etilendiamina (partida 90.01).
3. Cualquier producto que pueda clasificarse en dos o más partidas de este Capítulo se clasificará en la última de dichas partidas por orden de numeración.
4. En las partidas 29.04 a 29.06, 29.08 a 29.11 y 29.13 a 29.20, cualquier referencia a los derivados halogenados, sulfonados, nitrados o nitrosados, se aplica también a los derivados mixtos, tales como los sulfohalogenados, nitrohalogenados, nitrosulfonados o nitrosulfohalogenados.
Para la aplicación de la partida 29.29, los grupos nitrados o nitrosados no deben considerarse funciones nitrogenadas.
En las partidas 29.11, 29.12, 29.14, 29.18 y 29.22, se entiende por funciones oxigenadas (grupos orgánicos característicos que contienen oxígeno) solamente las citadas en los textos de las partidas 29.05 a 29.20.
5. A) Los ésteres de compuestos orgánicos de función ácida de los Subcapítulos I a VII con compuestos orgánicos de los mismos Subcapítulos se clasifican con el compuesto que pertenezca a la última partida por orden de numeración de dichos Subcapítulos.
B) Los ésteres del alcohol etílico con compuestos orgánicos de función ácida de los Subcapítulos I a VII se clasifican en la partida de los compuestos de función ácida correspondientes.
C) Salvo lo dispuesto en la Nota 1 de la Sección VI y en la Nota 2 del Capítulo 28:
1°) las sales inorgánicas de compuestos orgánicos, tales como los compuestos de función ácida, función fenol o función enol o las bases orgánicas, de los Subcapítulos I a X o de la partida 29.42, se clasifican en la partida que comprenda el compuesto orgánico correspondiente;
2°) las sales formadas por reacción entre compuestos orgánicos de los Subcapítulos I a X o de la partida 29.42 se clasifican en la última partida del Capítulo por orden de numeración que comprenda la base o el ácido del que se han formado (incluidos los compuestos de función fenol o de función enol);
3°) los compuestos de coordinación, excepto los productos del Subcapítulo XI o la partida 29.41, se clasifican en la partida del Capítulo 29 situada en último lugar por orden de numeración entre las correspondientes a los fragmentos formados por escisión de todos los enlaces metálicos, excepto los enlaces metal-carbono.
D) Los alcoholatos metálicos se clasifican en la misma partida que los alcoholes correspondientes, salvo en el caso del etanol (partida 29.05).
E) Los halogenuros de los ácidos carboxílicos se clasifican en la misma partida que los ácidos correspondientes.
6. Los compuestos de las partidas 29.30 y 29.31 son compuestos orgánicos cuya molécula contiene, además de átomos de hidrógeno, oxígeno o nitrógeno, átomos de otros elementos no metálicos o de metales, tales como azufre, arsénico o plomo, directamente unidos al carbono.
Las partidas 29.30 (tiocompuestos orgánicos) y 29.31 (los demás compuestos órgano-inorgánicos) no comprenden los derivados sulfonados o halogenados ni los derivados mixtos, que solo contengan en unión directa con el carbono, los átomos de azufre o de halógeno que les confieran el carácter de tales, sin considerar el hidrógeno, oxígeno o nitrógeno que puedan contener.
7. Las partidas 29.32, 29.33 y 29.34 no comprenden los epóxidos con tres átomos en el ciclo, los peróxidos de cetonas, los polímeros cíclicos de los aldehídos o de los tioaldehídos, los anhídridos de ácidos carboxílicos polibásicos, los ésteres cíclicos de polialcoholes o de polifenoles con ácidos polibásicos ni las imidas de ácidos polibásicos.
Las disposiciones anteriores solo se aplican cuando la estructura heterocíclica proceda exclusivamente de las funciones ciclantes antes citadas.
8. En la partida 29.37:
a) el término hormonas comprende los factores liberadores o estimulantes de hormonas, los inhibidores de hormonas y los antagonistas de hormonas (antihormonas);
b) la expresión utilizados principalmente como hormonas, se aplica no solamente a los derivados de hormonas y a sus análogos estructurales utilizados principalmente por su acción hormonal, sino también a los derivados y análogos estructurales de hormonas utilizados principalmente como intermedios en la síntesis de productos de esta partida.
°
° °
Notas de subpartida.
1. Dentro de una partida de este Capítulo, los derivados de un compuesto químico (o de un grupo de compuestos químicos) se clasifican en la misma subpartida que el compuesto (o grupo de compuestos), siempre que no estén comprendidos más específicamente en otra subpartida y que no exista una subpartida residual «Los/Las demás» en la serie de subpartidas involucradas.
2. La Nota 3 del Capítulo 29 no se aplica a las subpartidas de este Capítulo.
LIST
OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ARRANGED IN ALPHABETICAL ORDER BY TYPE OF DRUG
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol
|
Name |
HS subheading |
CAS No. |
Convention Schedule No |
|
Acetorphine (INN) |
2939.19 |
25333-77-1 |
4 |
|
Acetorphine hydrochloride |
2939.19 |
25333-78-2 |
4 |
|
Acetyldihydrocodeine |
2939.19 |
3861-72-1 |
2 |
|
Acetyldihydrocodeine hydrochloride |
2939.19 |
|
2 |
|
Acetylmethadol (INN) |
2922.19 |
509-74-0 |
1 |
|
Acetyl-a-methylfentanyl |
2933.39 |
|
4 |
|
Acetylmorphine |
2939.19 |
|
1 |
|
3-Acetylmorphine |
2939.19 |
|
1 |
|
6-Acetylmorphine |
2939.19 |
2784-73-8 |
1 |
|
Alfentanil (INN) |
2933.33 |
71195-58-9 |
1 |
|
Alfentanil hydrochloride |
2933.33 |
69049-06-5 |
1 |
|
Allylprodine (INN) |
2933.39 |
25384-17-2 |
1 |
|
Allylprodine hydrochloride |
2933.39 |
|
1 |
|
Alphacetylmethadol (INN) |
2922.19 |
17199-58-5 |
1 |
|
L-Alphacetylmethadol |
2922.19 |
|
|
|
Alphacetylmethadol hydrochloride |
2922.19 |
|
1 |
|
Alphameprodine (INN) |
2933.39 |
468-51-9 |
1 |
|
Alphamethadol (INN) |
2922.19 |
17199-54-1 |
1 |
|
Alphaprodine (INN) |
2933.39 |
77-20-3 |
1 |
|
Alphaprodine hydrochloride |
2933.39 |
561-78-4 |
1 |
|
Anileridine (INN) |
2933.33 |
144-14-9 |
1 |
|
Anileridine dihydrochloride |
2933.33 |
126-12-5 |
1 |
|
Anileridine phosphate |
2933.39 |
4268-37-5 |
1 |
|
Benzethidine (INN) |
2933.39 |
3691-78-9 |
1 |
|
Benzethidine hydrobromide |
2933.39 |
|
1 |
|
Benzethidine hydrochloride |
2933.39 |
|
1 |
|
Benzoylmorphine |
2939.19 |
|
1 |
|
Benzylmorphine |
2939.19 |
14297-87-1 |
1 |
|
Benzylmorphine hydrochloride |
2939.19 |
630-86-4 |
1 |
|
Benzylmorphine mesilate |
2939.19 |
|
1 |
|
Betacetylmethadol (INN) |
2922.19 |
17199-59-6 |
1 |
|
Betameprodine (INN) |
2933.39 |
468-50-8 |
1 |
|
Betamethadol (INN) |
2922.19 |
17199-55-2 |
1 |
|
Betaprodine (INN) |
2933.39 |
468-59-7 |
1 |
|
Betaprodine hydrochloride |
2933.39 |
|
1 |
|
Bezitramide (INN) |
2933.33 |
15301-48-1 |
1 |
|
Bezitramide hydrochloride |
2933.33 |
|
1 |
|
Cannabis |
1211.90 |
|
4 |
|
Cannabis extracts and tinctures |
1302.19 |
|
|
|
Cannabis oil |
1302.19 |
|
|
|
Cannabis resin |
1301.90 |
|
|
|
Clonitazene (INN) |
2933.99 |
3861-76-5 |
1 |
|
Clonitazene hydrochloride |
2933.99 |
|
1 |
|
Clonitazene mesilate |
2933.99 |
|
1 |
|
Coca leaf |
1211.30 |
|
|
|
Cocaine |
2939.71 |
50-36-2 |
1 |
|
d-Cocaine |
2939.71 |
478-73-9 |
|
|
Cocaine benzoate |
2939.71 |
|
1 |
|
Cocaine borate |
2939.71 |
|
1 |
|
Cocaine citrate |
2939.71 |
|
1 |
|
Cocaine formate |
2939.71 |
|
1 |
|
Cocaine hydriodide |
2939.71 |
|
1 |
|
Cocaine hydrobromide |
2939.71 |
|
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Cocaine hydrochloride |
2939.71 |
53-21-4 |
1 |
|
Cocaine lactate |
2939.71 |
1 |
|
|
Cocaine nitrate |
2939.71 |
5913-62-2 |
1 |
|
Cocaine salicylate |
2939.71 |
5913-64-4 |
1 |
|
Cocaine sulfate |
2939.71 |
1 |
|
|
Cocaine tartrate |
2939.71 |
1 |
|
|
Codeine |
2939.11 |
76-57-3 |
2 |
|
Codeine acetate |
2939.11 |
2 |
|
|
Codeine allobarbiturate |
2939.11 |
2 |
|
|
Codeine barbiturate |
2939.11 |
2 |
|
|
Codeine camphosulfonate |
2939.11 |
2 |
|
|
Codeine citrate |
2939.11 |
5913-73-5 |
2 |
|
Codeine cyclobarbiturate |
2939.11 |
2 |
|
|
Codeine cyclopentobarbiturate |
2939.11 |
2 |
|
|
Codeine 6-glucuronide |
2939.19 |
2 |
|
|
Codeine hydrobromide |
2939.11 |
125-25-7 |
2 |
|
Codeine hydrochloride |
2939.11 |
1422-07-7 |
2 |
|
Codeine hydroiodide |
2939.11 |
125-26-8 |
2 |
|
Codeine methylbromide |
2939.19 |
125-27-9 |
2 |
|
Codeine phenobarbiturate |
2939.11 |
2 |
|
|
Codeine phosphate |
2939.11 |
52-28-8 |
2 |
|
Codeine resinate |
3003.49 |
2 |
|
|
Codeine salicylate |
2939.11 |
2 |
|
|
Codeine sulfate |
2939.11 |
1420-53-7 |
2 |
|
Codeine-N-oxide |
2939.19 |
3688-65-1 |
|
|
Codeine-N-oxide hydrochloride |
2939.19 |
||
|
Codoxime (INN) |
2939.19 |
7125-76-0 |
1 |
|
Concentrate of poppy straw |
1302.11 |
1 |
|
|
2939.11 |
|
||
|
Desomorphine (INN) |
2939.19 |
427-00-9 |
4 |
|
Desomorphine hydrobromide |
2939.19 |
4 |
|
|
Desomorphine hydrochloride |
2939.19 |
4 |
|
|
Desomorphine sulfate |
2939.19 |
4 |
|
|
Dextromoramide (INN) |
2934.91 |
357-56-2 |
1 |
|
Dextromoramide dihydrochloride |
2934.91 |
1 |
|
|
Dextromoramide hydrochloride |
2934.91 |
1 |
|
|
Dextromoramide hydrogen tartrate (bitartrate) |
2934.99 |
2922-44-3 |
1 |
|
Dextropropoxyphene (INN) |
2922.14 |
469-62-5 |
2 |
|
Dextropropoxyphene hydrochloride |
2922.14 |
1639-60-7 |
2 |
|
Napsilate |
2922.19 |
17140-78-2 |
2 |
|
Dextropropoxyphene resinate |
3003.90 |
2 |
|
|
Diampromide (INN) |
2924.29 |
552-25-0 |
1 |
|
Diampromide sulfate |
2924.29 |
1 |
|
|
Diethylthiambutene (INN) |
2934.99 |
86-14-6 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Diethylthiambutene hydrochloride |
2934.99 |
132-19-4 |
1 |
|
Difenoxin (INN) |
2933.33 |
28782-42-5 |
1 |
|
Difenoxin hydrochloride |
2933.33 |
35607-36-4 |
1 |
|
Dihydrocodeine (INN) |
2939.11 |
125-28-0 |
2 |
|
Dihydrocodeine hydrochloride |
2939.11 |
2 |
|
|
Dihydrocodeine hydrogen tartrate (bitartrate) |
2939.11 |
5965-13-9 |
2 |
|
Dihydrocodeine phosphate |
2939.11 |
24204-13-5 |
2 |
|
Dihydrocodeine resinate |
3003.49 |
2 |
|
|
Dihydrocodeine thiocyanate |
2939.11 |
2 |
|
|
Dihydroisomorphin |
2939.19 |
||
|
Dihydroisomorphin 6-glucuronide |
2939.19 |
||
|
Dihydromorphine |
2939.19 |
509-60-4 |
2 |
|
Dihydromorphine hydriodide |
2939.19 |
2 |
|
|
Dihydromorphine hydrochloride |
2939.19 |
1421-28-9 |
2 |
|
Dihydromorphine picrate |
2939.19 |
2 |
|
|
Dimenoxadol (INN) |
2922.19 |
509-78-4 |
1 |
|
Dimenoxadol hydrochloride |
2922.19 |
242-75-1 |
1 |
|
Dimepheptanol (INN) |
2922.19 |
545-90-4 |
1 |
|
Dimepheptanol hydrochloride |
2922.19 |
1 |
|
|
Dimethylthiambutene (INN) |
2934.99 |
524-84-5 |
1 |
|
Dimethylthiambutene hydrochloride |
2934.99 |
1 |
|
|
Dioxaphetyl butyrate (INN) |
2934.99 |
467-86-7 |
1 |
|
Dioxaphetyl butyrate hydrochloride |
2934.99 |
1 |
|
|
Diphenoxylate (INN) |
2933.33 |
915-30-0 |
1 |
|
Diphenoxylate hydrochloride |
2933.33 |
3810-80-8 |
1 |
|
Dipipanone (INN) |
2933.33 |
467-83-4 |
1 |
|
Dipipanone hydrobromide |
2933.33 |
1 |
|
|
Dipipanone hydrochloride |
2933.33 |
75783-06-1 |
1 |
|
Drotebanol (INN) |
2933.49 |
3176-03-2 |
1 |
|
Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine |
2939.71 |
481-37-8 |
1 |
|
Ecgonine benzoylethyl ester |
2939.71 |
1 |
|
|
Ecgonine benzoylpropyl ester |
2939.71 |
1 |
|
|
Ecgonine cinnamoylmethyl ester |
2939.71 |
1 |
|
|
Ecgonine 2,6-dimethyl-benzoylmethyl ester |
2939.71 |
1 |
|
|
Ecgonine hydrochloride |
2939.71 |
1 |
|
|
Ecgonine methyl ester |
2939.71 |
1 |
|
|
Ecgonine methyl ester hydrochloride |
2939.71 |
1 |
|
|
Ecgonine phenylacetyl-methyl ester |
2939.71 |
1 |
|
|
Ethylmethylthiambutene (INN) |
2934.99 |
441-61-2 |
1 |
|
Ethylmethylthiambutene hydrochloride |
2934.99 |
1 |
|
|
Ethylmorphine |
2939.11 |
76-58-4 |
2 |
|
Ethylmorphine camphosulfonate |
2939.11 |
2 |
|
|
Ethylmorphine hydrobromide |
2939.11 |
2 |
|
|
Ethylmorphine hydrochloride |
2939.11 |
125-30-4 |
2 |
|
Ethylmorphine methyliodide |
2939.19 |
2 |
|
|
Ethylmorphine phenobarbiturate |
2939.11 |
2 |
|
|
Etonitazene (INN) |
2933.99 |
911-65-9 |
1 |
|
Etonitazene hydrochloride |
2933.99 |
1 |
|
|
Etorphine (INN) |
2939.11 |
14521-96-1 |
4 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Etorphine hydrochloride |
2939.11 |
13764-49-3 |
4 |
|
Etorphine 3-methyl ether |
2939.19 |
4 |
|
|
Etoxeridine (INN) |
2933.39 |
469-82-9 |
1 |
|
Etoxeridine hydrochloride |
2933.39 |
1 |
|
|
Fentanyl (INN) |
2933.33 |
437-38-7 |
1 |
|
Fentanyl citrate |
2933.33 |
990-73-8 |
1 |
|
p-Fluorofentanyl |
2933.39 |
4 |
|
|
p-Fluorofentanyl hydrochloride |
2933.39 |
4 |
|
|
Furethidine (INN) |
2934.99 |
2385-81-1 |
1 |
|
Furethidine hydrobromide |
2934.99 |
1 |
|
|
Furethidine methyliodide |
2934.99 |
1 |
|
|
Furethidine picrate |
2934.99 |
1 |
|
|
Heroin |
2939.11 |
561-27-3 |
4 |
|
Heroin hydrochloride |
2939.11 |
1502-95-0 |
4 |
|
Heroin methyliodide |
2939.19 |
4 |
|
|
Hydrocodone (INN) |
2939.11 |
125-29-1 |
1 |
|
Hydrocodone citrate |
2939.11 |
1 |
|
|
Hydrocodone hydriodide |
2939.11 |
1 |
|
|
Hydrocodone hydrochloride |
2939.11 |
25968-91-6 |
1 |
|
Hydrocodone hydrogen tartrate (bitartrate) |
2939.11 |
143-71-5 |
1 |
|
Hydrocodone methyliodide |
2939.19 |
1 |
|
|
Hydrocodone phosphate |
2939.11 |
34366-67-1 |
1 |
|
Hydrocodone resinate |
3003.49 |
1 |
|
|
Hydrocodone terephthalate |
2939.11 |
1 |
|
|
Hydromorphinol (INN) |
2939.19 |
2183-56-4 |
1 |
|
Hydromorphinol hydrochloride |
2939.19 |
1 |
|
|
Hydromorphinol hydrogen tartrate (bitartrate) |
2939.19 |
1 |
|
|
Hydromorphone (INN) |
2939.11 |
466-99-9 |
1 |
|
Hydromorphone hydrochloride |
2939.11 |
71-68-1 |
1 |
|
Hydromorphone sulfate |
2939.11 |
1 |
|
|
Hydromorphone terephthalate |
2939.11 |
1 |
|
|
ß-Hydroxyfentanyl |
2933.39 |
4 |
|
|
ß-Hydroxyfentanyl hydrochloride |
2933.39 |
4 |
|
|
(+)-cis-ß-Hydroxy-3-m-methylfentanyl |
2933.39 |
||
|
ß-Hydroxy-3-methylfentanyl |
2933.39 |
4 |
|
|
ß-Hydroxy-3-methylfentanyl hydrochloride |
2933.39 |
4 |
|
|
Hydroxypethidine (INN) |
2933.39 |
468-56-4 |
1 |
|
Hydroxypethidine hydrochloride |
2933.39 |
1 |
|
|
Isomethadone (INN) |
2922.39 |
466-40-0 |
1 |
|
d-Isomethadone |
2922.39 |
||
|
l-Isomethadone |
2922.39 |
||
|
Isomethadone hydrobromide |
2922.39 |
1 |
|
|
Isomethadone hydrochloride |
2922.39 |
1 |
|
|
Ketobemidone (INN) |
2933.33 |
469-79-4 |
4 |
|
Ketobemidone hydrochloride |
2933.33 |
5965-49-1 |
4 |
|
Levacetylmethadol (INN) |
2922.19 |
34433-66-4 |
1 |
|
Levomethorphan (INN)(*) |
2933.49 |
125-70-2 |
1 |
|
Levomethorphan hydrobromide |
2933.49 |
1 |
|
|
Levomethorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Levomoramide (INN) |
2934.99 |
5666-11-5 |
1 |
|
Levomoramide dihydrochloride |
2934.99 |
1 |
|
|
Levophenacylmorphan (INN) |
2933.49 |
10061-32-2 |
1 |
|
Levophenacylmorphan hydrochloride |
2933.49 |
1 |
|
|
Levophenacylmorphan methylsulfonate |
2933.49 |
1 |
|
|
Levopropoxyphene (INN) |
2922.19 |
2338-37-6 |
|
|
Levorphanol (INN)(**) |
2933.41 |
77-07-6 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Levorphanol hydrogen tartrate (bitartrate) |
2933.41 |
125-72-4 |
1 |
|
Levorphanol hydrochloride |
2933.41 |
1 |
|
|
Metazocine (INN) |
2933.39 |
3734-52-9 |
1 |
|
Metazocine hydrobromide |
2933.39 |
1 |
|
|
Metazocine hydrochloride |
2933.39 |
1 |
|
|
l-Methadol |
2922.19 |
||
|
Methadone (INN) |
2922.31 |
76-99-3 |
1 |
|
d-Methadone |
2922.31 |
||
|
l-Methadone |
2922.31 |
1 |
|
|
Methadone hydrobromide |
2922.31 |
1 |
|
|
Methadone hydrochloride |
2922.31 |
1095-90-5 |
1 |
|
Methadone hydrogen tartrate (bitartrate) |
2922.31 |
1 |
|
|
d-Methadone hydrochloride |
2922.31 |
||
|
l-Methadone hydrochloride |
2922.31 |
||
|
l-Methadone hydrogen tartrate (bitartrate) |
2922.31 |
1 |
|
|
Methadone (INN) intermediate4-cyano-2-dimethylamino-4,4-diphenylbutane or 2-dimethylamino-4,4-diphenyl-4-cyanobutane |
2926.30 |
1 |
|
|
Methyldesorphine (INN) |
2939.19 |
16008-36-9 |
1 |
|
Methyldesorphine hydrochloride |
2939.19 |
1 |
|
|
Methyldihydromorphine (INN) |
2939.19 |
509-56-8 |
1 |
|
3-Methylfentanyl |
2933.39 |
4 |
|
|
3-Methylfentanyl hydrochloride |
2933.39 |
|
4 |
|
α-Methylfentanyl |
2933.39 |
4 |
|
|
α-Methylfentanyl hydrochloride |
2933.39 |
4 |
|
|
α-Methylthiofentanyl |
2934.99 |
1 |
|
|
α-Methylthiofentanyl hydrochloride |
2934.99 |
1 |
|
|
3-Methylthiofentanyl |
2934.99 |
4 |
|
|
3-Methylthiofentanyl hydrochloride |
2934.99 |
4 |
|
|
(+)-cis-3-Methylthiofentanyl |
2934.99 |
4 |
|
|
(+)-cis-3-Methylthioentanyl-hydrochloride |
2934.99 |
||
|
Metopon (INN) |
2939.19 |
143-52-2 |
1 |
|
Metopon hydrochloride |
2939.19 |
1 |
|
|
Moramide intermediate |
2934.99 |
1 |
|
|
Morpheridine (INN) |
2934.99 |
469-81-8 |
1 |
|
Morpheridine dihydrochloride |
2934.99 |
1 |
|
|
Morpheridine picrate |
2934.99 |
1 |
|
|
Morphine |
2939.11 |
57-27-2 |
1 |
|
Morphine acetate |
2939.11 |
596-15-6 |
1 |
|
Morphine citrate |
2939.11 |
1 |
|
|
Morphine 3,6-diglucuronide |
2939.19 |
1 |
|
|
Morphine dimethyl ether |
2939.19 |
||
|
Morphine gluconate |
2939.19 |
1 |
|
|
Morphine 3-glucuronide |
2939.19 |
1 |
|
|
Morphine 3-glucuronide |
2939.19 |
1 |
|
|
Morphine 6-glucuronide |
2939.19 |
1 |
|
|
Morphine 3-β-D-glucuronide |
2939.19 |
1 |
|
|
Morphine 6-β-D-glucuronide |
2939.19 |
1 |
|
|
Morphine hydriodide |
2939.11 |
1 |
|
|
Morphine hydrobromide |
2939.11 |
630-81-9 |
1 |
|
Morphine hydrochloride |
2939.11 |
52-26-6 |
1 |
|
Morphine hypophosphite |
2939.11 |
1 |
|
|
Morphine isobutyrate |
2939.11 |
1 |
|
|
Morphine lactate |
2939.11 |
1 |
|
|
Morphine meconate |
2939.11 |
1 |
|
|
Morphine methobromide |
2939.19 |
1 |
|
|
Morphine methylbromide |
2939.19 |
1 |
|
|
Morphine methylchoride |
2939.19 |
1 |
|
|
Morphine methyliodide |
2939.19 |
1 |
|
|
Morphine methylsulfonate |
2939.11 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Morphine mucate |
2939.11 |
1 |
|
|
Morphine nitrate |
2939.11 |
596-16-7 |
1 |
|
Morphine phenylpropionate |
2939.11 |
1 |
|
|
Morphine phosphate |
2939.11 |
1 |
|
|
Morphine phthalate |
2939.11 |
1 |
|
|
Morphine stearate |
2939.11 |
1 |
|
|
Morphine sulfate |
2939.11 |
64-31-3 |
1 |
|
Morphine tartrate |
2939.11 |
302-31-8 |
1 |
|
Morphine valerate |
2939.11 |
1 |
|
|
Morphine-N-oxide |
2939.19 |
639-46-3 |
1 |
|
Morphine-N-oxide quinate |
2939.19 |
1 |
|
|
MPPP |
2933.39 |
4 |
|
|
MPPP hydrochloride |
2933.39 |
4 |
|
|
MT-45 |
2933.59 |
1 |
|
|
Myrophine (INN) |
2939.19 |
467-18-5 |
1 |
|
Myrophine hydrochloride |
2939.19 |
1 |
|
|
Nicocodine (INN) |
2939.19 |
3688-66-2 |
2 |
|
Nicocodine hydrochloride |
2939.19 |
2 |
|
|
Nicodicodine (INN) |
2939.19 |
808-24-2 |
2 |
|
Nicomorphine (INN) |
2939.11 |
639-48-5 |
1 |
|
Nicomorphine hydrochloride |
2939.11 |
1 |
|
|
Noracymethadol (INN) |
2922.19 |
1477-39-0 |
1 |
|
Noracymethadol gluconate |
2922.19 |
1 |
|
|
Noracymethadol hydrochloride |
2922.19 |
1 |
|
|
Norcodeine (INN) |
2939.19 |
467-15-2 |
2 |
|
Norcodeine acetate |
2939.19 |
2 |
|
|
Norcodeine hydriodide |
2939.19 |
2 |
|
|
Norcodeine hydrochloride |
2939.19 |
14648-14-7 |
2 |
|
Norcodeine nitrate |
2939.19 |
2 |
|
|
Norcodeine platinichloride |
2843.90 |
2 |
|
|
Norcodeine sulfate |
2939.19 |
2 |
|
|
Norlevorphanol (INN) |
2933.49 |
1531-12-0 |
1 |
|
Norlevorphanol hydrobromide |
2933.49 |
1 |
|
|
Norlevorphanol hydrochloride |
2933.49 |
1 |
|
|
Normethadone (INN) |
2922.31 |
467-85-6 |
1 |
|
Normethadone 2,6-di-tert- butylnaphthalenedisulfonate |
2922.31 |
1 |
|
|
Normethadone hydrobromide |
2922.31 |
1 |
|
|
Normethadone hydrochloride |
2922.31 |
847-84-7 |
1 |
|
Normethadone methyliodide |
2922.39 |
1 |
|
|
Normethadone oxalate |
2922.31 |
1 |
|
|
Normethadone picrate |
2922.31 |
1 |
|
|
Normethadone (INN) intermediate |
2926.90 |
||
|
Normorphine (INN) |
2939.19 |
466-97-7 |
1 |
|
Normorphine hydrochloride |
2939.19 |
1 |
|
|
Norpipanone (INN) |
2933.39 |
561-48-8 |
1 |
|
Norpipanone hydrobromide |
2933.39 |
1 |
|
|
Norpipanone hydrochloride |
2933.39 |
1 |
|
|
Ocfentanil (INN) |
2933.39 |
1 |
|
|
Opium |
1302.11 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Opium, mixed alkaloids of |
1302.11(*) |
||
|
2939.11(**) |
|||
|
Opium, prepared |
1302.19 |
||
|
2939.11 |
|||
|
Oripavine |
2939.19 |
|
1 |
|
Oripavine hydrochloride |
2939.19 |
|
1 |
|
Oxycodone (INN) |
2939.11 |
76-42-6 |
1 |
|
Oxycodone camphosulfonate |
2939.11 |
1 |
|
|
Oxycodone hydrochloride |
2939.11 |
124-90-3 |
1 |
|
Oxycodone hydrogen tartrate (bitartrate) |
2939.11 |
1 |
|
|
Oxycodone pectinate |
2939.11 |
1 |
|
|
Oxycodone phenylpropionate |
2939.11 |
1 |
|
|
Oxycodone phosphate |
2939.11 |
1 |
|
|
Oxycodone terephthalate |
2939.11 |
1 |
|
|
Oxymorphone (INN) |
2939.11 |
76-41-5 |
1 |
|
Oxymorphone hydrochloride |
2939.11 |
357-07-3 |
1 |
|
Papaver bracteatum |
1211.90 |
||
|
PEPAP |
2933.39 |
4 |
|
|
PEPAP hydrochloride |
2933.39 |
4 |
|
|
Pethidine (INN) |
2933.33 |
57-42-1 |
1 |
|
Pethidine hydrochloride |
2933.33 |
50-13-5 |
1 |
|
Pethidine (INN) intermediate A |
2933.33 |
1 |
|
|
Pethidine (INN) intermediate B |
2933.39 |
1 |
|
|
Pethidine intermediate B hydrobromide |
2933.39 |
1 |
|
|
Pethidine intermediate B hydrochloride |
2933.39 |
1 |
|
|
Pethidine (INN) intermediate C |
2933.39 |
1 |
|
|
Phenadoxone (INN) |
2934.99 |
467-84-5 |
1 |
|
Phenadoxone hydrochloride |
2934.99 |
545-91-5 |
1 |
|
Phenampromide (INN) |
2933.39 |
129-83-9 |
1 |
|
Phenampromide hydrochloride |
2933.39 |
1 |
|
|
Phenazocine (INN) |
2933.39 |
127-35-5 |
1 |
|
Phenazocine hydrobromide |
2933.39 |
1 |
|
|
Phenazocine hydrochloride |
2933.39 |
7303-75-5 |
1 |
|
Phenazocine mesilate |
2933.39 |
1 |
|
|
Phenomorphan (INN) |
2933.49 |
468-07-5 |
1 |
|
Phenomorphan hydrobromide |
2933.49 |
1 |
|
|
Phenomorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Phenomorphan methylbromide |
2933.49 |
1 |
|
|
Phenoperidine (INN) |
2933.33 |
562-26-5 |
1 |
|
Phenoperidine hydrochloride |
2933.33 |
3627-49-4 |
1 |
|
Pholcodine (INN) |
2939.11 |
509-67-1 |
2 |
|
Pholcodine hydrogen tartrate (bitartrate) |
2939.11 |
2 |
|
|
Pholcodine citrate |
2939.11 |
2 |
|
|
Pholcodine guaiacolsulfonate |
2939.11 |
2 |
|
|
Pholcodine hydrochloride |
2939.11 |
2 |
|
|
Pholcodine phenylacetate |
2939.11 |
2 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Pholcodine phosphate |
2939.11 |
2 |
|
|
Pholcodine sulfonate |
2939.11 |
2 |
|
|
Pholcodine tartrate |
2939.11 |
7369-11-1 |
2 |
|
Piminodine (INN) |
2933.39 |
13495-09-5 |
1 |
|
Piminodine dihydrochloride |
2933.39 |
1 |
|
|
Piminodine esilate |
2933.39 |
7081-52-9 |
1 |
|
Piritramide (INN) |
2933.33 |
302-41-0 |
1 |
|
Poppy straw |
1211.40 |
||
|
Proheptazine (INN) |
2933.99 |
77-14-5 |
1 |
|
Proheptazine citrate |
2933.99 |
1 |
|
|
Proheptazine hydrobromide |
2933.99 |
1 |
|
|
Proheptazine hydrochloride |
2933.99 |
1 |
|
|
Properidine (INN) |
2933.39 |
561-76-2 |
1 |
|
Properidine hydrochloride |
2933.39 |
1 |
|
|
Propiram (INN) |
2933.33 |
15686-91-6 |
2 |
|
Propiram fumarate |
2933.33 |
2 |
|
|
Racemethorphan (INN) |
2933.49 |
510-53-2 |
1 |
|
Racemethorphan hydrobromide |
2933.49 |
1 |
|
|
Racemethorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Racemoramide (INN) |
2934.99 |
545-59-5 |
1 |
|
Racemoramide dihydrochloride |
2934.99 |
1 |
|
|
Racemoramide hydrogen tartrate (bitartrate) |
2934.99 |
1 |
|
|
Racemoramide tartrate |
2934.99 |
1 |
|
|
Racemorphan (INN) |
2933.49 |
297-90-5 |
1 |
|
Racemorphan hydrobromide |
2933.49 |
1 |
|
|
Racemorphan hydrochloride |
2933.49 |
1 |
|
|
Racemorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Remifentanil (INN) |
2933.39 |
1 |
|
|
Remifentanil hydrochloride |
2933.39 |
1 |
|
|
Sufentanil (INN) |
2934.91 |
56030-54-7 |
1 |
|
Sufentanil citrate |
2934.91 |
1 |
|
|
Thebacon (INN) |
2939.11 |
466-90-0 |
1 |
|
Thebacon hydrochloride |
2939.11 |
20236-82-2 |
1 |
|
Thebaine hydrochloride |
2939.11 |
1 |
|
|
Thebaine hydrogen tartrate (bitartrate) |
2939.11 |
1 |
|
|
Thebaine oxalate |
2939.11 |
1 |
|
|
Thebaine salicylate |
2939.11 |
1 |
|
|
Tetrahydrofuranylfentanyl |
2934.99 |
1 |
|
|
Thiofentanyl |
2934.99 |
4 |
|
|
Thiofentanyl acetate |
2934.99 |
1 |
|
|
Thiofentanyl hydrochloride |
2934.99 |
4 |
|
|
Tilidine (INN) |
2922.44 |
20380-58-9 |
1 |
|
Tilidine hydrochloride |
2922.44 |
27107-79-5 |
1 |
|
Trimeperidine (INN) |
2933.33 |
64-39-1 |
1 |
|
Trimeperidine hydrochloride |
2933.33 |
125-80-4 |
1 |
|
U-47700 |
2924.29 |
|
1 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
AB-CHMINACA |
2933.99 |
|
2 |
|
AB-PINACA |
2933.99 |
|
2 |
|
Allobarbital (INN) |
2933.53 |
52-43-7 |
4 |
|
Allobarbital aminophenazone |
2933.54 |
4 |
|
|
Alprazolam (INN) |
2933.91 |
28981-97-7 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
AM-2201; JWH-2201 |
2933.99 |
|
2 |
|
Amfepramone (INN) |
2922.31 |
90-84-6 |
4 |
|
Amfepramone glutamate |
2922.42 |
4 |
|
|
Amfepramone hydrochloride |
2922.31 |
134-80-5 |
4 |
|
Amfepramone resinate |
3003.90 |
4 |
|
|
Amfetamine (INN) |
2921.46 |
300-62-9 |
2 |
|
Amfetamine acetylsalicylate |
2921.46 |
2 |
|
|
Amfetamine adipate |
2921.46 |
2 |
|
|
Amfetamine p-aminophenylacetate |
2922.49 |
2 |
|
|
Amfetamine aspartate |
2922.49 |
2 |
|
|
Amfetamine p-chloro- phenoxyacetate |
2921.46 |
2 |
|
|
Amfetamine hydrochloride |
2921.46 |
2 |
|
|
Amfetamine hydrogen tartrate (bitartrate) |
2921.46 |
2 |
|
|
Amfetamine pentobarbiturate |
2933.54 |
2 |
|
|
Amfetamine phosphate |
2921.46 |
139-10-6 |
2 |
|
Amfetamine resinate |
3003.90 |
2 |
|
|
Amfetamine sulfate |
2921.46 |
60-13-9 |
2 |
|
Amfetamine tannate |
3201.90 |
2 |
|
|
Amfetamine tartrate |
2921.46 |
2 |
|
|
Amineptine (INN) |
2922.49 |
2 |
|
|
Amineptine hydrochloride |
2922.49 |
2 |
|
|
Aminorex (INN) |
2934.91 |
2207-50-3 |
4 |
|
Aminorex fumarate |
2934.91 |
|
4 |
|
Aminorex hydrochloride |
2934.91 |
|
4 |
|
Amobarbital (INN) |
2933.53 |
57-43-2 |
3 |
|
Amobarbital resinate |
3003.90 |
3 |
|
|
Amobarbital sodium |
2933.53 |
64-43-7 |
3 |
|
Barbital (INN) |
2933.53 |
57-44-3 |
4 |
|
Barbital calcium |
2933.53 |
4 |
|
|
Barbital magnesium |
2933.53 |
4 |
|
|
Barbital sodium |
2933.53 |
144-02-5 |
4 |
|
Benzfetamine (INN) |
2921.46 |
156-08-1 |
4 |
|
Benzfetamine hydrochloride |
2921.46 |
5411-22-3 |
4 |
|
N-Benzylpiperazine; Benzylpiperazine; BZP |
2933.59 |
|
2 |
|
N-Benzylpiperazine dihydrochloride |
2933.59 |
|
2 |
|
N-Benzylpiperazine hydrochloride |
2933.59 |
|
2 |
|
25B-NBOMe; 2C-B-NBOMe |
2922.29 |
|
1 |
|
25B-NBOMe hydrochloride |
2922.29 |
|
1 |
|
Brolamfetamine (INN) (DOB) |
2922.29 |
64638-07-9 |
1 |
|
Brolamfetamine (DOB) hydrochloride |
2922.29 |
1 |
|
|
Bromazepam (INN) |
2933.33 |
1812-30-2 |
4 |
|
Brotizolam (INN) |
2934.91 |
57801-81-7 |
4 |
|
Buprenorphine (INN) |
2939.11 |
52485-79-7 |
3 |
|
Buprenorphine hydrochloride |
2939.11 |
53152-21-9 |
3 |
|
Buprenorphine hydrogen tartrate (bitartrate) |
2939.11 |
3 |
|
|
Buprenorphine sulfate |
2939.11 |
3 |
|
|
Butalbital (INN) |
2933.53 |
77-26-9 |
3 |
|
Butobarbital |
2933.53 |
77-28-1 |
4 |
|
Camazepam (INN) |
2933.91 |
36104-80-0 |
4 |
|
Cathine (INN) |
2939.43 |
492-39-7 |
3 |
|
Cathine hydrochloride |
2939.43 |
2153-98-2 |
3 |
|
Cathine phenobarbiturate |
2939.43 |
3 |
|
|
Cathine resinate |
3003.49 |
3 |
|
|
Cathine sulfate |
2939.43 |
3 |
|
|
Cathinone (INN) |
2939.79 |
71031-15-7 |
1 |
|
Cathinone hydrochloride |
2939.79 |
1 |
|
|
2C-B |
2922.29 |
2 |
|
|
2C-B hydrochloride |
2922.29 |
2 |
|
|
Chlordiazepoxide (INN) |
2933.91 |
58-25-3 |
4 |
|
Chlordiazepoxide dibunate |
2933.91 |
4 |
|
|
Chlordiazepoxide hydrochloride |
2933.91 |
438-41-5 |
4 |
|
Clobazam (INN) |
2933.72 |
22316-47-8 |
4 |
|
Clonazepam (INN) |
2933.91 |
1622-61-3 |
4 |
|
Clorazepate |
2933.91 |
4 |
|
|
Clorazepate dipotassium |
2933.91 |
57109-90-7 |
4 |
|
Clorazepate monopotassium |
2933.91 |
5991-71-9 |
4 |
|
Clotiazepam (INN) |
2934.91 |
33671-46-4 |
4 |
|
Cloxazolam (INN) |
2934.91 |
24166-13-0 |
4 |
|
Cyclobarbital (INN) |
2933.53 |
52-31-3 |
3 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Cyclobarbital calcium |
2933.53 |
5897-20-1 |
3 |
|
Delorazepam (INN) |
2933.91 |
2894-67-9 |
4 |
|
DET |
2939.79 |
61-51-8 |
1 |
|
DET hydrochloride |
2939.79 |
1 |
|
|
Dexamfetamine (INN) |
2921.46 |
51-64-9 |
2 |
|
Dexamfetamine adipate |
2921.46 |
2 |
|
|
Dexamfetamine carboxy- methylcellulose |
3912.31 |
2 |
|
|
Dexamfetamine hydrochloride |
2921.46 |
405-41-4 |
2 |
|
Dexamfetamine hydrogen tartrate (bitartrate) |
2921.46 |
2 |
|
|
Dexamfetamine pento- barbiturate |
2933.54 |
2 |
|
|
Dexamfetamine phosphate |
2921.46 |
7528-00-9 |
2 |
|
Dexamfetamine resinate |
3003.90 |
2 |
|
|
Dexamfetamine saccharate |
2921.49 |
2 |
|
|
Dexamfetamine sulfate |
2921.46 |
51-63-8 |
2 |
|
Dexamfetamine tannate |
3201.90 |
2 |
|
|
Diazepam (INN) |
2933.91 |
439-14-5 |
4 |
|
DMA |
2922.29 |
1 |
|
|
DMA hydrochloride |
2922.29 |
1 |
|
|
DMHP |
2932.99 |
1 |
|
|
DMT |
2939.79 |
61-50-7 |
1 |
|
DMT hydrochloride |
2939.79 |
1 |
|
|
DMT methyliodide |
2939.79 |
1 |
|
|
DOET |
2922.29 |
1 |
|
|
DOET hydrochloride |
2922.29 |
1 |
|
|
Estazolam (INN) |
2933.91 |
29975-16-4 |
4 |
|
Ethchlorvynol (INN) |
2905.51 |
113-18-8 |
4 |
|
Ethinamate (INN) |
2924.24 |
126-52-3 |
4 |
|
Ethyl loflazepate (INN) |
2933.91 |
29177-84-2 |
4 |
|
N-Ethyl MDA |
2932.99 |
1 |
|
|
N-Ethyl MDA hydrochloride |
2932.99 |
1 |
|
|
Eticyclidine (PCE) (INN) |
2921.49 |
2201-15-2 |
1 |
|
Eticyclidine (PCE) hydrochloride |
2921.49 |
1 |
|
|
Etilamfetamine (INN) |
2921.46 |
457-87-4 |
4 |
|
Etilamfetamine hydrochloride |
2921.46 |
4 |
|
|
Etryptamine (INN) |
2939.79 |
1 |
|
|
Etryptamine acetate |
2939.79 |
1 |
|
|
Etryptamine hydrochloride |
2939.79 |
1 |
|
|
5F-ADB; 5F-MDMB-PINACA |
2933.99 |
2 |
|
|
5F-APINACA; 5F-AKB-48 |
2933.99 |
2 |
|
|
5F-PB-22 |
2933.49 |
2 |
|
|
Fencamfamin (INN) |
2921.46 |
1209-98-9 |
4 |
|
Fencamfamin hydrochloride |
2921.46 |
2240-14-4 |
4 |
|
Fenetylline (INN) |
2939.51 |
3736-08-1 |
2 |
|
Fenetylline hydrochloride |
2939.51 |
1892-80-4 |
2 |
|
Fenproporex (INN) |
2926.30 |
15686-61-0 |
4 |
|
Fenproporex diphenylacetate |
2926.30 |
4 |
|
|
Fenproporex hydrochloride |
2926.30 |
18305-29-8 |
4 |
|
Fenproporex resinate |
3003.90 |
4 |
|
|
Fludiazepam (INN) |
2933.91 |
3900-31-0 |
4 |
|
Flunitrazepam (INN) |
2933.91 |
1622-62-4 |
4 |
|
Flurazepam (INN) |
2933.91 |
17617-23-1 |
4 |
|
Flurazepam dihydrochloride |
2933.91 |
1172-18-5 |
4 |
|
Flurazepam hydrochloride |
2933.91 |
36105-20-1 |
4 |
|
Glutethimide (INN) |
2925.12 |
77-21-4 |
3 |
|
Halazepam (INN) |
2933.91 |
23092-17-3 |
4 |
|
Haloxazolam (INN) |
2934.91 |
59128-97-1 |
4 |
|
N-Hydroxy MDA |
2932.99 |
1 |
|
|
N-Hydroxy MDA hydrochloride |
2932.99 |
1 |
|
|
Ketazolam (INN) |
2934.91 |
27223-35-4 |
4 |
|
Lefetamine (INN) |
2921.46 |
7262-75-1 |
4 |
|
Lefetamine hydrochloride |
2921.46 |
14148-99-3 |
4 |
|
Levamfetamine (INN) |
2921.46 |
156-34-3 |
2 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Levamfetamine alginate |
3913.10 |
2 |
|
|
Levamfetamine succinate |
2921.49 |
5634-40-2 |
2 |
|
Levamfetamine sulfate |
2921.49 |
2 |
|
|
Levometamfetamine |
2939.71 |
2 |
|
|
Levometamfetamine hydrochloride |
2939.71 |
2 |
|
|
Loprazolam (INN) |
2933.55 |
61197-73-7 |
4 |
|
Loprazolam mesilate |
2933.55 |
4 |
|
|
Lorazepam (INN) |
2933.91 |
846-49-1 |
4 |
|
Lorazepam acetate |
2933.91 |
4 |
|
|
Lorazepam mesilate |
2933.91 |
4 |
|
|
Lorazepam pivalate |
2933.91 |
4 |
|
|
Lormetazepam (INN) |
2933.91 |
848-75-9 |
4 |
|
Lysergide (INN), LSD, LSD-25 |
2939.69 |
50-37-3 |
1 |
|
(+)-Lysergide tartrate |
2939.69 |
1 |
|
|
Mazindol (INN) |
2933.91 |
22232-71-9 |
4 |
|
MDMA |
2932.99 |
1 |
|
|
MDMA hydrochloride |
2932.99 |
1 |
|
|
Mecloqualone (INN) |
2933.55 |
340-57-8 |
2 |
|
Mecloqualone hydrochloride |
2933.55 |
2 |
|
|
Medazepam (INN) |
2933.91 |
2898-12-6 |
4 |
|
Medazepam dibunate |
2933.91 |
4 |
|
|
Medazepam hydrochloride |
2933.91 |
4 |
|
|
Mefenorex (INN) |
2921.46 |
17243-57-1 |
4 |
|
Mefenorex hydrochloride |
2921.46 |
4 |
|
|
Meprobamate (INN) |
2924.11 |
57-53-4 |
4 |
|
Mescaline |
2939.79 |
54-04-6 |
1 |
|
Mescaline aurichloride |
2843.30 |
1 |
|
|
Mescaline hydrochloride |
2939.79 |
832-92-8 |
1 |
|
Mescaline picrate |
2939.79 |
1 |
|
|
Mescaline platinichloride |
2843.90 |
1 |
|
|
Mescaline sulfate |
2939.79 |
1152-76-7 |
1 |
|
Mesocarb (INN) |
2934.71 |
34262-84-5 |
4 |
|
Metamfetamine (INN) |
2939.71 |
537-46-2 |
2 |
|
Metamfetamine hydrochloride |
2939.71 |
51-57-0 |
2 |
|
Metamfetamine hydrogen tartrate (bitartrate) |
2939.71 |
2 |
|
|
Metamfetamine racemate |
2939.71 |
4846-07-5 |
2 |
|
Metamfetamine sulfate |
2939.71 |
2 |
|
|
Methaqualone (INN) |
2933.55 |
72-44-6 |
2 |
|
Methaqualone hydrochloride |
2933.55 |
340-56-7 |
2 |
|
Methaqualone resinate |
3003.90 |
2 |
|
|
Methylaminorex |
2934.99 |
1 |
|
|
Methylaminorex hydrochloride |
2934.99 |
1 |
|
|
Methylphenidate (INN) |
2933.33 |
113-45-1 |
2 |
|
Methylphenidate hydrochloride |
2933.33 |
298-59-9 |
2 |
|
Methylphenobarbital (INN) |
2933.53 |
115-38-8 |
4 |
|
Methylphenobarbital sodium |
2933.53 |
4 |
|
|
Methyprylon (INN) |
2933.72 |
125-64-4 |
4 |
|
Midazolam (INN) |
2933.91 |
59467-70-8 |
4 |
|
Midazolam hydrochloride |
2933.91 |
4 |
|
|
Midazolam maleate |
2933.91 |
4 |
|
|
MMDA |
2932.99 |
1 |
|
|
MMDA hydrochloride |
2932.99 |
1 |
|
|
Nimetazepam (INN) |
2933.91 |
2011-67-8 |
4 |
|
Nitrazepam (INN) |
2933.91 |
146-22-5 |
4 |
|
Nordazepam (INN) |
2933.91 |
1088-11-5 |
4 |
|
Oxazepam (INN) |
2933.91 |
604-75-1 |
4 |
|
Oxazepam acetate |
2933.91 |
4 |
|
|
Oxazepam hemisuccinate |
2933.91 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Oxazepam succinate |
2933.91 |
4 |
|
|
Oxazepam valproate |
2933.91 |
4 |
|
|
Oxazolam (INN) |
2934.91 |
24143-17-7 |
4 |
|
Parahexyl |
2932.99 |
1 |
|
|
Pemoline (INN) |
2934.91 |
2152-34-3 |
4 |
|
Pemoline copper |
2934.91 |
4 |
|
|
Pemoline iron |
2934.91 |
4 |
|
|
Pemoline magnesium |
2934.91 |
4 |
|
|
Pemoline nickel |
2934.91 |
4 |
|
|
Pentazocine (INN) |
2933.33 |
359-83-1 |
3 |
|
Pentazocine hydrochloride |
2933.33 |
3 |
|
|
Pentazocine lactate |
2933.33 |
17146-95-1 |
3 |
|
Pentobarbital (INN) |
2933.53 |
76-74-4 |
3 |
|
Pentobarbital calcium |
2933.53 |
7563-42-0 |
3 |
|
Pentobarbital sodium |
2933.53 |
57-33-0 |
3 |
|
Phencyclidine (INN) (PCP) |
2933.33 |
77-10-1 |
2 |
|
Phencyclidine hydrobromide |
2933.33 |
2 |
|
|
Phencyclidine hydrochloride |
2933.33 |
956-90-1 |
2 |
|
Phendimetrazine (INN) |
2934.91 |
634-03-7 |
4 |
|
Phendimetrazine hydrochloride |
2934.91 |
4 |
|
|
Phendimetrazine hydrogen tartrate (bitartrate) |
2934.91 |
50-58-8 |
4 |
|
Phendimetrazine pamoate |
2934.91 |
4 |
|
|
Phenmetrazine (INN) |
2934.91 |
134-49-6 |
2 |
|
Phenmetrazine hydrochloride |
2934.91 |
1707-14-8 |
2 |
|
Phenmetrazine hydrogen tartrate (bitartrate) |
2934.91 |
2 |
|
|
Phenmetrazine sulfate |
2934.91 |
2 |
|
|
Phenmetrazine teoclate |
2939.59 |
13931-75-4 |
2 |
|
Phenobarbital (INN) |
2933.53 |
50-06-6 |
4 |
|
Phenobarbital ammonium |
2933.53 |
4 |
|
|
Phenobarbital calcium |
2933.53 |
58766-25-9 |
4 |
|
Phenobarbital diethylamine |
2933.53 |
4 |
|
|
Phenobarbital diethylaminoethanol |
2933.53 |
4 |
|
|
Phenobarbital lysidine |
2933.53 |
4 |
|
|
Phenobarbital magnesium |
2933.53 |
4 |
|
|
Phenobarbital propylhexedrine |
2933.53 |
4 |
|
|
Phenobarbital quinidine |
2939.20 |
4 |
|
|
Phenobarbital sodium, magnesium |
2933.53 |
4 |
|
|
Phenobarbital sodium (INN) |
2933.53 |
57-30-7 |
4 |
|
Phenobarbital sparteine |
2939.79 |
4 |
|
|
Phenobarbital tetramethyl- ammonium |
2933.53 |
4 |
|
|
Phenobarbital yohimbine |
2939.79 |
4 |
|
|
Phentermine (INN) |
2921.46 |
122-09-8 |
4 |
|
Phentermine hydrochloride |
2921.46 |
1197-21-3 |
4 |
|
Phentermine resinate |
3003.90 |
4 |
|
|
Pinazepam (INN) |
2933.91 |
52463-83-9 |
4 |
|
Pipradrol (INN) |
2933.33 |
467-60-7 |
4 |
|
Pipradrol hydrochloride |
2933.33 |
71-78-3 |
4 |
|
PMA |
2922.29 |
1 |
|
|
PMA hydrochloride |
2922.29 |
1 |
|
|
Prazepam (INN) |
2933.91 |
2955-38-6 |
4 |
|
Psilocine, psilotsin |
2939.79 |
1 |
|
|
Psilocine, psilotsin hydrochloride |
2939.79 |
1 |
|
|
Psilocybine (INN) |
2939.79 |
520-52-5 |
1 |
|
Psilocybine hydrochloride |
2939.79 |
1 |
|
|
Pyrovalerone (INN) |
2933.91 |
3563-49-3 |
4 |
|
Pyrovalerone hydrochloride |
2933.91 |
1147-62-2 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Rolicyclidine (INN) (PHP, PCPY) |
2933.99 |
2201-39-0 |
1 |
|
Secbutabarbital (INN) |
2933.53 |
125-40-6 |
4 |
|
Secbutabarbital sodium |
2933.53 |
4 |
|
|
Secobarbital (INN) |
2933.53 |
76-73-3 |
2 |
|
Secobarbital calcium |
2933.53 |
2 |
|
|
Secobarbital resinate |
3003.90 |
2 |
|
|
Secobarbital sodium |
2933.53 |
309-43-3 |
2 |
|
STP, DOM |
2922.29 |
15588-95-1 |
1 |
|
STP, DOM hydrochloride |
2922.29 |
1 |
|
|
Temazepam (INN) |
2933.91 |
846-50-4 |
4 |
|
Tenamfetamine (INN) (MDA) |
2932.99 |
51497-09-7 |
1 |
|
Tenamfetamine (MDA) hydrochloride |
2932.99 |
1 |
|
|
Tenocyclidine (INN) |
2934.99 |
21500-98-1 |
1 |
|
Tenocyclidine hydrochloride |
2934.99 |
1 |
|
|
Tetrahydrocannabinols, all isomers |
2932.95 |
various |
2 |
|
d-9-Tetrahydrocannabinol |
2932.95 |
1972-08-3 |
2 |
|
Tetrazepam (INN) |
2933.91 |
10379-14-3 |
4 |
|
TMA |
2922.29 |
1 |
|
|
TMA hydrochloride |
2922.29 |
1 |
|
|
Triazolam (INN) |
2933.91 |
28911-01-5 |
4 |
|
Vinylbital (INN) |
2933.53 |
2430-49-1 |
4 |
|
Zipeprol (INN) |
2933.55 |
34758-83-3 |
2 |
III. Precursors
|
Name |
HS subheading |
CAS No. |
|
Acetic anhydride |
2915.24 |
108-24-7 |
|
Acetone |
2914.11 |
67-64-1 |
|
N-Acetylanthranilic acid |
2924.23 |
89-52-1 |
|
alpha-Phenylacetoacetonitrile (APAAN) |
2926.40 |
4468-48-8 |
|
Anthranilic acid |
2922.43 |
118-92-3 |
|
Butanone (ethyl methyl ketone) |
2914.12 |
78-93-3 |
|
Diethyl ether |
2909.11 |
60-29-7 |
|
Ephedrine |
2939.41 |
299-42-3 |
|
Ephedrine hydrochloride |
2939.41 |
50-98-6 |
|
Ephedrine nitrate |
2939.41 |
81012-98-8 |
|
Ephedrine sulfate |
2939.41 |
134-72-5 |
|
Ergometrine (INN) |
2939.61 |
60-79-7 |
|
Ergometrine hydrochloride |
2939.61 |
74283-21-9 |
|
Ergometrine hydrogen maleate |
2939.61 |
129-51-1 |
|
Ergometrine oxalate |
2939.61 |
|
|
Ergometrine tartrate |
2939.61 |
129-50-0 |
|
Ergotamine (INN) |
2939.62 |
113-15-5 |
|
Ergotamine hydrochloride |
2939.62 |
|
|
Ergotamine succinate |
2939.62 |
|
|
Ergotamine tartrate |
2939.62 |
379-79-3 |
|
Hydrogen chloride (hydrochloric acid) |
2806.10 |
7647-01-0 |
|
Isosafrole |
2932.91 |
120-58-1 |
|
Lysergic acid |
2939.63 |
82-58-6 |
|
3,4-(Methylenedioxy)phenyl-2- propanone |
2932.92 |
4676-39-5 |
|
Norephedrine |
2939.44 |
14838-15-4 |
|
Norephedrine hydrochloride |
2939.44 |
154-41-6 |
|
Phenylacetone (benzyl methyl ketone, phenylpropan-2-one) |
2914.31 |
103-79-7 |
|
Phenylacetic acid |
2916.34 |
103-82-2 |
|
Piperidine |
2933.32 |
110-89-4 |
|
Piperidine aurichloride |
2843.30 |
|
|
Piperidine hydrochloride |
2933.32 |
6091-44-7 |
|
Piperidine hydrogen tartrate (bitartrate) |
2933.32 |
6091-46-9 |
|
Piperidine nitrate |
2933.32 |
6091-45-8 |
|
Piperidine phosphate |
2933.32 |
|
|
Piperidine picrate |
2933.32 |
6091-49-2 |
|
Piperidine platinichloride |
2843.90 |
|
|
Piperidine thiocyanate |
2933.32 |
22205-64-7 |
|
Piperonal |
2932.93 |
120-57-0 |
|
Potassium permanganate |
2841.61 |
7722-64-7 |
|
Pseudoephedrine (INN) |
2939.42 |
90-82-4 |
|
Pseudoephedrine hydrochloride |
2939.42 |
345-78-8 |
|
Pseudoephedrine sulfate |
2939.42 |
7460-12-0 |
|
Safrole |
2932.94 |
94-59-7 |
|
Sulphuric acid |
2807.00 |
7664-93-9 |
|
Toluene |
2902.30 |
108-88-3 |
______________________
LIST OF PRECURSORS AND ESSENTIAL CHEMICALS WHICH ARE MOST COMMONLY USED IN THE ILLEGAL PRODUCTION OF CERTAIN CONTROLLED SUBSTANCES
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
HEROIN or DIACETY- MORPHINE (2939.11) |
(i) Codeine (P) (2939.11) |
Codicept Coducept 7,8-Didehydro‑4,5- epoxy-3-methoxy-17-methylmorphinan-6-o1 Methylmorphine 3‑O‑Methylmorphine Morphinan‑6‑ol, 7,8‑ didehydro‑4,5‑epoxy‑ 3‑methoxy‑17‑methyl Morphine, 3-methyl ether Morphine monomethyl ether |
76‑57‑3 52‑28‑8 (S) |
|
(ii) Morphine (P) (2939.11) |
7,8‑Didehydro‑4,5‑ epoxy‑17‑methyl‑ morphinan‑3,6‑diol Morphinan‑3,6‑diol, 7,8‑didehydro‑4,5‑ epoxy‑17‑methyl |
57-27-2 (anhydrous) 6009-81-0 (monohydrate) |
|
|
(iii) Acetic anhydride (E) (2915.24) |
Acetanhydride Acetic oxide Acetyl oxide Ethanoic anhydride |
108‑24‑7 |
|
|
(iv) Acetyl chloride (E) (2915.90) |
Ethanoyl chloride |
75‑36‑5 |
|
|
(v) Ethylidene diacetate (E) (2915.39) |
Acetic acid, ethylidene ester 1,1‑Diacetoxyethane |
542‑10‑9 |
|
|
COCAINE or METHYL BENZOYL- ECGONINE (2939.71) |
(i) Acetone (E) (2914.11) |
2‑Propanone Dimethylketone β‑Ketopropane Pyroacetic ether Propane‑2‑one |
67‑64‑1 |
|
(ii) Diethyl ether (E) (2909.11) |
Ethyl ether Ether Ethoxyethane Ethyl oxide Diethyl oxide Anaesthetic ether |
60‑29‑7 |
|
|
(iii) Methyl ethyl ketone (MEK) (E) (2914.12) |
Butanone |
78‑93‑3 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
LYSERGIDE (INN) or LSD or N,N‑DIETHYL- LYSERGAMIDE (2939.69) |
(i) Ergotamine (INN) (P) (2939.62) |
5'‑Benzyl‑12'‑hydroxy‑ 2'‑ methylergotaman-3',6',18‑trione Ergotaman‑3',6',18‑ trione, 12'‑hydroxy‑2'‑ methyl‑5'‑ (phenylmethyl) 12'‑Hydroxy‑2'‑methyl-5'‑(phenylmethyl) ergotaman‑3',6', 18‑ trione Indolo[4,3‑fg]quinoline, ergotaman‑3',6',18‑ trione derivative 8H‑Oxazolo[3,2,‑a]- pyrrolo[2,1‑c]pyrazine, ergotaman‑3',6',18‑ trione derivative N‑(5‑Benzyl‑10b‑ hydroxy‑ 2‑methyl‑3,6-dioxoperhydrooxazolo- [3,2‑a]pyrrolo[2,1‑c]- pyrazin‑2‑yl)‑D‑ lysergamide Ergam Ergate Ergomar Ergostat Ergotamine bitartrate Ergotamine, tartrate (2 : 1) (S) Ergotamini tartras Ergotaman‑3',6',18‑ trione, 12'‑hydroxy‑2'-methyl‑5'‑(phenyl- methyl)‑, ‑2,3dihydroxy-butanedioate (2 : 1) (S) Ergotartrate Etin Exmigra Femergin Gotamine tartrate Gynergene Lingraine Lingran Medihaler Ergotamine Neo‑Ergotine Rigetamine Secagyne Secupan |
113‑15‑5 379‑79‑3 (S) |
|
(ii) Lysergamide (P) (2939.69) |
9,10‑Didehydro‑6‑ methylergoline‑8‑ carboxamide Ergine Ergoline‑8‑carboxamide, 9,10‑didehydro‑6‑methyl Indolo[4,3‑fg]quinoline, ergoline‑8-carboxamide derivative |
478‑94‑4 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
(iii) Lysergic acid (P) (2939.63) |
Ergoline‑8‑carboxylic acid, 9,10‑didehydro‑6‑ methyl- indolo [4,3‑fg] quinoline, ergoline‑8‑carboxylic acid derivative 4,6,6a,7,8,9‑Hexahydro‑ 7‑methylindolo‑[4,3‑fg]- quinoline‑9‑carboxylic acid 9,10‑Didehydro‑ 6‑methyl- ergoline‑8‑ carboxylic acid |
82‑58‑6 |
|
|
(iv) Methyl 6-methylnicotinate (P) (2933.39) |
Methyl 6‑methylpyridine‑3‑ carboxylate 6‑Methylnicotinic acid, methyl ester Nicotinic acid, 6‑methyl‑, methyl ester 3‑Pyridinecarboxylic acid, 6‑methyl‑, methyl ester |
5470‑70‑2 |
|
|
(v) Ergometrine (INN) (P) (2939.61) |
Ergonovine Ergobasine Ergotocine Ergostetrine Ergotrate Ergoklinine Syntometrine 9,10‑Didehydro‑N‑(2‑ hydroxy‑1‑methylethyl)‑ 6‑methylergoline‑8‑ carboxamide N‑(2‑Hydroxy‑1‑methyl‑ etethyl)lysergamide Lysergic acid, 2‑propanolamide |
60‑79‑7 60-79-7 |
|
|
Lysergic acid, 2‑hydroxy‑1‑methylethyl amide Hydroxypropyllyserg‑ amide Basergin Neofemergen Cornocentin Ermetrine |
129‑50‑0 (S) 129‑51‑1 (S) |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
AMFETAMINE (INN) (AMPHETAMINE) or α‑METHYL- PHENETHYLAMINE (2921.46) |
(i) Allylbenzene (P) (2902.90) |
3‑Phenylprop‑1‑ene |
300‑57‑2 |
|
(ii) Phenyl-acetone (P) (2914.31) |
P‑2‑P Phenylpropan‑2‑one 1‑Phenyl‑2‑oxopropane Benzyl methyl ketone BMK |
103-79-7 |
|
|
(iii) Cathine (INN) (P) (2939.43) |
Norpseudoephedrine Adiposetten N 2‑Amino‑1‑hydroxy‑1‑ phenylpropane 2‑Amino‑2‑methyl‑1‑ phenylethanol 2‑Amino‑1‑phenylpropan-1-ol Benzenemethanol, α‑(1‑aminoethyl) E 50 Exponcit Fugoa‑Depot Katine Miniscap M.D. Minusin(e) Norisoephedrine 1‑Phenyl‑2‑aminopropan-1-ol Phenylpropanolamine Pseudonorephedrin(e) Reduform |
37577-07-04 36393‑56‑3 492-39-7 |
|
|
(iv) Phenylacetic acid (P) (2916.34) |
Benzeneacetic acid α‑Toluic acid |
103‑82‑2 |
|
|
(v) Formamide (P) (2924.19) |
Methanamide Carbamaldehyde Formic acid amide |
75‑12‑7 |
|
|
(vi) Benzaldehyde (P) (2912.21) |
Benzoic aldehyde Benzenecarbonal |
100‑52‑7 |
|
|
(vii) Ammonium formate (E) (2915.12) |
― |
540‑69‑2 |
|
|
(viii) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(ix) Hydroxyl- ammonium chloride (E) (2825.10) |
Hydroxylamine hydrochloride Oxammonium hydro‑ chloride |
5470‑11‑1 |
|
|
(x) Trans-β-Methyl-styrene (P) (2902.90) |
1‑Phenylpropene Prop-1-enylbenzene |
873‑66‑5 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
METHYLENE DIOXYAMPHETA- MINE or MDA or α‑METHYL‑3,4‑ METHYLENE- DIOXYPHEN-ETHYLAMINE (2932.99) |
(i) Piperonal (P) (2932.93) |
1,3‑Benzodioxole‑5‑ carbaldehyde Protocatechualdehyde, methylene ether 1,3‑Benzodioxole‑5‑ carboxaldehyde 3,4‑(Methylenedioxy)-benzaldehyde Heliotropin Piperonylaldehyde Dioxymethyleneproto‑ catechuic aldehyde |
120‑57‑0 |
|
(ii) Safrole (P) (2932.94) |
5‑Allyl‑1,3-benzodioxole 1,2‑Methylenedioxy‑ 4‑prop‑2‑enylbenzene 5‑Prop‑2‑enyl‑1,3‑ benzodioxole |
94‑59‑7 |
|
|
(iii) Isosafrole (P) (2932.91) |
5‑Prop‑1‑enyl‑1,3-benzodioxole 1,2‑Methylenedioxy‑4-prop‑1‑enylbenzene |
120‑58‑1 |
|
|
(iv) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(v) 1-(1,3‑Benzo-dioxole‑5‑yl) propan‑2‑ one (P) (2932.92) |
3,4‑Methylenedioxy-phenylacetone 3,4‑Methylenedioxy-phenylpropane-2-one |
4676‑39‑5 |
|
|
(vi) Ammonium formate (E) (2915.12) |
― |
540‑69‑2 |
|
|
(vii) Hydroxyl-ammonium chloride (E) (2825.10) |
Hydroxylamine hydrochloride Oxammonium hydrochloride |
5470‑11‑1 |
|
|
(viii) Formamide (E) (2924.19) |
Methanamide Carbamaldehyde Formic acid amide |
75‑12‑7 |
|
|
METAMFETAMINE (INN) (METHAMPHE-TAMINE) or 2-METHYLAMINO-1- PHENYLPROPANE or DEOXYEPHEDRINE (2939.71) |
(i) Pheny-lacetone (P) (2914.31) |
P‑2‑P Phenylpropan‑2‑one 1‑Phenyl‑2‑oxopropane Benzyl methyl ketone BMK |
103‑79‑7 |
|
(ii) N‑Methyl-formamide (P) (2924.19) |
Methylformamide |
123‑39‑7 |
|
|
(iii) Benzyl chloride(P) (2903.99) |
(Chloromethyl)benzene α‑Chlorotoluene |
100‑44‑7 |
|
|
(iv) Ephedrine (P) (2939.41) |
1‑Phenyl‑1‑hydroxy‑2‑ methylaminopropane 2‑Methylamino‑1-phenyl-propan-1-ol |
299‑42‑3 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
(v) Methylamine (P) (2921.11) |
Aminomethane Monomethylamin(e) Methanamine |
74‑89‑5 |
|
|
(vi) Phenylacetic acid (P) (2916.34) (vii) Benzaldehyde (P) (2912.21) |
Benzeneacetic acid α‑Toluic acid Benzoic aldehyde Benzenecarbonal |
103‑82‑2 100‑52‑7 |
|
|
METHYLENE- DIOXYMETHAM-PHETAMINE or MDMA or α‑METHYL‑3,4-METHYLENE- DIOXYPHENETHYL- (METHYL)AMINE or XTC (Ecstasy) (2932.99) |
(i) Methylamine (E) (2921.11) |
Aminomethane Monomethylamine Methanamine |
74‑89‑5 |
|
(ii) Piperonal (P) (2932.93) |
1,3‑Benzodioxole‑5‑ carbaldehyde Protocatechualdehyde, methylene ether 1,3‑Benzodioxole‑5‑ carboxaldehyde 3,4‑(Methylenedioxy)‑ benzaldehyde Heliotropin Piperonylaldehyde Dioxymethyleneprotoca‑ technic aldehyde |
120‑57‑0 |
|
|
(iii) Safrole (P) (2932.94) |
5‑Allyl‑1,3‑ benzodioxole 1,2‑Methylenedioxy‑4-prop‑2‑enylbenzene 5‑Prop‑2‑enyl‑1,3‑ benzodioxole |
94‑59‑7 |
|
|
(iv) Isosafrole (P) (2932.91) |
5‑Prop‑1‑enyl‑1,3‑ benzodioxole 1,2‑Methylenedioxy‑4-prop‑1‑enylbenzene |
120‑58‑1 |
|
|
(v) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(vi) 1‑(1,3‑Benzo-dioxole‑5‑yl) propan- 2‑one (P) (2932.92) |
3,4‑Methylenedioxy‑ phenylacetone 3,4‑Methylenedioxyphenyl-propane-2-one |
4676‑39‑5 |
|
|
METHAQUALONE (INN) or 2‑METHYL‑3‑O-TOLYL‑4‑(3H)-QUINAZOLINONE (2933.55) |
(i) Anthranilic acid (P) (2922.43) |
o‑Aminobenzoic acid 2‑Aminobenzoic acid |
118‑92‑3 |
|
(ii) o‑Toluidine (P) (2921.43) |
o‑Aminotoluene 2‑Aminotoluene |
95‑53‑4 |
|
|
(iii) o‑Nitro- toluene (P) (2904.20) |
1-Methyl‑2-nitrobenzene 2‑Nitrotoluene |
88‑72‑2 |
|
|
(iv) Acetic anhydride (E) (2915.24) |
Acetanhydride Acetic oxide Acetyl oxide Ethanoic anhydride |
108‑24‑7 |
|
|
(v) 2‑Methyl‑ 1,3-benzoxazole (P) (2934.99) |
― |
95‑21‑6 |
|
|
(vi) 2-Acetamido- benzoic acid (P) (2924.23) |
2‑Acetylaminobenzoic acid o‑Acetylaminobenzoic acid N‑Acetylanthranilic acid |
89‑52‑1 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
MESCALINE or 3,4,5-TRIMETHOXY-PHENETHYLAMINE (2939.79) |
(i) 3,4,5-Trimethoxy-benzalde-hyde (P) (2912.49) (ii) 3,4,5‑ Trimethoxy-benzoic acid (P) (2918.99) |
3,4,5‑Trimethoxyformyl‑ benzene Gallic acid, trimethyl |
86‑81‑7 118‑41‑2 |
|
(iii) 3,4,5‑Trimeth-oxybenzoyl chloride (P) (2918.99) |
― |
4521‑61‑3 |
|
|
(iv) 3,4,5‑Trimeth-oxybenzyl alcohol (P) (2909.49) |
― |
3840‑31‑1 |
|
|
(v) Nitromethane (E) (2904.20) |
― |
75‑52‑5 |
|
|
PHENCYCLIDINE (INN) or PCP or 1‑(1‑PHENYLCYCLOHEXYL) PIPERIDINE (2933.33) |
(i) Piperidine (P) (2933.32) |
Hexahydropyridine Pentamethylenimine |
110‑89‑4 |
|
(ii) Cyclohexanone (P) (2914.22) |
Pimelic ketone Ketohexamethylene Hytrol o Anone Nadone |
108‑94‑1 |
|
|
(iii) Bromobenzene (P) (2903.99) |
Monobromobenzene Phenyl bromide |
108‑86‑1 |
______________________
CHEMICAL STRUCTURES OF CERTAIN PRODUCTS DESCRIBED IN THE EXPLANATORY NOTES TO CHAPTER 29
|
Page |
Heading |
Paragraph
|
Description in the Explanatory Notes |
Chemical Structure |
||||
|
General |
(G) |
Classification of esters, salts, co-ordination compounds and certain halides |
||||||
|
(1) |
Esters |
|||||||
|
VI-29-7 |
(a) |
|
||||||
|
(b) |
|
|||||||
|
(c) |
(Butyl hydrogenphthalate) 29.17 |
|||||||
|
(VI-29-7) |
(G) |
(1) |
(d) |
|
||||
|
(d) |
|
|||||||
|
(2) |
Salts |
|||||||
|
(a)(i) |
|
|||||||
|
(VI-29-7) |
(G) |
(2) |
(a)(i) |
|
||||
|
VI-29-8 |
(ii) |
|
||||||
|
(b)(i) |
|
|||||||
|
(ii) |
|
|||||||
|
VI-29-9 |
(G) |
(4) |
Halides of carboxylic acids (Isobutyryl chloride : 29.15) |
|
||||
|
29.02 |
Cyclic hydrocarbons |
|||||||
|
(B) |
CYCLOTERPENES |
|||||||
|
VI-2902-2 |
(3) |
Limonene |
|
|||||
|
(C) |
AROMATIC HYDROCARBONS |
|||||||
|
VI-2902-3 |
(I) |
(c) |
o-xylene |
|
||||
|
(d)(1) |
Styrene |
|
||||||
|
(VI-2902-3) |
(29.02) |
(C) |
(I) |
(d)(4) |
p-Cymene |
|
||
|
29.03 |
Halogenated derivatives of hydrocarbons |
|||||||
|
(F) |
HALOGANATED DERIVATIVES OF AROMATIC HYDROCARBONS |
|||||||
|
VI-2903-4 |
(6) |
DDT (ISO) (clofenotane (INN), 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane or dichlorodiphenyltrichloroethane) |
|
|||||
|
(11) |
2.2'.4.4'.5.5'-hexabromobiphenyl |
|
||||||
|
29.04 |
Sulphonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated |
|||||||
|
(A) |
SULPHONATED DERIVATIVES |
|||||||
|
VI-2904-1 |
(1) |
(a) |
Ethylenesulphonic acid |
|
||||
|
(B) |
NITRATED DERIVATIVES |
|||||||
|
(1) |
(d) |
Trinitromethane |
CH(NO2)3 |
|||||
|
(C) |
NITROSATED DERIVATIVES |
|||||||
|
VI-2904-2 |
(2) |
Nitrosotoluene |
|
|||||
|
(D) |
SULPHOHALOGENATED DERIVATIVES |
|||||||
|
(1) |
Chlorobenzenesulphonic acid |
|
||||||
|
(5) |
Perfluorooctane sulphonic acid (PFOS) |
|
||||||
|
3 |
29.05 |
Acyclic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives |
||||||
|
(B) |
UNSATURATED MONOHYDRIC ALCOHOLS |
|||||||
|
VI-2905-3 |
(1) |
Allyl alcohol |
|
|||||
|
(C) |
DIOLS AND OTHER POLYHYDRIC ALCOHOLS |
|||||||
|
(II) |
(4) |
Mannitol |
|
|||||
|
29.06 |
Cyclic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
CYCLANIC, CYCLENIC OR CYCLOTERPENIC ALCOHOLS AND THEIR HALOGENATED, SULPHONATED, NITRATED OR NITROSATED DERIVATIVES |
|||||||
|
VI-2906-1 |
(1) |
Menthol |
|
|||||
|
29.07 |
Phenols; phenol‑alcohols |
|||||||
|
(A) |
MONONUCLEAR MONOPHENOLS |
|||||||
|
VI-2907-2 |
(2) |
Cresol(s) |
(o-Cresol) (m-Cresol) (p-Cresol) |
|||||
|
(B) |
POLYNUCLEAR MONOPHENOLS |
|||||||
|
(1) |
Naphthol(s) |
(α-Naphthol) (β-Naphthol) |
||||||
|
(C) |
POLYPHENOLS |
|||||||
|
(1) |
Resorcinol |
|
||||||
|
VI-2907-3 |
(29.07) |
(C) |
(3) |
Bisphenol A |
|
|||
|
29.09 |
Ethers, ether‑alcohols, ether‑phenols, ether-alcohol-phenols, alcohol peroxides, ether peroxides, ketone peroxides (whether or not chemically defined), and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(C) |
ETHER-PHENOLS AND ETHER-ALCOHOL-PHENOLS |
|||||||
|
VI-2909-3 |
(1) |
Guaiacol |
|
|||||
|
(D) |
ALCOHOL PEROXIDES, ETHER PEROXIDES AND KETONE PEROXIDES |
|||||||
|
VI-2909-4 |
Ketone peroxides (Cyclohexanone peroxide) |
|
||||||
|
29.10 |
Epoxides, epoxyalcohols, epoxyphenols and epoxyethers, with a three-membered ring, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2910-1 |
(1) |
Oxirane |
|
|||||
|
29.11 |
Acetals and hemiacetals, whether or not with other oxygen function, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2911-1 |
(A) |
ACETALS AND HEMIACETALS |
|
|||||
|
Peroxyketals 1,1-di(tert-butylperoxy)cyclohexane |
|
|||||||
|
29.12 |
Aldehydes, whether or not with other oxygen function; cyclic polymers of aldehydes; paraformaldehyde |
|||||||
|
VI-2912-2 |
(A) |
ALDEHYDES |
|
|||||
|
VI-2912-3 |
(IV) |
(1) |
Benzaldehyde |
|
||||
|
(B) |
ALDEHYDE-ETHERS, ALDEHYDE-PHENOLS AND ALDEHYDES WITH OTHER OXYGEN FUNCTION |
|||||||
|
(4) |
Vanillin |
|
||||||
|
(C) |
CYCLIC POLYMERS OF ALDEHYDES |
|||||||
|
VI-2912-4 |
(1) |
Trioxan |
|
|||||
|
29.14 |
Ketones and quinones, whether or not with other oxygen function, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2914-2 |
(A) |
(I) |
KETONES |
|
||||
|
(8) |
Diacetyl |
|
||||||
|
(9) |
Acetylacetone |
|
||||||
|
(10) |
Acetonylacetone |
|
||||||
|
(II) |
(1) |
Camphor |
|
|||||
|
VI-2914-4 |
(29.14) |
(E) |
QUINONES |
|||||
|
(1) |
Anthraquinone |
|
||||||
|
|
(29.14) |
(F) |
|
|
QUINONE-ALCOHOLS, QUINONE-PHENOLS, QUINONE-ALDEHYDES AND OTHER OXYGEN FUNCTION QUINONES |
|||
|
(4) |
Coenzyme Q10 (ubidecarenone (INN)) |
|
||||||
|
29.15 |
Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2915-1 |
(C) |
ACID PEROXIDES |
|
|||||
|
VI-2915-5 |
(V) |
(a) |
n-Butyric acid |
|
||||
|
29.16 |
Unsaturated acyclic monocarboxylic acids, cyclic monocarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
UNSATURATED ACYCLIC MONOCARBOXYLIC ACIDS AND THEIR SALTS, ESTERS AND OTHER DERIVATIVES |
|||||||
|
VI-2916-1 |
(1) |
Acrylic acid |
|
|||||
|
(C) |
AROMATIC SATURATED MONOCARBOXYLIC ACIDS AND THEIR SALTS, ESTERS AND OTHER DERIVATIVES |
|||||||
|
VI-2916-2 |
(1) |
Benzoic acid |
|
|||||
|
(a) |
Benzoyl peroxide |
|
||||||
|
(VI-2916-2) |
(29.16) |
(C) |
(1) |
(b) |
Benzoyl chloride |
|
||
|
29.17 |
Polycarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
ACYCLIC POLYCARBOXYLIC ACIDS AND THEIR ESTERS, SALTS AND DERIVATIVES |
|||||||
|
VI-2917-1 |
(3) |
Azelaic acid |
|
|||||
|
VI-2917-2 |
(5) |
Maleic anhydride |
|
|||||
|
(C) |
AROMATIC POLYCARBOXYLIC ACIDS AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
(1) |
Phthalic anhydride |
|
||||||
|
(VI-2917-2) |
(29.17) |
(C) |
(2) |
Terephthalic acid |
|
|||
|
29.18 |
Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
CARBOXYLIC ACIDS WITH ALCOHOL FUNCTION AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
VI-2918-2 |
(3) |
Citric acid |
|
|||||
|
VI-2918-3 |
(29.18) |
(A) |
(6) |
Phenylglycolic acid |
|
|||
|
(8) |
2,2-Diphenyl-2-hydroxyacetic acid (benzilic acid) |
|
||||||
|
(B) |
CARBOXYLIC ACIDS WITH PHENOL FUNCTION AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
(VI-2918-3) |
(29.18) |
(B) |
(I) |
Salicylic acid |
|
|||
|
29.19 |
Phosphoric esters and their salts, including lactophosphates; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|
|||||
|
VI-2919-2 |
(3) |
Tributyl phosphate |
|
|||||
|
29.20 |
Esters of other inorganic acids of non-metals (excluding esters of hydrogen halides) and their salts; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
Thiophosphoric esters |
|||||||
|
VI-2920-1 |
Sodium O,O-dibutyldithiophosphates |
|
||||||
|
|
(B) |
|
|
PHOSPHITE ESTERS AND THEIR SALTS. |
|
|||
|
Dimethyl phosphite |
|
|||||||
|
VI-2920-2 |
(D) |
Nitrous and nitric esters |
||||||
|
Methyl nitrite |
|
|||||||
|
(VI-2920-2) |
(29.20) |
(D) |
Nitroglycerol |
|
||||
|
(E) |
Carbonic or peroxocarbonic esters and their salts |
|||||||
|
(1) |
Diguaiacyl carbonate |
|
||||||
|
(F) |
Silicic acid esters and their salts |
|||||||
|
Tetraethyl silicate |
|
|||||||
|
VI-2921-1 |
29.21 |
Amine-function compounds |
|
|||||
|
(A) |
ACYCLIC MONOAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
VI-2921-2 |
(4) |
Ethylamine |
CH3-CH2-NH2 |
|||||
|
(VI-2921-2) |
(29.21) |
(B) |
ACYCLIC POLYAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
VI-2921-3 |
(2) |
Hexamethylenediamine |
|
|||||
|
(D) |
AROMATIC MONOAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
(1) |
Aniline |
|
||||||
|
(2) |
Toluidine(s) |
|
||||||
|
(4) |
1-Naphtylamine |
|
||||||
|
(VI-2921-4) |
(29.21) |
(E) |
AROMATIC POLYAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
(1) |
Phenylenediamine(s) |
|
||||||
|
29.22 |
Oxygen-function amino-compounds |
|||||||
|
(A) |
AMINO-ALCOHOLS, THEIR ETHERS AND ESTERS; SALTS THEREOF |
|||||||
|
VI-2922-2 |
(1) |
Monoethanolamine |
|
|||||
|
(B) |
AMINO-NAPHTHOLS AND OTHER AMINO-PHENOLS, THEIR ETHERS AND ESTERS; SALTS THEREOF |
|||||||
|
(1) |
Aminohydroxynaphthalenesulphonic acids |
|
||||||
|
VI-2922-3 |
(29.22) |
(B) |
(a) |
Anisidine(s) |
|
|||
|
(b) |
Dianisidine(s) |
|
||||||
|
(D) |
AMINO-ACIDS AND THEIR ESTERS; SALTS THEREOF |
|||||||
|
(1) |
Lysine |
|
||||||
|
29.23 |
Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined |
|||||||
|
VI-2923-1 |
(1) |
Choline (Choline hydroxide) |
|
|||||
|
(VI-2923-1) |
(29.23) |
(2) |
Lecithin |
|
||||
|
29.24 |
Carboxyamide-function compounds; amide-function compounds of carbonic acid |
|||||||
|
(B) |
CYCLIC AMIDES |
|||||||
|
VI-2924-2 |
(1) |
(ii) |
Diethyldiphenylurea |
|
||||
|
29.25 |
Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds |
|||||||
|
(A) |
IMIDES |
|||||||
|
VI-2925-1 |
(1) |
Saccharin |
|
|||||
|
(VI-2925-1) |
(29.25) |
(B) |
IMINES |
|||||
|
(1) |
guanidine |
|
||||||
|
VI-2925-2 |
(a) |
Diphenylguanidine |
|
|||||
|
(3) |
Imino ethers |
|
||||||
|
29.26 |
Nitrile-function compounds |
|||||||
|
VI-2926-1 |
(1) |
Acrylonitrile |
|
|||||
|
(2) |
1-Cyanoguanidine |
|
||||||
|
(VI-2926-1) |
(29.26) |
(19) |
alpha-Phenylacetoacetonitrile (APAAN) |
|
||||
|
29.27 |
Diazo-, azo- or azoxy-compounds |
|||||||
|
(A) |
DIAZO-COMPOUNDS |
|||||||
|
VI-2927-1 |
(1) |
(a) |
Benzenediazonium chloride |
|
||||
|
(B) |
AZO-COMPOUNDS |
R1N = NR2 |
||||||
|
VI-2927-2 |
(C) |
AZOXY-COMPOUNDS |
R1-N2O-R2 |
|||||
|
(1) |
Azoxybenzene |
|
||||||
|
29.28 |
Organic derivatives of hydrazine or of hydroxylamine |
|||||||
|
VI-2928-1 |
(1) |
Phenylhydrazine |
|
|||||
|
(11) |
Phenylglyoxime |
|
||||||
|
29.29 |
Compounds with other nitrogen function |
|||||||
|
VI-2929-1 |
(1) |
Isocyanates |
|
|||||
|
S-Ch. X General |
ORGANO-INORGANIC COMPOUNDS, HETEROCYCLIC COMPOUNDS, NUCLEIC ACIDS AND THEIR SALTS, AND SULPHONAMIDES |
|||||||
|
(A) |
FIVE-MEMBERED RINGS |
|||||||
|
VI-2930-1 |
(1) |
(a) |
Furan |
|
||||
|
(VI-2930-1) |
(General) |
(A) |
(1) |
(b) |
Thiophen |
|
||
|
(c) |
Pyrrole |
|
||||||
|
(2) |
(a) |
Oxazole |
|
|||||
|
(a) |
Isoxazole |
|
||||||
|
(b) |
Thiazole |
|
||||||
|
(VI-2930-1) |
(General) |
(A) |
(2) |
(c) |
Imidazole |
|
||
|
(c) |
Pyrazole |
|
||||||
|
(3) |
(a) |
Furazan |
|
|||||
|
(b) |
Triazole (1,2,4-Triazole) |
|
||||||
|
(c) |
Tetrazole |
|
||||||
|
VI-2930-2 |
(General) |
(B) |
SIX-MEMBERED RINGS |
|||||
|
(1) |
(a) |
Pyran (2H-Pyran) |
|
|||||
|
(b) |
Thiin |
|
||||||
|
(c) |
Pyridine |
|
||||||
|
(2) |
(a) |
Oxazine (1,4-Oxazine) |
|
|||||
|
(b) |
Thiazine (1,4-Thiazine) |
|
||||||
|
(VI-2930-2) |
(General) |
(B) |
(2) |
(c) |
Pyridazine |
|
||
|
(c) |
Pyrimidine |
|
||||||
|
(c) |
Pyrazine |
|
||||||
|
(c) |
Piperazine |
|
||||||
|
(C) |
OTHER MORE COMPLEX HETEROCYCLIC COMPOUNDS |
|||||||
|
(a) |
Coumarone |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(b) |
Benzopyran |
|
|||
|
(c) |
Xanthene |
|
||||||
|
(d) |
Indole |
|
||||||
|
(e) |
Quinoline and isoquinoline |
|
||||||
|
(f) |
Acridine |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(g) |
Benzothiophene (Thionaphthene) |
|
|||
|
(h) |
Indazole |
|
||||||
|
(ij) |
Benzimidazole |
|
||||||
|
(k) |
Phenazine |
|
||||||
|
(l) |
Phenoxazine |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(m) |
Benzoxazole |
|
|||
|
(n) |
Carbazole |
|
||||||
|
(o) |
Quinazoline |
|
||||||
|
(p) |
Benzothiazole |
|
||||||
|
29.30 |
Organo-sulphur compounds |
Compounds with C-S bond |
||||||
|
VI-2930-3 |
(A) |
DITHIOCARBONATES (XANTHATES) |
ROC(S)SR1 R1 = Metal or an organic radical |
|||||
|
(1) |
Sodium ethyldithiocarbonate |
|
||||||
|
(VI-2930-3) |
(29.30) |
(B) |
THIOCARBAMATES, DITHIOCARBAMATES AND THIURAM SULPHIDES |
|||||
|
(2) |
Dithiocarbamates |
|
||||||
|
VI-2930-4 |
(C) |
SULPHIDES (OR THIOETHERS) |
|
|||||
|
(1) |
Methionine |
|
||||||
|
(D) |
THIOAMIDES |
|
||||||
|
(2) |
Thiocarbanilide |
|
||||||
|
29.31 |
Other organo-inorganic compounds |
|||||||
|
|
(3) |
|
|
Organo-phosphorus compounds |
Compounds with C-P bond |
|||
|
Dimethyl methylphosphonate |
|
|||||||
|
(VI-2931-1) |
(29.31) |
(4) |
Organo-silicon compounds |
Compounds with C-Si bond |
||||
|
Hexamethyldisiloxane |
|
|||||||
|
29.32 |
Heterocyclic compounds with oxygen hetero-atom(s) only |
|||||||
|
VI-2932-1 |
(A) |
Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure |
(See structure of furan against page VI-2930-1 for Sub-Chapter X (A) (1) (a)) |
|||||
|
(2) |
2-Furaldehyde |
|
||||||
|
(3) |
Furfuryl alcohol |
|
||||||
|
(5) |
Sucralose |
|
||||||
|
VI-2932-2 |
(29.32) |
(B) |
Lactones |
|
||||
|
(a) |
Coumarin |
|
||||||
|
VI-2932-3 |
(p) |
Phenolphthalein |
|
|||||
|
(C) |
Other heterocyclic compounds with oxygen hetero-atom(s) only |
|||||||
|
(5) |
Safrole |
|
||||||
|
(VI-2932-3) |
(29.32) |
(C) |
(8) |
Piperonal |
|
|||
|
VI-2932-4 |
(10) |
1-(1,3-Benzodioxol-5-yl)propan-2-one |
|
|||||
|
Ketone peroxides (exclusion) – see 29.09 |
|
|||||||
|
Example for esters (lactone) forming part of two rings (Subheading Explanatory Notes) |
|
|||||||
|
Example for dilactone (Subheading Explanatory Notes) |
|
|||||||
|
(VI-2932-4) |
(29.32) |
Internal Hemiacetals |
|
|||||
|
29.33 |
Heterocyclic compounds with nitrogen hetero-atom(s) only |
|||||||
|
VI-2933-2 |
(A) |
Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure |
(See structure of pyrazole against page VI-2930-1 for Sub-Chapter X (A) (2) (c)) |
|||||
|
(1) |
Phenazone |
|
||||||
|
(VI-2933-2) |
(29.33) |
(B) |
Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure |
(See structure of imidazole against page VI-2930-1 for Sub-Chapter X (A) (2) (c)) |
||||
|
(1) |
Hydantoin |
|
||||||
|
VI-2933-3 |
(C) |
Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure |
(See structure of pyridine against page VI-2930-2 for Sub-Chapter X (B) (1) (c)) |
|||||
|
VI-2933-4 |
(D) |
Compounds containing a quinoline or isoquiniline ring-system (whether or not hydrogenated), not further fused |
(See structures of quinoline and isoquinoline against page VI-2930-2 for Sub-Chapter X (C) (e)) |
|||||
|
(4) |
Tetrahydromethylquinoline (5,6,7,8-Tetrahydromethylquinoline) |
|
||||||
|
(E) |
Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure |
(See structure of pyrimidine against page VI-2930-2 for Sub-Chapter X (B) (2) (c)) |
||||||
|
(1) |
Malonylurea (Barbituric acid) |
|
||||||
|
VI-2933-5 |
(29.33) |
(F) |
Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure |
|
||||
|
(1) |
Melamine |
|
||||||
|
(G) |
Lactams |
|
||||||
|
VI-2933-6 |
(29.33) |
(H) |
Other heterocyclic compounds with nitrogen hetero-atom(s) only |
|||||
|
(1) |
Carbazole |
|
||||||
|
(2) |
Acridine |
(See structure of acridine against page VI-2930-2 for Sub-Chapter X (C) (f)) |
||||||
|
VI-2933-7 |
Oxazepam (Subheading Explanatory Notes) |
|
||||||
|
Example for amide (lactam) forming part of two rings (Subheading Explanatory Notes) |
|
|||||||
|
29.34 |
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds |
|||||||
|
VI-2934-1 |
(A) |
Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure |
(See structure of thiazole against page VI-2930-1 for Sub-Chapter X (A) (2) (b)) |
|||||
|
(B) |
Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fused |
(See structure of benzothiazole against page VI-2930-2 for Sub-Chapter X (C) (p)) |
||||||
|
VI-2934-2 |
(C) |
Compounds containing a phenothiazine ring-system (whether or not hydrogenated), not further fused |
|
|||||
|
(D) |
Other heterocyclic compounds |
|||||||
|
(1) |
Sultones |
|
||||||
|
(a) |
Phenolsulfonephthalein |
|
||||||
|
(VI-2934-2) |
(29.34) |
(D) |
(2) |
Sultams |
|
|||
|
(4) |
Furazolidone (INN) |
|
||||||
|
VI-2935-1 |
29.35 |
Sulphonamides |
|
|||||
|
(1) |
Perfluorooctane sulphonamide |
|
||||||
|
(5) |
p-Aminobenzenesulphonamide |
|
||||||
|
29.37 |
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones |
|||||||
|
(V) |
Analogues of hormones, prostaglandins, thromboxanes and leukotrienes |
|||||||
|
VI-2937-2 |
(b) |
Gonane |
|
|||||
|
(B) |
STEROIDAL HORMONES, THEIR DERIVATIVES AND STRUCTURAL ANALOGUES |
|||||||
|
(1) |
Corticosteroid hormones |
|||||||
|
VI-2937-5 |
(a) |
Cortisone (INN) |
|
|||||
|
(VI-2937-5) |
(29.37) |
(B) |
(1) |
(b) |
Hydrocortisone (INN) |
|
||
|
VI-2937-6 |
(3) |
Oestrogens and progestogens |
||||||
|
(a) |
Progesterone (INN) |
|
||||||
|
VI-2937-8 |
List |
Androstane |
|
|||||
|
VI-2937-9 |
(29.37) |
List |
Estrone (INN) |
|
||||
|
VI-2937-12 |
Prednisolone (INN) |
|
||||||
|
Prednisone (INN) |
|
|||||||
|
VI-2937-13 |
(29.37) |
List |
Testosterone (INN) |
|
||||
|
- |
Estrane |
|
||||||
|
- |
Pregnane |
|
||||||
|
29.38 |
Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives |
|||||||
|
VI-2938-1 |
(1) |
Rutoside |
|
|||||
|
29.39 |
Vegetable alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives |
|||||||
|
(A) |
ALKALOIDS OF OPIUM AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
VI-2939-2 |
(1) |
Morphine |
|
|||||
|
(VI-2939-3) |
(29.39) |
(B) |
ALKALOIDS OF CINCHONA AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
(1) |
Quinine |
|
||||||
|
(C) |
CAFFEINE AND ITS SALTS |
|||||||
|
Caffeine |
|
|||||||
|
(VI-2939-3) |
(29.39) |
(D) |
EPHEDRINES AND THEIR SALTS |
|||||
|
(1) |
Ephedrine |
|
||||||
|
(E) |
THEOPHYLLINE AND AMINOPHYLLINE (THEOPHYLLINE-ETHYLENEDIAMINE) AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
(E) |
Theophylline |
|
||||||
|
(VI-2939-3) |
(29.39) |
(G) |
NICOTINE AND ITS SALTS |
|||||
|
Nicotine |
|
|||||||
|
VI-2939-6 |
|
|
OTHER ALKALOIDS OF NON VEGETAL ORIGIN |
|||||
|
(IJ) |
Viridicatin (fungal), histrionicotoxin (animal), coccinelline (insect), varacin (marine) and procyanine (bacterial) |
|
||||||
|
29.40 |
Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 29.37, 29.38 or 29.39 |
|||||||
|
(A) |
SUGARS, CHEMICALLY PURE |
|||||||
|
(1) |
Galactose |
|
||||||
|
(B) |
SUGAR ETHERS, SUGAR ACETALS AND SUGAR ESTERS, AND THEIR SALTS |
|||||||
|
VI-2940-2 |
(1) |
Hydroxypropyl sucrose |
|
|||||
|
29.41 |
Antibiotics |
|||||||
|
VI-2941-1 |
(1) |
Penicillins |
|
|||||
|
(VI-2941-1) |
(29.41) |
(2) |
Streptomycin |
|
||||
|
VI-2941-2 |
Streptamine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
||||||
|
(VI-2941-2) |
(29.41) |
Streptidine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||
|
Methylglucosamine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||||
|
5-deoxylyxose (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||||
|
VI-2941-1 |
(3) |
Tetracycline |
|
|||||
|
VI-2941-3 |
(29.41) |
(3) |
4-dimethylamino-naphthacene-2-carboxamide (fully hydrogenated) (constituent of the tetracycline skeleton) (Subheading Explanatory Notes) |
|
||||
|
(4) |
N-(2-hydroxy-1-methyl-2-phenethyl)acetamide (constituent of the chloramphenicol skeleton) (Subheading Explanatory Notes) |
|
||||||
|
VI-2941-1 |
(5) |
Erythromycin |
|
|||||
|
(VI-2941-3) |
(29.41) |
(5) |
13-ethyl-13-tridecanolide (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
|
||||
|
Desosamine (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
|
|||||||
|
Mycarose (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
|
|||||||
|
29.42 |
Other organic compounds |
|||||||
|
VI-2942-1 |
(1) |
Ketenes |
|
|||||
|
(2) |
Boron trifluoride complexes with diethyl ether |
|
||||||
______________________
(*) Dextromethorphan (INN) ((+)-3- methoxy-N- Methylmorphinan) is specifically excluded from thislist.
(**) Dextrophane (INN) ((+)-3-hydroxy-N-methylmorphinan) is specifically excluded from this list.
(*) Other substances not added.
(**) Natural mixtures, constituents other than alkaloids sufficiently removed, other substances not added .
WCO Trade Tools provides essential information to support your trade activity.
